
<html lang="en"     class="pb-page"  data-request-id="7abaf8ff-3e9d-481d-a533-a4ad69303ea7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-13;article:article:10.1021/acs.jmedchem.6b01755;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity" /></meta><meta name="dc.Creator" content="Li-Juan  Deng" /></meta><meta name="dc.Creator" content="Long-Hai  Wang" /></meta><meta name="dc.Creator" content="Cheng-Kang  Peng" /></meta><meta name="dc.Creator" content="Yi-Bin  Li" /></meta><meta name="dc.Creator" content="Mao-Hua  Huang" /></meta><meta name="dc.Creator" content="Min-Feng  Chen" /></meta><meta name="dc.Creator" content="Xue-Ping  Lei" /></meta><meta name="dc.Creator" content="Ming  Qi" /></meta><meta name="dc.Creator" content="Yun  Cen" /></meta><meta name="dc.Creator" content="Wen-Cai  Ye" /></meta><meta name="dc.Creator" content="Dong-Mei  Zhang" /></meta><meta name="dc.Creator" content="Wei-Min  Chen" /></meta><meta name="dc.Description" content="Bufadienolides are the major pharmacologic constituents of traditional Chinese medicine Chan’su, which is frequently used clinically for cancer treatment in China. Motivated by reducing or avoiding..." /></meta><meta name="Description" content="Bufadienolides are the major pharmacologic constituents of traditional Chinese medicine Chan’su, which is frequently used clinically for cancer treatment in China. Motivated by reducing or avoiding..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 22, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01755" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01755" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01755" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01755" /></link>
        
    
    

<title>Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01755" /></meta><meta property="og:title" content="Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0009.jpeg" /></meta><meta property="og:description" content="Bufadienolides are the major pharmacologic constituents of traditional Chinese medicine Chan’su, which is frequently used clinically for cancer treatment in China. Motivated by reducing or avoiding the cardiac toxicity of bufadienolides, we have designed, synthesized, and evaluated the fibroblast activation protein α (FAPα) activated tripeptide arenobufagin prodrugs with the purpose of improving the safety of arenobufagin (a representative bufadienolide). Among these FAPα-activated prodrugs, 3f exhibited the best hydrolytic efficiency by recombinant human FAPα (rhFAPα) and was activated in tumors. The LD50 of 3f was 6.5-fold higher than that of arenobufagin. We also observed that there are nonapparent changes in echocardiography, pathological section of cardiac muscle, and the lactate dehydrogenase activities (LDH) in 3f-treatment tumor-bearing mice, even when the dose reached 3 times the amount of parent drug arenobufagin that was used. Compound 3f also exhibits significant antitumor activity in vitro and in vivo. The improved safety profile and favorable anticancer properties of 3f warrant further studies of the potential clinical implications. Our study suggests that FAPα prodrug strategy is an effective approach for successful increasing the therapeutic window of bufadienolides." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01755"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01755">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01755&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01755&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01755&amp;href=/doi/10.1021/acs.jmedchem.6b01755" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5320-5333</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01444" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01538" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Juan++Deng">Li-Juan Deng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Long-Hai++Wang">Long-Hai Wang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Kang++Peng">Cheng-Kang Peng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Bin++Li">Yi-Bin Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mao-Hua++Huang">Mao-Hua Huang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min-Feng++Chen">Min-Feng Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xue-Ping++Lei">Xue-Ping Lei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming++Qi">Ming Qi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Cen">Yun Cen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wen-Cai++Ye">Wen-Cai Ye</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2810-1001" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong-Mei++Zhang">Dong-Mei Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei-Min++Chen">Wei-Min Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0292-7841" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div><div class="corresp-info"><strong>*</strong>W.-C.Y.: e-mail, <a href="/cdn-cgi/l/email-protection#6f0c07160a180c2f08020e0603410c0002"><span class="__cf_email__" data-cfemail="a3c0cbdac6d4c0e3c4cec2cacf8dc0ccce">[email protected]</span></a>; phone, +86 20 85221559.</div><div class="corresp-info"><strong>*</strong>D.-M.Z.: e-mail, <a href="/cdn-cgi/l/email-protection#0a6e6770626b646d3d3a3b4a6c6572676b636624696567"><span class="__cf_email__" data-cfemail="6a0e0710020b040d5d5a5b2a0c0512070b030644090507">[email protected]</span></a>; phone, +86 20 85222653.</div><div class="corresp-info"><strong>*</strong>W.-M.C.: e-mail, <a href="/cdn-cgi/l/email-protection#acd8dbc1cfc4c9c2ecc6c2d982c9c8d982cfc2"><span class="__cf_email__" data-cfemail="7703001a141f1219371d190259121302591419">[email protected]</span></a>; phone, +86 20 85224497.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01755&amp;href=/doi/10.1021%2Facs.jmedchem.6b01755" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5320–5333</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 December 2016</li><li><span class="item_label"><b>Published</b> online</span>22 June 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01755" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01755</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5320%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi-Juan%2BDeng%252C%2BLong-Hai%2BWang%252C%2BCheng-Kang%2BPeng%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b01755%26title%3DFibroblast%2BActivation%2BProtein%2B%25CE%25B1%2BActivated%2BTripeptide%2BBufadienolide%2BAntitumor%2BProdrug%2Bwith%2BReduced%2BCardiotoxicity%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5333%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01755"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1869</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01755" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li-Juan&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Long-Hai&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Cheng-Kang&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Yi-Bin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Mao-Hua&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Min-Feng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xue-Ping&quot;,&quot;last_name&quot;:&quot;Lei&quot;},{&quot;first_name&quot;:&quot;Ming&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Cen&quot;},{&quot;first_name&quot;:&quot;Wen-Cai&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Dong-Mei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Wei-Min&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5320-5333&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01755&quot;},&quot;abstract&quot;:&quot;Bufadienolides are the major pharmacologic constituents of traditional Chinese medicine Chan’su, which is frequently used clinically for cancer treatment in China. Motivated by reducing or avoiding the cardiac toxicity of bufadienolides, we have designed, synthesized, and evaluated the fibroblast activation protein α (FAPα) activated tripeptide arenobufagin prodrugs with the purpose of improving the safety of arenobufagin (a representative bufadienolide). Among these FAPα-activated prodrugs, 3f exhibited the best hydrolytic efficiency by recombinant human FAPα (rhFAPα) and was activated in tumors. The LD50 of 3f was 6.5-fold higher than that of arenobufagin. We also observed that there are nonapparent changes in echocardiography, pathological section of cardiac muscle, and the lactate dehydrogenase activities (LDH) in 3f-treatment tumor-bearing mice, even when the dose reached 3 times the amount of parent drug arenobufagin that was used. Compound 3f also exhibits significant antitumor activity in vitro and in&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01755&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01755" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01755&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01755" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01755&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01755" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01755&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01755&amp;href=/doi/10.1021/acs.jmedchem.6b01755" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01755" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01755" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01755%26sid%3Dliteratum%253Aachs%26pmid%3D28595013%26genre%3Darticle%26aulast%3DDeng%26date%3D2017%26atitle%3DFibroblast%2BActivation%2BProtein%2B%25CE%25B1%2BActivated%2BTripeptide%2BBufadienolide%2BAntitumor%2BProdrug%2Bwith%2BReduced%2BCardiotoxicity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5320%26epage%3D5333%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Bufadienolides are the major pharmacologic constituents of traditional Chinese medicine Chan’su, which is frequently used clinically for cancer treatment in China. Motivated by reducing or avoiding the cardiac toxicity of bufadienolides, we have designed, synthesized, and evaluated the fibroblast activation protein α (FAPα) activated tripeptide arenobufagin prodrugs with the purpose of improving the safety of arenobufagin (a representative bufadienolide). Among these FAPα-activated prodrugs, <b>3f</b> exhibited the best hydrolytic efficiency by recombinant human FAPα (rhFAPα) and was activated in tumors. The LD<sub>50</sub> of <b>3f</b> was 6.5-fold higher than that of arenobufagin. We also observed that there are nonapparent changes in echocardiography, pathological section of cardiac muscle, and the lactate dehydrogenase activities (LDH) in <b>3f</b>-treatment tumor-bearing mice, even when the dose reached 3 times the amount of parent drug arenobufagin that was used. Compound <b>3f</b> also exhibits significant antitumor activity in vitro and in vivo. The improved safety profile and favorable anticancer properties of <b>3f</b> warrant further studies of the potential clinical implications. Our study suggests that FAPα prodrug strategy is an effective approach for successful increasing the therapeutic window of bufadienolides.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bufadienolides, including arenobufagin, bufalin, and cinobufaginare, are C-24 steroids with a characteristic α-pyrone ring located at position C-17β.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> They are the major pharmacological constituents of traditional Chinese medicine Chan’su and several well-known Chinese patent medicines, such as Toad Venom Injection and Huachansu Injection which have been used clinically for cancer treatment in China.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Currently, many experimental and clinical studies have suggested that bufadienolides have significant antitumor activities toward different types of human cancers, such as breast cancer, non-small-cell lung cancer, liver cancer, and gastric cancer.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8">(3-8)</a> However, bufadienolides as Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitors exhibit significant cardiotoxicity, which limits their clinical usage and drug development.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> In recent years, numerous analogues of bufalin, cinobufagin, and resibufogenin have been prepared by chemical synthesis or biological transformation, and the cytotoxicities of these bufadienolide analogues have been evaluated in vitro.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16">(12-16)</a> Unfortunately, these efforts have shown little evidence of reduced toxicity or cardiotoxicity of bufadienolide analogues. Consequently, new approaches are needed to extend investigations toward reducing or relieving the cardiotoxicity of bufadienolides when used as anticancer agents.</div><div class="NLM_p">Tumor-specific protease-activated prodrugs are a promising approach to reduction of the toxicity of anticancer agents.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In this prodrug strategy, coupling of the peptides to the toxic anticancer agents is accomplished to generate a low or nontoxic prodrug, which is a specific substrate of enzymes known to be expressed in tumor tissues. This prodrug can be activated by tumor specific proteases to kill tumor cells, while it is inactive in normal tissues. Fibroblast activation protein α (FAPα) is a tumor-specific protease, which is observed on the surface of carcinoma-associated fibroblasts (CAFs) in the stroma of >90% of solid tumors that have been examined but is generally absent from adjacent normal tissues and nonmalignant tumors.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> FAPα, a type II integral membrane serine protease, is distinguished from other proteases in the dipeptidyl deptidase (DPP) subfamily, as its activity is restricted to substrates containing the N-terminal benzyloxycarbonyl blocked Gly-Pro (Z-GP).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The specific proteolytic activity and highly tumor-restricted distribution of FAPα makes it a very attractive target for the design of anticancer prodrugs.</div><div class="NLM_p">Motivated by reducing or avoiding the cardiac toxicity of bufadienolide agents, we have attempted to design and synthesize FAPα-activated bufadienolide prodrugs. Theoretically, FAPα-activated bufadienolide prodrugs are maintained in the inactive form in normal tissues including the heart but are only activated in tumors with high expression of FAPα. In this way, the cardiotoxicity induced by bufadienolides might be reduced or relieved. Previous reports have demonstrated that FAPα-activated prodrugs can result in significantly less toxicity when compared with the parent toxic compounds, including melittin, thapsigargin, and emetine.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> This further supports our hypothesis that FAPα-activated prodrugs might be an effective means with which to reduce the cardiac toxicity of bufadienolides.</div><div class="NLM_p">Arenobufagin (<b>1</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), a representative bufadienolide, exerts broad-spectrum and potent antitumor activities independent of its cardiac toxicity as reported previously by our group. We have found that arenobufagin induces apoptosis and autophagy,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> intercalates with DNA leading to cell cycle arrest,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and inhibits angiogenesis.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In this report, we describe the design and synthesis of the FAPα-activated prodrugs by conjugating arenobufagin with FAPα-specific tripeptides to generate a series of prodrugs with different uncharged residues in the position of P1′ (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Among the prodrugs, we found compound <b>3f</b> could be specifically activated by recombinant human FAPα (rhFAPα) and FAPα-expressing tumor tissue. We also demonstrated that this FAPα-activated prodrug (<b>3f</b>) not only exhibits negligible cardiac toxicity at doses 3 times higher than those of arenobufagin but also maintains antitumor activity in vitro and in vivo against human breast cancer models. This FAPα prodrug strategy successfully reduces the cardiac toxicity and increases the therapeutic safety of arenobufagin, which leads to a significant benefit for the preclinical development and clinical usage of bufadienolide derivatives as cancer agents.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design strategy of FAPα-activated tripeptide arenobufagin prodrugs: (a) A; (b) V; (c) L; (d) I; (e) F; (f) W; (g) <i>p</i>-aminobenzoic acid; (h) <i>p</i>-aminophenylacetic acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Compounds Design</h3><div class="NLM_p last">FAPα has a strict preference for substrates with <span class="smallcaps smallerCapital">l</span>-Pro at P1 and Gly at P2,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> while it has broader tolerance at P1′ position of the cleavage site (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> It was demonstrated that uncharged residues are favored at the P1′ position of FAPα-specific substrates because the substrate-binding site of FAPα is surrounding by multiple tyrosine residues and some negatively charged residues.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The structure–activity relationship (SAR) analysis revealed that the 3β-OH of arenobufagin can be modified without significant influence on its antitumor activity. Thus, hydrophobic amino acids including aromatic and nonaromatic amino acids were located at P1′ positions to produce prodrugs such as Z-GP-Xaa-arenobufagin (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). To evaluate the affinities of prodrugs to FAPα, all the compounds were docked to FAPα by SYBYL-X2.1.1. The docking scores were found to range between 4.7561 and 8.0692, indicating that the prodrugs are suitable substrates of FAPα. Accordingly, we synthesized these prodrugs for further investigations.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthetic Chemistry</h3><div class="NLM_p">The synthetic route used is shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. First, an N-blocked amino acid is coupled to the 3β-OH of arenobufagin by esterification. Next, the N-terminal amino acid is deprotected using Et<sub>3</sub>SiH/PdCl<sub>2</sub> to give compound <b>2</b>. Finally, the prodrug was obtained through the condensation between the terminal amino group of compound <b>2</b> and the carboxyl group of N-Cbz-glycine-<span class="smallcaps smallerCapital">l</span>-proline. The active compounds <b>2a</b>–<b>h</b> and synthetic tripeptide arenobufagin prodrugs <b>3a</b>–<b>h</b> are shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthetic route to FAPα-activated tripeptide arenobufagin prodrugs. Reagents and conditions: (i) <i>N</i>-Cbz-amino acid, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDCI), 1-hydroxybenzotriazole (HOBt), DMAP, DCM, rt, 8–16 h; (ii) Et<sub>3</sub>SiH, PdCl<sub>2</sub>, triethanolamine (TEA), DCM, rt, 20–50 min; (iii) <i>N</i>-Cbz-Gly-<span class="smallcaps smallerCapital">l</span>-Pro, EDCI, HOBt, TEA, rt, 40–90 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of compounds <b>2a</b>–<b>h</b> and <b>3a</b>–<b>h</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Evaluation of the Hydrolytic Efficiency of Prodrugs by rhFAPα</h3><div class="NLM_p">First, we determined if the eight synthetic prodrugs <b>3a</b>–<b>h</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) can be hydrolyzed by rhFAPα to release the corresponding active forms (<b>2a</b>–<b>h</b>). After incubation with rhFAPα buffer, there was no measurable active form (<b>2g</b>) in the rhFAPα buffer treated with prodrug <b>3g</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A), indicating that <b>3g</b> was not a substrate of rhFAPα. We found that less than 40% of prodrugs <b>3b</b>–<b>3d</b> and <b>3h</b> were hydrolyzed by rhFAPα, whereas ∼80% of <b>3a</b> was hydrolyzed by rhFAPα. And more than 95% of the prodrugs <b>3e</b> and <b>3f</b> were hydrolyzed by rhFAPα. Furthermore, pretreatment of <b>3e</b> and <b>3f</b> with talabostat (TAL), a selective inhibitor of FAPα, completely blocks their hydrolysis to release <b>2e</b> or <b>2f</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B), demonstrating that <b>3e</b> and <b>3f</b> were specifically cleaved by rhFAPα. The kinetic parameters of <b>3a</b>–<b>f</b> and <b>3h</b> were also explored and were found to follow an allosteric sigmoidal model<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> consistently (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). The measured quantities <i>S</i><sub>50</sub> and <i>V</i><sub>max</sub> are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, and CL<sub>int</sub>, calculated from the ratio of <i>V</i><sub>max</sub> to <i>S</i><sub>50</sub>, was further used to compare the hydrolytic efficacy of these prodrugs. On the basis of CL<sub>int</sub> values, the enzymatic hydrolysis efficiency of these prodrugs by rhFAPα is as follows: <b>3f</b> > <b>3e</b> > <b>3a</b>> <b>3c</b> & <b>3h</b> > <b>3b</b> & <b>3d</b> > <b>3g</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), which almost agrees with the above results (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Prodrugs <b>3a</b>–<b>h</b> are hydrolyzed by rhFAPα: (A) evaluation of the hydrolytic efficiency of <b>3a</b>–<b>h</b> by rhFAPα; (B) TAL blocks the hydrolysis of <b>3e</b> and <b>3f</b>; (C) kinetic profiles for <b>3a</b>–<b>f</b> and <b>3h</b> reactions mediated by rhFAPα enzyme. Data are shown as the mean ± SEM from three independent experiments. Statistical analysis was conducted using GraphPad Prism 5 software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinetic Parameters of Prodrugs Calculated by the Allosteric Sigmoidal Model</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>max</sub> (μmol min<sup>–1</sup> mg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>S</i><sub>50</sub> (μmol/L)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> (mL min<sup>–1</sup> mg<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.494</td><td class="colsep0 rowsep0" align="char" char=".">21.26</td><td class="colsep0 rowsep0" align="char" char=".">23.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="char" char=".">34.52</td><td class="colsep0 rowsep0" align="char" char=".">1.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.042</td><td class="colsep0 rowsep0" align="char" char=".">11.92</td><td class="colsep0 rowsep0" align="char" char=".">3.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">8.82</td><td class="colsep0 rowsep0" align="char" char=".">1.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="char" char=".">0.366</td><td class="colsep0 rowsep0" align="char" char=".">8.64</td><td class="colsep0 rowsep0" align="char" char=".">42.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.682</td><td class="colsep0 rowsep0" align="char" char=".">10.36</td><td class="colsep0 rowsep0" align="char" char=".">65.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.026</td><td class="colsep0 rowsep0" align="char" char=".">3.68</td><td class="colsep0 rowsep0" align="char" char=".">7.07</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Docking Analysis</h3><div class="NLM_p">FAPα was unable to cleave <b>3g</b> when a PABA is at the P1′ site. However, FAPα was able to cleave the peptide bond between P1–P′ if the P′ site is occupied by A (<b>3a</b>), V (<b>3b</b>), L (<b>3c</b>), I (<b>3d</b>), F (<b>3e</b>), and <i>p</i>-aminophenylacetic acid (<b>3h</b>). FAPα tolerated the peptide bond between P1–P′ best if the P′ site is occupied by W (<b>3f</b>). Aggarwal et al. suggested that FAP prefers to cleave the peptide with GP in P2–P1 than A in P′1 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which is inconsistent with our data.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As the substrate of FAP hydrolysis, recombinant human collagen I is a synthetic peptide chain.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Our substrates <b>3a</b>, <b>3e</b>, and <b>3f</b> are semisynthetic peptides with a compound arenobufagin in P2′ position instead of an amino acid (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). This suggests that the component in P2′ position may affect the FAP catalytic efficiency.</div><div class="NLM_p">We performed a docking analysis in an attempt to explain the interaction of <b>3a</b>, <b>3e</b>, or <b>3f</b> with FAPα.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32-35)</a> The docking scores of <b>3a</b>, <b>3e</b>, and <b>3f</b> are 5.10, 8.0322, and 8.0692, respectively. The number of hydrogen bonds between these substrates and the residues of FAPα are <b>3a</b> < <b>3e</b>, <b>3f</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Importantly, <b>3e</b> and <b>3f</b>, when docked into the active site of FAPα characterized by the P1 of <b>3e</b> and <b>3f</b>, fit well with the cleavage site formed by five Y (Y124, Y541, Y625, Y656, and Y660), along with two E (E203 and E204) and one D (D703) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), which contributes to P1–P1′ being cleavable by FAP.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, the P1 of <b>3a</b> is apparently not in the cleavage site (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S1 in Supporting Information</a>). These results above not only provide evidence that F and W of <b>3e</b> and <b>3f</b> are better tolerated in the P1′ position than A of <b>3a</b> but also demonstrate that <b>3e</b> and <b>3f</b> have stronger binding ability to FAPα than <b>3a</b>. In addition, <b>3f</b> is predicted to form more hydrogen bonds with FAPα than <b>3e</b>, indicating that <b>3f</b> binds to FAPα more strongly than <b>3e</b>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking analysis of the interactions of <b>3a</b>, <b>3e</b>, or <b>3f</b> with FAPα. <b>3a</b> (A), <b>3e</b> (B), and <b>3f</b> (C) are docked with FAPα in a three-dimensional view (left). Red dashed lines: hydrogen bonds. Details of the interaction of <b>3a</b> (A), <b>3e</b> (B), or <b>3f</b> (C) with FAPα in a two-dimensional view (right). Black dashed lines: hydrogen bonds. Green dashed lines with dots: π interactions including π–π stacking and π–cation interactions. Green full lines: hydrophobic contacts. The FAPα structure was obtained from the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68">1Z68</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <b>3f</b> Is Mainly Activated in Tumors</h3><div class="NLM_p">As previously reported, the expression of FAPα was observed on the surface of CAFs of solid tumors.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> Here, we also observed the expression of FAPα in MDA-MB-231 xenograft tissues (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A) but not in MDA-MB-231 cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). These prodrugs were designed to be inactivated in the heart but specifically activated in tumors with FAPα expression. Since <b>3f</b> is the most readily hydrolyzed of the prodrugs <b>3a</b>–<b>h</b>, its hydrolytic efficiency in homogenates of heart and tumor from mice bearing MDA-MB-231 xenografts was further examined. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C, the concentration of the activated form (<b>2f</b>) was about 19.82 ± 0.12 μmol/L after homogenates of tumors were incubated with the prodrug (<b>3f</b>). In addition, <b>2f</b> in homogenates of tumors treated with <b>3f</b> in the presence of TAL was about 20-fold less than that of homogenates incubated with <b>3f</b> alone, suggesting that the release of <b>2f</b> in tumor tissues was FAPα-dependent.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Expression of FAPα in MDA-MB-231 xenograft tissues. Immunofluorescence analysis was conducted with anti-FAPα antibody (green). Representative figure was shown. Original magnification: 40×. Scale bar: 20 μm. (B) The FAPα plasmids and the pCMV6-Entry vector were transfected into MDA-MB-231 cells. The expression of FAPα in these MDA-MB-231 cells was tested by Western blot with the indicated antibody. β-Actin was used as a loading control. (C) <b>3f</b> was hydrolyzed by 10% FBS, 10% heat-inactivated FBS, rat serum, BMSCs, homogenates of heart and tumor. Each column represents the mean ± SEM of three independent samples. Statistical analysis was conducted using GraphPad Prism 5 software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It have been demonstrated that FAP-like activity is present multipotent bone marrow stromal cells (BMSCs)<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> and in plasma or serum of several species.<a onclick="showRef(event, 'ref24 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref24 ref38 ref39">(24, 38, 39)</a> In this present study, approximately 5.3% (1.05 ± 0.24 μmol/L), 2.6% (0.51 ± 0.14 μmol/L), 14.77% (2.93 ± 0.60 μmol/L), and 23.46% (4.65 ± 0.53 μmol/L) of active form (<b>2f</b>) was detected in rat serum, BMSCs, 10% FBS, and homogenates of heart respectively when compared with tumor homogenates (19.82 ± 0.16 μmol/L). These results suggest that <b>3f</b> is mainly hydrolyzed in tumor tissues. <b>2f</b> was activated in homogenates of heart may be due to the hydrolysis of <b>3f</b> by the small amount of blood in the heart.</div><div class="NLM_p last">Previously, it was reported that some FAP-targeting strategies which were focused on targeting BMSCs with FAP-reactive T cells or depletion of FAPα<sup>+</sup> stromal cells induced cachexia and bone toxicity.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> It is noteworthy that our FAP-activated prodrug strategy only takes advantage of FAP’s post-prolyl endopeptidase activity to activate the prodrug, and this can avoid the side effects caused by the alteration of FAP expression and enzymatic activity. Furthermore, although a small amount of prodrug <b>3f</b> is activated by BMSCs, arenobufagin, <b>2f</b>, and <b>3f</b> at the concentration of 1000 nmol/L are only marginally toxic to BMSCs in vitro (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S2A in Supporting Information</a>). The bone marrow toxicity reflected in the femur histology was not observed in <b>3f</b>-treated mice (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S3 in Supporting Information</a>). No abnormal pathological changes were observed in liver, spleen, lung, and kidney tissue morphology (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S3 in Supporting Information</a>). In addition, mice maintained normal weight gain throughout the <b>3f</b> treatment and did not show any abnormal food intake or behavior. These data indicate that prodrug <b>3f</b> with reduced cardiotoxicity may be minimally toxic to nontarget tissues.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <b>3f</b> Exhibits a Potent Antitumor Effect in Vitro</h3><div class="NLM_p">The in vitro anticancer activities of <b>3f</b> and its active form <b>2f</b> or arenobufagin were determined using an MTT assay in either FAPα-negative cells (MDA-MB-231 and MCF-7)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> or wild-type FAPα-positive cells (MDA-MB-435, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S4 in Supporting Information</a>). The prodrug <b>3f</b> exhibited cytotoxicity comparable to that of arenobufagin in all tested cell lines. In FAPα-negative cells MDA-MB-231 and MCF-7, the cytotoxicity of the prodrug was approximately 6–10 times less than that of their corresponding hydrolysis products (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In contrast, the prodrug (<b>3f</b>) exhibits cytotoxicity comparable to that of its corresponding hydrolysis product in the FAPα-positive cells, MDA-MB-435. Similar results were observed in FAPα-transfected MDA-MB-231<sup>FAPα</sup> and MDA-MB-231<sup>NC</sup> cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B and <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These results indicate that the prodrugs can be activated by FAPα.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Activities of Areonbufagin, <b>2f</b>, and <b>3f</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MDA-MB-435</th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">MDA-MB-231<sup>NC</sup></th><th class="colsep0 rowsep0" align="center">MDA-MB-231<sup>FAPα</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">arenobufagin</td><td class="colsep0 rowsep0" align="left">22.45 ± 1.21</td><td class="colsep0 rowsep0" align="left">8.88 ± 4.41</td><td class="colsep0 rowsep0" align="left">15.67 ± 1.10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="left">10.01 ± 3.68</td><td class="colsep0 rowsep0" align="left">1.06 ± 0.34</td><td class="colsep0 rowsep0" align="left">4.81 ± 0.54</td><td class="colsep0 rowsep0" align="left">5.19 ± 1.19</td><td class="colsep0 rowsep0" align="left">7.19 ± 3.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="left">10.64 ± 3.52</td><td class="colsep0 rowsep0" align="left">11.60 ± 4.03</td><td class="colsep0 rowsep0" align="left">27.00 ± 2.433</td><td class="colsep0 rowsep0" align="left">23.97 ± 2.58</td><td class="colsep0 rowsep0" align="left">11.72 ± 2.82</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are shown as the mean ± SEM from at least three independent experiments. Statistical analysis was conducted using GraphPad Prism 5 software.</p></div></div></div><div class="NLM_p last">In order to further analyze whether there is something other than FAPα activating the prodrug <b>3f</b> in the cytotoxicity assay in vitro, we determined the active form <b>2f</b> level in <b>3f</b>-treated MCF-7 and MDA-MB-231 (FAP-negative) and MDA-MB-435 (FAP-positive) cells by LC–MS. About 4.2% and 2.5% of <b>2f</b> was detected in <b>3f</b>-treated MCF-7 and MDA-MB-231 cells, respectively, whereas about 80% of <b>3f</b> was hydrolyzed into <b>2f</b> in <b>3f</b>-treated MDA-MB-435 cells, indicating that <b>3f</b> is activated selectively by FAP in the in vitro assay (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S5 in Supporting Information</a>). These results are consistent with the results of the cytotoxicity evaluation.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Acute Toxicities of <b>3f</b> and Arenobufagin</h3><div class="NLM_p last">Prior to the in vivo antitumor assay, acute toxicity tests of <b>3f</b> and arenobufagin were conducted in KM mice. A single intravenous dose of <b>3f</b> or arenobufagin at different concentrations, based on the predetermined LD<sub>0</sub> and LD<sub>100</sub> values, was administered. Toxic effects such as tachypnea, paralysis, muscle spasm, and arrhythmia are observed in all the groups, and all deaths occur less than 4 h after administration. The LD<sub>50</sub> and 95% confidence limits of <b>3f</b> are 44.036 and 40.717–49.597 μmol/kg, respectively. The corresponding LD<sub>50</sub> values for arenobufagin is 6.816 μmol/kg, and the 95% confidence limits were found to fall within the range 6.293–7.567 μmol/kg. The LD<sub>50</sub> of <b>3f</b> is 6.5-fold higher than that of arenoufagin, demonstrating that the toxicity of prodrug <b>3f</b> toward mice is much lower than that of arenobufagin. After intravenous injection with <b>3f</b> at 12 μmol/kg and arenobufagin at 4 μmol/kg for 10 days, no mice died. Consequently, 4 or 12 μmol/kg of <b>3f</b> and 4 μmol/kg of arenobufagin respectively were selected as the doses for the in vivo antitumor assay.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <b>3f</b> Exhibits Potent Antitumor Effects in Vivo</h3><div class="NLM_p">The antitumor effect of <b>3f</b> was examined in nude mice carrying an MDA-MB-231 tumor xenograft, with arenobufagin used as a reference. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A, compared with a control group, <b>3f</b> treatment showed a tumor regression effect similar to that of arenobufagin. The tumor weight of <b>3f</b>-treated (12 μmol/kg) group was 0.43 ± 0.18 g, which is much lower than that in the control group (0.67 ± 0.14 g) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). We found that bufadienolide <b>3f</b> at the concentrations of 4 and 12 μmol kg<sup>–1</sup> day<sup>–1</sup> failed to produce a dose-dependent in vivo antitumor activity. We think that this may be associated with the anticancer characteristics of bufadienolide (<b>2f</b>) and arenobufagin. We have found that <b>2f</b> and arenobufagin at a concentration of 62.5–500 nmol/L did not show a dose-dependent antitumor effect in MDA-MB-231 cells in vitro (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S2B in Supporting Information</a>). Nevertheless, the reasons for the phenomenon may be complex, and we intend to investigate it further in the future.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Anticancer activity of <b>3f</b> and arenobufagin in a MDA-MB-231 xenograft model. (A) Growth curves of subcutaneous xenografts of MDA-MB-231 (<i>n</i> = 6). (B) Tumor weights of MDA-MB-231 xenografts. (C) Stable body weight curves of treated mice (<i>n</i> = 6). (D) IHC was conducted with anti-Ki67 antibody. Representative figures of the Ki67 staining are shown (left), and quantitation of Ki67 indices was calculated using Image-Pro Plus 6.0 software (right). (E) IHC was conducted with Tunel staining. These stained mice tissue sections were examined by a pathologist who was blind to the treatment conditions. Representative figures were shown (left), and quantitation of apoptotic cells (%) was calculated using Image-Pro Plus 6.0 software (right). Original magnification: 40×. Scale bar: 100 μm. Each column represents the mean ± SEM (<i>n</i> = 6). Statistical analysis was conducted using GraphPad Prism 5 software with a one-way ANOVA with post hoc comparisons and Tukey’s test: (∗) <i>P</i> < 0.05 versus the 5% Solutol-HS15 (HS15) control; (∗∗) <i>P</i> < 0.01 versus the 5% Solutol-HS15 (HS15) control; (∗∗∗) <i>P</i> < 0.001 versus the 5% Solutol-HS15 (HS15) control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Ki67 staining was utilized to determine the effect of the FAPα prodrug <b>3f</b> on tumor proliferation, and as expected, in the <b>3f</b>- or arenobufagin-treated groups, Ki67-positive cells were reduced by 45–50% when compared with the control group (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D). In addition, TUNEL-positive nuclei were observed ∼5 times more clearly in tumors treated with prodrug <b>3f</b> when compared with those from the control group (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>E). These results demonstrate a remarkable increase of apoptotic cells in the <b>3f</b>-treated mice.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Effects of <b>3f</b> and Arenobufagin on Cardiac Function in Vivo</h3><div class="NLM_p">The cardiac function of mice was recorded by transthoracic echocardiography. As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A, the interventricular septal dimension in systole (IVSs) and the interventricular septal dimension in diastole (IVSd) increased remarkably in the arenobufagin-treated group and the left ventricular internal dimension in systole (LVIDs) and left ventricular internal dimension in diastole (LVIDd) decreased. There were no apparent changes in echocardiography after treatment with <b>3f</b>. Furthermore, pathological analysis demonstrated that the cardiac muscle in mice treated with arenobufagin presented extensive cytoplasmic vacuolization, whereas almost no vacuolization was observed in <b>3f</b>-treated group (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B). Lactate dehydrogenase (LDH) being the main biochemical marker of myocardial damage, the activities of LDH in serum were determined. As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>C, the activities of LDH were significantly increased in the arenobufagin-treated group, while the activities of LDH were unchanged in the <b>3f-</b>treated group. We also detected that the concentration of the activated form <b>2f</b> was approximately 30-fold less than the prodrug <b>3f</b> in heart tissues (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">Figure S6 in Supporting Information</a>), demonstrating that a very small amount of the prodrug <b>3f</b> was activated by some other process in serum or heart in vivo. This result explains why the FAP-activated prodrug <b>3f</b> might possess a reduced cardiotoxicity in tumor-bearing mice, even when the dose reaches 3 times that of arenobufagin.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of <b>3f</b> and arenobufagin on cardiac function in the left ventricles of MDA-MB-231 tumor-bearing mice. (A) Analysis of cardiac morphology and function of mice by echocardiography after 22 days drug administration. Representative figures for echocardiography (top) and LVIDd, LVIDs, IVSd, and IVSs were calculated (<i>n</i> = 6) (bottom). (B) Representative images of morphological changes of myocardial cells observed by HE staining. Original magnification: 40×. Scale bar: 100 μm. (C) Effect of <b>3f</b> and arenobufagin on serum levels of LDH. Each column represents the mean ± SEM. Statistical analysis was conducted using GraphPad Prism 5 software with a one-way ANOVA with post hoc comparisons and Tukey’s test: (∗) <i>P</i> < 0.05 versus the 5% HS15 control; (#) <i>P</i> < 0.05 versus the arenobufagin group alone (<i>n</i> = 6). These stained mice tissue sections were examined by a pathologist who was blind to the treatment conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, we report on the design and synthesis of FAPα-activated prodrugs designed to overcome the cardiotoxicity of arenobufagin. It is clearly demonstrated that the arenobufagin analog (<b>3f</b>) is activated by rhFAPα and FAPα, enzymes that are expressed in tumor tissues. We also provide evidence that the prodrug <b>3f</b> shows obvious reduced cardiac toxicity and exhibits significant antitumor activity in vitro and in vivo. The improved safety profile and favorable anticancer druglike properties of <b>3f</b> warrant further studies of <b>3f</b> as a drug candidate for cancer treatment. Our study suggests that FAPα prodrug strategy successfully increases the therapeutic window of bufadienolides and enhances the clinical benefit of bufadienolide derivatives. We also hope that this strategy could also be applied to the relief of the cardiac toxicity of the chemotherapeutic drugs frequently used in clinic. Further studies will be directed toward four interesting issues: (1) whether <b>3f</b> is FAPα-selectively activated in vivo by developing a FAPα knockout transgenic mouse model; (2) how to increase the specificity and selectivity of bufadienolide prodrugs for FAPα by structural modification; (3) why the similar antitumor efficacy at different doses of bufadienolides or prodrugs (<b>3f</b>) failed to produce a dose-dependent in vivo antitumor activity; (4) exploring the effectiveness of FAP-activated arenobufagin in steroidogenesis and immune systems.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Docking Analysis</h3><div class="NLM_p last">The FAPα structure was obtained from the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68">1Z68</a>). Docking experiments were performed by SYBYL-X2.1.1 to give the three-dimensional diagrams, and the details of ligand–protein interaction were performed by PoseView giving two-dimensional diagrams.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32-35)</a> Authors will release the atomic coordinates and experimental data upon article publication.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of Compounds</h3><div class="NLM_p"><i>Method A.</i> Arenobufagin, 4-dimethylaminopyridine, EDCI, HOBt, and <i>N</i>-Cbz-amino acid in anhydrous DCM were stirred under nitrogen gas at room temperature. After the reaction, monitored by TLC, was terminated, brine was added. The organic phase was then separated and washed with brine and 5% NaHCO<sub>3</sub>. Finally, the organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to obtain a residue, which was purified by flash column chromatography to yield compound <b>1</b>.</div><div class="NLM_p"><i>Method B.</i> The solution of Et<sub>3</sub>SiH in 1 mL of anhydrous DCM was added dropwise to a stirred solution of compound <b>1</b>, PdCl<sub>2</sub>, and TEA in anhydrous DCM under nitrogen at room temperature. Gas evolution was observed, and the mixture slowly turned black. The reaction was monitored by TLC and terminated after 20–50 min. The mixture was filtered through diatomite and extracted with DCM. The DCM layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to obtain a residue. The residue was then purified by flash column chromatography to yield compound <b>2</b>.</div><div class="NLM_p"><i>Method C.</i> Compound <b>2</b>, Z-Gly-Pro, EDCI, HOBt, and TEA were added to anhydrous DCM, and the mixture was stirred under nitrogen at room temperature. Brine was added after the reaction, monitored by TLC was complete. The organic phase was washed with brine and 5% NaHCO<sub>3</sub> and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The organic was finally concentrated to obtain a residue, which was purified by flash column chromatography to yield compound <b>3</b>. The purity of all biologically evaluated compounds <b>2a</b>–<b>h</b> and <b>3a</b>–<b>h</b> determined by HPLC is >95%.</div><div class="NLM_p"><b>1a</b>. Synthesis of compound <b>1a</b> with method A yielded a white foamy solid. Yield, 88%; mp 107–110 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.76 (dd, <i>J</i> = 9.6, 1.7 Hz, 1H), 7.40 (s, 1H), 7.35 (s, 6H), 6.27 (d, <i>J</i> = 9.7 Hz, 1H), 5.47 (d, <i>J</i> = 7.5 Hz, 1H), 5.11 (s, 3H), 4.36 (dd, <i>J</i> = 19.0, 9.2 Hz, 2H), 4.14–4.05 (m, 1H), 3.86 (s, 1H), 3.47 (s, 2H), 2.45 (d, <i>J</i> = 13.7 Hz, 1H), 2.13–1.99 (m, 2H), 1.97–1.63 (m, 10H), 1.55 (d, <i>J</i> = 7.1 Hz, 1H), 1.49 (s, 1H), 1.43 (d, <i>J</i> = 7.1 Hz, 5H), 1.33 (d, <i>J</i> = 8.5 Hz, 5H), 1.18 (s, 3H), 0.91 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.77, 172.39, 162.36, 155.70, 150.09, 146.96, 136.20, 128.56, 128.21, 128.05, 120.92, 115.52, 85.44, 73.30, 71.94, 66.90, 61.97, 50.70, 49.89, 40.80, 40.75, 39.43, 38.61, 36.75, 32.76, 32.65, 30.64, 28.02, 26.30, 25.53, 23.44, 21.58, 18.82, 17.51. ESI-MS (<i>m</i>/<i>z</i>): 622.3 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 622.3011 [M + H]<sup>+</sup>; calcd for C<sub>35</sub>H<sub>43</sub>NO<sub>9</sub> 622.3011.</div><div class="NLM_p"><b>1b</b>. Synthesis of compound <b>1b</b> with method A yielded a white foamy solid. Yield, 90%; mp 226–228 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.76 (d, <i>J</i> = 9.7, 2.5 Hz, 1H), 7.40 (s, 1H), 7.32 (d, <i>J</i> = 19.6 Hz, 5H), 6.27 (d, <i>J</i> = 9.3 Hz, 1H), 5.38 (d, <i>J</i> = 8.2 Hz, 1H), 5.11 (s, 3H), 4.33 (d, <i>J</i> = 9.4 Hz, 2H), 4.10 (s, 1H), 3.86 (s, 1H), 2.63 (s, 1H), 2.46 (d, <i>J</i> = 13.1 Hz, 1H), 2.19 (s, 1H), 2.14–2.00 (m, 3H), 1.96–1.57 (m, 10H), 1.40 (dd, <i>J</i> = 39.4, 11.4 Hz, 6H), 1.18 (s, 3H), 0.98 (s, 4H), 0.91 (s, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.75, 171.43, 162.33, 156.34, 150.10, 146.95, 136.20, 128.57, 128.24, 128.07, 120.90, 115.53, 85.46, 73.31, 71.86, 67.03, 61.97, 59.15, 40.79, 39.43, 38.75, 36.76, 32.75, 31.43, 30.75, 28.03, 26.27, 25.61, 23.48, 21.57, 19.01, 17.52, 17.41. ESI-MS (<i>m</i>/<i>z</i>): 650.3 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 650.3324 [M + H]<sup>+</sup>; calcd for C<sub>37</sub>H<sub>48</sub>NO<sub>9</sub> 650.3244.</div><div class="NLM_p"><b>1c</b>. Synthesis of compound <b>1c</b> with method A yielded a white foamy solid. Yield, 91%; mp 95–97 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.75 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 7.41 (d, <i>J</i> = 1.7 Hz, 1H), 7.34 (d, <i>J</i> = 11.5 Hz, 5H), 6.28 (d, <i>J</i> = 9.7 Hz, 1H), 5.25 (d, <i>J</i> = 8.6 Hz, 1H), 5.09 (d, <i>J</i> = 13.3 Hz, 3H), 4.43–4.29 (m, 2H), 4.11 (dd, <i>J</i> = 9.3, 7.2 Hz, 1H), 3.85 (d, <i>J</i> = 3.5 Hz, 1H), 2.48 (s, 1H), 2.44 (s, 1H), 2.18 (s, 1H), 2.14–2.00 (m, 2H), 2.01–1.23 (m, 20H), 1.16 (d, <i>J</i> = 11.3 Hz, 3H), 0.97 (d, <i>J</i> = 5.0 Hz, 6H), 0.92 (s, 3H), 0.88 (d, <i>J</i> = 2.0 Hz, 1H), 0.86 (s, 1H), 0.84 (s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.71, 172.44, 162.26, 155.97, 150.10, 146.83, 136.19, 128.56, 128.22, 128.07, 120.80, 115.59, 85.50, 73.32, 71.78, 66.98, 61.92, 52.82, 41.89, 40.80, 40.75, 39.48, 38.67, 36.74, 32.81, 32.69, 31.59, 30.66, 28.01, 26.25, 25.56, 24.86, 23.48, 22.76, 22.12, 21.57, 17.51. ESI-MS (<i>m</i>/<i>z</i>): 664.6 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 644.3484 [M + H]<sup>+</sup>; calcd for C<sub>38</sub>H<sub>50</sub>NO<sub>9</sub> 644.3480.</div><div class="NLM_p"><b>1d</b>. Synthesis of compound <b>1d</b> with method A yielded a white foamy solid. Yield, 89%; mp 104–106 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.73 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.39 (d, <i>J</i> = 1.7 Hz, 1H), 7.38–7.27 (m, 5H), 6.27 (d, <i>J</i> = 9.7 Hz, 1H), 5.33 (d, <i>J</i> = 9.1 Hz, 1H), 5.13 (s, 1H), 5.10 (s, 2H), 4.34 (dd, <i>J</i> = 14.1, 7.7 Hz, 2H), 4.14–4.06 (m, 1H), 2.46 (d, <i>J</i> = 14.1 Hz, 1H), 2.31 (s, 1H), 2.16 (d, <i>J</i> = 4.2 Hz, 1H), 2.05 (t, <i>J</i> = 10.8 Hz, 2H), 1.93 (s, 1H), 1.88 (s, 2H), 1.81 (d, <i>J</i> = 9.6 Hz, 1H), 1.79–1.60 (m, 6H), 1.46 (d, <i>J</i> = 14.0 Hz, 1H), 1.41–1.29 (m, 4H), 1.29–1.21 (m, 3H), 1.18 (s, 3H), 1.00–0.93 (m, 4H), 0.91 (s, 3H), 0.85 (dd, <i>J</i> = 8.1, 5.1 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.65, 171.37, 162.19, 156.19, 150.10, 146.70, 136.22, 128.57, 128.23, 128.11, 120.70, 115.64, 85.53, 73.31, 71.80, 67.02, 61.89, 58.46, 40.81, 40.76, 39.53, 38.77, 38.22, 36.75, 32.84, 32.75, 30.75, 29.27, 27.99, 26.21, 24.97, 23.50, 21.57, 17.50, 15.59, 11.75. ESI-MS (<i>m</i>/<i>z</i>): 664.6 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 664.3485 [M + H]<sup>+</sup>; calcd for C<sub>38</sub>H<sub>50</sub>NO<sub>9</sub> 664.3480.</div><div class="NLM_p"><b>1e</b>. Synthesis of compound <b>1e</b> with method A yielded a white foamy solid. Yield, 86%; mp 118–120 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.75 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 7.37 (t, <i>J</i> = 2.8 Hz, 1H), 7.35–7.27 (m, 5H), 7.23 (t, <i>J</i> = 7.2 Hz, 3H), 7.15–7.09 (m, 2H), 6.24 (d, <i>J</i> = 9.7 Hz, 1H), 5.41 (d, <i>J</i> = 6.3 Hz, 1H), 5.06 (dd, <i>J</i> = 10.5, 5.0 Hz, 3H), 4.64 (dd, <i>J</i> = 14.2, 6.6 Hz, 1H), 4.28 (dd, <i>J</i> = 10.9, 2.4 Hz, 1H), 4.14–4.01 (m, 2H), 3.83 (d, <i>J</i> = 3.1 Hz, 1H), 3.19–2.98 (m, 2H), 2.79 (s, 1H), 2.34 (t, <i>J</i> = 14.2 Hz, 1H), 2.11–1.94 (m, 4H), 2.05–1.98 (m, 3H), 1.92–1.44 (m, 9H), 1.46–1.15 (m, 8H), 1.09 (s, 3H), 0.88 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.80, 171.34, 171.12, 162.40, 155.71, 150.09, 147.04, 136.17, 135.90, 129.23, 128.57, 128.25, 128.07, 127.06, 120.98, 115.49, 85.43, 73.28, 72.11, 66.98, 61.99, 60.48, 55.01, 40.78, 40.71, 39.36, 38.64, 38.34, 36.67, 32.71, 32.62, 30.57, 28.04, 26.31, 25.55, 23.32, 21.10, 17.52. ESI-MS (<i>m</i>/<i>z</i>): 698.3 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 698.3324 [M + H]<sup>+</sup>; calcd for C<sub>41</sub>H<sub>48</sub>NO<sub>9</sub> 698.3324.</div><div class="NLM_p"><b>1f</b>. Synthesis of compound <b>1f</b> with method A yielded a white foamy solid. Yield, 90%; mp 138–140 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H), 7.72 (dd, <i>J</i> = 9.7, 2.5 Hz, 1H), 7.57 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 1.7 Hz, 1H), 7.36–7.27 (m, 6H), 7.20–7.04 (m, 2H), 6.95 (d, <i>J</i> = 1.9 Hz, 1H), 6.25 (d, <i>J</i> = 9.7 Hz, 1H), 5.46 (d, <i>J</i> = 8.2 Hz, 1H), 5.11 (s, 1H), 5.09 (s, 1H), 5.01 (s, 1H), 4.75 (dd, <i>J</i> = 13.9, 6.1 Hz, 1H), 4.25 (dd, <i>J</i> = 11.0, 3.3 Hz, 1H), 3.81 (d, <i>J</i> = 3.5 Hz, 1H), 3.33–3.25 (m, 1H), 2.53 (s, 1H), 2.31 (t, <i>J</i> = 11.9 Hz, 1H), 2.17 (s, 1H), 2.10–1.90 (m, 3H), 0.99 (s, 3H), 0.86 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.75, 171.61, 162.46, 155.89, 150.12, 147.02, 136.22, 128.58, 128.25, 128.11, 127.55, 122.74, 122.18, 120.96, 119.61, 118.70, 115.52, 111.33, 109.93, 85.46, 73.28, 71.93, 66.98, 61.92, 54.69, 40.77, 40.67, 39.38, 38.19, 36.55, 32.72, 32.51, 30.51, 28.54, 28.01, 26.18, 25.47, 23.21, 21.54, 17.47. ESI-MS (<i>m</i>/<i>z</i>): 737.7 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 737.3433 [M + H]<sup>+</sup>; calcd for C<sub>43</sub>H<sub>49</sub>N<sub>2</sub>O<sub>9</sub> 737.3433.</div><div class="NLM_p"><b>1g</b>. Synthesis of compound <b>1g</b> with method A yielded a white foamy solid. Yield, 60%; mp 215–217 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.99 (d, <i>J</i> = 8.7 Hz, 2H), 7.73 (dd, <i>J</i> = 9.7, 2.5 Hz, 1H), 7.48 (d, <i>J</i> = 8.7 Hz, 2H), 7.43–7.32 (m, 6H), 7.18 (s, 1H), 6.26 (d, <i>J</i> = 9.7 Hz, 1H), 5.29 (s, 1H), 5.21 (s, 2H), 4.34 (d, <i>J</i> = 11.0 Hz, 1H), 4.10 (dd, <i>J</i> = 9.3, 7.0 Hz, 1H), 3.86 (s, 1H), 2.51 (d, <i>J</i> = 13.8 Hz, 1H), 2.07 (ddd, <i>J</i> = 12.7, 10.4, 3.4 Hz, 3H), 1.95 (s, 1H), 1.86 (t, <i>J</i> = 9.5 Hz, 4H), 1.76 (dd, <i>J</i> = 15.5, 12.0 Hz, 5H), 1.61 (d, <i>J</i> = 7.5 Hz, 1H), 1.57–1.46 (m, 1H), 1.45–1.29 (m, 4H), 1.22 (s, 3H), 0.92 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.83, 165.66, 162.38, 153.09, 150.19, 146.88, 142.23, 135.78, 130.95, 128.78, 128.62, 128.46, 125.75, 120.88, 117.75, 115.71, 85.67, 73.49, 70.97, 67.43, 62.01, 40.93, 40.91, 39.68, 38.95, 36.99, 33.05, 31.00, 29.80, 28.11, 26.42, 25.94, 23.66, 21.75, 17.61. ESI-MS (<i>m</i>/<i>z</i>): 692.5 [M + Na]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 670.2977 [M + H]<sup>+</sup>; calcd for C<sub>39</sub>H<sub>44</sub>NO<sub>9</sub> 670.3011.</div><div class="NLM_p"><b>1h</b>. Synthesis of compound <b>1h</b> with method A yielded a white foamy solid. Yield, 83%; mp 125–126 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 7.42–7.29 (m, 8H), 7.20 (d, <i>J</i> = 8.5 Hz, 2H), 6.96 (s, 1H), 6.25 (d, <i>J</i> = 9.7 Hz, 1H), 5.18 (s, 2H), 5.04 (s, 1H), 4.30 (t, <i>J</i> = 9.5 Hz, 1H), 4.07 (dd, <i>J</i> = 9.4, 7.1 Hz, 1H), 3.55 (s, 2H), 2.36 (d, <i>J</i> = 13.8 Hz, 1H), 2.04 (dd, <i>J</i> = 20.8, 9.0 Hz, 3H), 1.90–1.77 (m, 3H), 1.73 (dd, <i>J</i> = 11.4, 7.9 Hz, 4H), 1.66–1.55 (m, 3H), 1.42 (d, <i>J</i> = 3.8 Hz, 1H), 1.38–1.17 (m, 6H), 1.11 (s, 3H), 0.88 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.84, 171.25, 162.35, 153.50, 150.16, 146.90, 136.91, 136.12, 129.94, 129.55, 128.69, 128.43, 128.32, 120.89, 118.87, 115.63, 85.58, 73.44, 71.08, 67.07, 61.99, 41.38, 40.92, 40.81, 39.60, 38.48, 36.79, 32.89, 32.62, 30.73, 28.08, 26.31, 25.63, 23.45, 21.65, 17.57. ESI-MS (<i>m</i>/<i>z</i>): 706.5 [M + Na]<sup>+</sup>, 701.4 [M + NH<sub>4</sub>]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 684.3168 [M + H]<sup>+</sup>; calcd for C<sub>40</sub>H<sub>46</sub>NO<sub>9</sub> 684.3167.</div><div class="NLM_p"><b>2a</b>. Synthesis of compound <b>2a</b> with method B yielded a white foamy solid. Yield, 85%; mp 117–119 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.71 (dd, <i>J</i> = 9.7, 2.6 Hz, 1H), 7.39 (d, <i>J</i> = 1.8 Hz, 1H), 6.28 (d, <i>J</i> = 9.8 Hz, 1H), 5.09 (s, 1H), 4.32 (d, <i>J</i> = 11.1 Hz, 1H), 4.15–4.06 (m, 1H), 3.56 (dd, <i>J</i> = 13.7, 6.6 Hz, 1H), 2.45 (dt, <i>J</i> = 14.7, 2.7 Hz, 1H), 2.11–1.93 (m, 3H), 1.92–1.59 (m, 11H), 1.53–1.28 (m, 7H), 1.25 (s, 2H), 1.19 (s, 1H), 0.92 (s, 3H), 0.88(s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.71, 162.16, 150.21, 146.56, 120.60, 115.89, 85.75, 73.45, 71.09, 61.93, 50.37, 40.95, 40.87, 39.78, 38.76, 36.91, 33.07, 32.86, 30.85, 29.83, 28.08, 26.40, 25.74, 23.58, 21.75, 20.93, 17.61. ESI-MS (<i>m</i>/<i>z</i>): 488.2 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 488.2643 [M + H]<sup>+</sup>; calcd for C<sub>27</sub>H<sub>38</sub>NO<sub>7</sub> 488.2643.</div><div class="NLM_p"><b>2b</b>. Synthesis of compound <b>2b</b> with method B yielded a white foamy solid. Yield, 86%; mp 75–76 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.76 (dd, <i>J</i> = 9.7, 2.4 Hz, 1H), 7.36 (d, <i>J</i> = 1.5 Hz, 1H), 6.21 (d, <i>J</i> = 9.7 Hz, 1H), 5.07 (s, 1H), 4.27 (d, <i>J</i> = 11.0 Hz, 1H), 4.05 (dd, <i>J</i> = 21.7, 14.3 Hz, 1H), 3.36 (s, 5H), 3.07 (q, <i>J</i> = 7.3 Hz, 2H), 2.38 (d, <i>J</i> = 13.7 Hz, 1H), 2.15–1.48 (m, 10H), 1.30–1.16 (m, 6H), 1.13 (s, 3H), 0.99–0.91 (m, 3H), 0.87 (d, <i>J</i> = 2.7 Hz, 6H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.94, 173.65, 162.48, 149.98, 147.25, 121.13, 115.33, 85.16, 73.21, 71.53, 62.08, 59.41, 40.72, 40.66, 39.20, 38.76, 36.72, 32.74, 32.55, 31.75, 30.72, 28.05, 26.25, 25.58, 23.45, 21.51, 18.94, 17.58, 17.26. ESI-MS (<i>m</i>/<i>z</i>): 516.3 [M + H]<sup>+</sup>, 560.5 [M + HCOO]<sup>−</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 516.2956 [M + H]<sup>+</sup>; calcd for C<sub>29</sub>H<sub>42</sub>NO<sub>7</sub> 516.2956.</div><div class="NLM_p"><b>2c</b>. Synthesis of compound <b>2c</b> with method B yielded a white foamy solid. Yield, 82%; mp 116–119 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.39 (s, 1H), 6.28 (d, <i>J</i> = 9.7 Hz, 1H), 5.09 (s, 1H), 4.32 (d, <i>J</i> = 11.2 Hz, 1H), 4.08 (d, <i>J</i> = 7.4 Hz, 1H), 3.46 (s, 1H), 2.45 (d, <i>J</i> = 13.2 Hz, 2H), 2.04 (dd, <i>J</i> = 37.1, 27.5 Hz, 6H), 1.76 (d, <i>J</i> = 9.4 Hz, 18H), 1.59–1.22 (m, 14H), 1.18 (s, 4H), 0.96 (s, 1H), 0.94 (s, 3H), 0.91 (s, 5H), 0.85 (d, <i>J</i> = 6.4 Hz, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.75, 176.12, 162.21, 150.24, 146.68, 120.70, 115.81, 85.71, 73.47, 71.00, 61.98, 53.26, 44.51, 40.98, 40.89, 39.75, 38.85, 36.90, 33.03, 32.89, 30.89, 28.10, 26.39, 25.77, 25.09, 23.61, 22.97, 22.30, 21.73, 17.61. ESI-MS (<i>m</i>/<i>z</i>): 530.7 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 530.3113 [M + H]<sup>+</sup>; calcd for C<sub>30</sub>H<sub>44</sub>NO<sub>7</sub> 530,3112.</div><div class="NLM_p"><b>2d</b>. Synthesis of compound <b>2d</b> with method B yielded a white foamy solid. Yield, 90%; mp 97–100 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.39 (d, <i>J</i> = 1.8 Hz, 1H), 6.28 (d, <i>J</i> = 9.7 Hz, 1H), 5.12 (s, 1H), 4.32 (d, <i>J</i> = 11.1 Hz, 1H), 4.10 (dd, <i>J</i> = 9.6, 7.2 Hz, 1H), 3.37 (d, <i>J</i> = 4.7 Hz, 1H), 2.45 (dt, <i>J</i> = 13.8, 2.7 Hz, 1H), 2.14–1.98 (m, 3H), 1.94 (d, <i>J</i> = 4.1 Hz, 1H), 1.92–1.57 (m, 16H), 1.52–1.21 (m, 10H), 1.19 (s, 3H), 0.97 (s, 2H), 0.95 (s, 2H), 0.93 (s, 1H), 0.91 (s, 3H), 0.91 (s, 2H), 0.85 (ddd, <i>J</i> = 11.3, 5.1, 2.6 Hz, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.72, 175.16, 162.22, 150.22, 146.65, 120.67, 115.84, 85.71, 73.47, 70.97, 61.96, 59.27, 40.94, 40.87, 39.74, 39.40, 38.90, 36.89, 33.03, 32.94, 30.93, 28.09, 26.33, 25.82, 24.76, 23.63, 21.71, 17.61, 15.95, 11.92. ESI-MS (<i>m</i>/<i>z</i>): 530.7 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 530.3112 [M + H]<sup>+</sup>; calcd for C<sub>30</sub>H<sub>44</sub>NO<sub>7</sub> 530.3112.</div><div class="NLM_p"><b>2e</b>. Synthesis of compound <b>2e</b> with method B yielded a white foamy solid. Yield, 78%; mp 97–99 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.76 (dd, <i>J</i> = 9.7, 2.6 Hz, 1H), 7.40 (d, <i>J</i> = 1.7 Hz, 1H), 7.35–7.14 (m, 5H), 6.27 (d, <i>J</i> = 9.7 Hz, 1H), 5.06 (s, 1H), 5.06 (s, 1H), 4.27 (dd, <i>J</i> = 17.2, 10.7 Hz, 1H), 4.08 (dt, <i>J</i> = 17.0, 8.6 Hz, 1H), 3.82–3.68 (m, 1H), 2.98 (ddd, <i>J</i> = 33.4, 13.5, 6.8 Hz, 2H), 2.39 (d, <i>J</i> = 13.8 Hz, 2H), 2.05 (dd, <i>J</i> = 20.4, 9.6 Hz, 3H), 1.92–1.54 (m, 9H), 1.51–1.16 (m, 8H), 1.12 (s, 2H), 0.90 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.82, 174.61, 162.39, 150.14, 146.99, 137.21, 129.26, 128.62, 126.87, 120.94, 115.57, 85.49, 73.35, 71.30, 61.99, 55.92, 41.53, 40.83, 40.75, 39.47, 38.41, 36.73, 32.80, 30.63, 28.09, 26.37, 25.65, 23.40, 21.62, 17.56. ESI-MS (<i>m</i>/<i>z</i>): 564.3 [M + H]<sup>+</sup>. 608.6 [M + HCOO]<sup>−</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 564.2955 [M + H]<sup>+</sup>; calcd for C<sub>33</sub>H<sub>42</sub>NO<sub>7</sub> 564.2956.</div><div class="NLM_p"><b>2f</b>. Synthesis of compound <b>2f</b> with method B yielded a light yellow foamy solid. Yield, 88%; mp 130–133 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.26 (s, 1H), 7.71 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.64 (s, 1H), 7.62 (s, 1H), 7.39 (d, <i>J</i> = 1.7 Hz, 1H), 7.37 (s, 1H), 7.34 (s, 1H), 7.22–7.03 (m, 5H), 6.27 (d, <i>J</i> = 9.6 Hz, 1H), 5.05 (s, 2H), 4.26 (t, <i>J</i> = 9.0 Hz, 2H), 4.13–4.04 (m, 1H), 3.88 (t, <i>J</i> = 6.6 Hz, 2H), 3.81 (s, 1H), 3.48 (s, 1H), 3.15 (ddd, <i>J</i> = 21.8, 14.3, 6.6 Hz, 4H), 3.02–2.93 (m, 1H), 2.35 (d, <i>J</i> = 13.8 Hz, 2H), 2.11–1.92 (m, 6H), 1.91–1.48 (m, 25H), 1.41–1.10 (m, 17H), 1.05 (s, 4H), 0.89 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.79, 175.02, 162.27, 150.21, 146.75, 136.43, 127.62, 122.83, 122.28, 120.75, 119.63, 118.90, 115.77, 111.54, 111.39, 85.65, 73.41, 71.09, 61.95, 55.25, 40.86, 39.64, 38.41, 36.68, 32.95, 32.74, 31.50, 30.71, 28.08, 26.33, 25.66, 23.38, 21.69, 17.57. ESI-MS (<i>m</i>/<i>z</i>): 603.6 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 603.3074 [M + H]<sup>+</sup>; calcd for C<sub>35</sub>H<sub>43</sub>N<sub>2</sub>O<sub>7</sub> 603.3056.</div><div class="NLM_p"><b>2g</b>. Synthesis of compound <b>2g</b> with method B yielded a white foamy solid. Yield, 83%; mp 235–237 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.82 (d, <i>J</i> = 8.5 Hz, 3H), 7.75 (dd, <i>J</i> = 9.7, 2.5 Hz, 1H), 7.38 (d, <i>J</i> = 1.9 Hz, 1H), 6.63 (d, <i>J</i> = 8.5 Hz, 3H), 6.25 (d, <i>J</i> = 9.7 Hz, 1H), 5.23 (s, 2H), 4.35–4.26 (m, 2H), 4.08 (dd, <i>J</i> = 9.0, 7.4 Hz, 1H), 2.46 (d, <i>J</i> = 13.2 Hz, 3H), 2.04 (dd, <i>J</i> = 20.9, 9.1 Hz, 4H), 1.95–1.78 (m, 8H), 1.79–1.63 (m, 9H), 1.61–1.43 (m, 5H), 1.33 (dd, <i>J</i> = 20.0, 10.1 Hz, 6H), 1.19 (s, 5H), 0.89 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.96, 166.33, 162.58, 150.95, 150.14, 147.10, 131.58, 121.08, 120.43, 115.55, 113.89, 85.40, 73.44, 70.35, 62.08, 40.89, 40.83, 39.55, 38.93, 36.95, 33.12, 32.79, 31.02, 28.12, 26.44, 25.95, 23.60, 21.66, 17.57. ESI-MS (<i>m</i>/<i>z</i>): 536.5 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 536.2649 [M + H]<sup>+</sup>; calcd for C<sub>31</sub>H<sub>38</sub>NO<sub>7</sub> 536.2643.</div><div class="NLM_p"><b>2h</b>. Synthesis of compound <b>2h</b> with method B yielded a white foamy solid. Yield, 86%; mp 85–87 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (dd, <i>J</i> = 9.7, 2.5 Hz, 1H), 7.38 (d, <i>J</i> = 1.7 Hz, 1H), 7.05 (d, <i>J</i> = 8.2 Hz, 2H), 6.63 (d, <i>J</i> = 8.2 Hz, 2H), 6.25 (d, <i>J</i> = 9.7 Hz, 1H), 5.02 (s, 1H), 4.29 (d, <i>J</i> = 11.1 Hz, 1H), 4.07 (dd, <i>J</i> = 9.3, 7.1 Hz, 1H), 3.48 (s, 2H), 2.36 (d, <i>J</i> = 13.8 Hz, 1H), 2.02 (dd, <i>J</i> = 12.2, 9.2 Hz, 2H), 1.91–1.77 (m, 3H), 1.73 (dd, <i>J</i> = 9.9, 7.0 Hz, 4H), 1.67–1.54 (m, 4H), 1.47–1.34 (m, 2H), 1.33–1.18 (m, 7H), 1.13 (s, 3H), 0.88 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.87, 171.85, 162.37, 150.16, 146.94, 130.18, 124.50, 120.92, 115.62, 115.41, 85.57, 73.48, 70.82, 62.00, 41.20, 40.90, 40.78, 39.59, 38.45, 36.79, 32.87, 32.62, 30.72, 29.77, 28.08, 26.32, 25.63, 23.44, 21.64, 17.58. ESI-MS (<i>m</i>/<i>z</i>): 548.6 [M – H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 550.2799 [M + H]<sup>+</sup>; calcd for C<sub>32</sub>H<sub>40</sub>NO<sub>7</sub> 550.2799.</div><div class="NLM_p"><b>3a</b>. Synthesis of compound <b>3a</b> with method C yielded a white foamy solid. Yield, 80%; mp 135–136 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.74 (dd, <i>J</i> = 9.8, 2.5 Hz, 1H), 7.39 (d, <i>J</i> = 1.7 Hz, 1H), 7.36–7.29 (m, 5H), 7.22 (d, <i>J</i> = 7.2 Hz, 1H), 6.26 (d, <i>J</i> = 9.6 Hz, 1H), 5.82 (d, <i>J</i> = 4.0 Hz, 1H), 5.09 (d, <i>J</i> = 7.5 Hz, 3H), 4.53 (d, <i>J</i> = 7.9 Hz, 1H), 4.45 (t, <i>J</i> = 7.2 Hz, 1H), 4.30 (d, <i>J</i> = 11.0 Hz, 1H), 4.15–4.04 (m, 2H), 4.01 (t, <i>J</i> = 4.0 Hz, 1H), 3.57 (dd, <i>J</i> = 16.5, 8.2 Hz, 1H), 3.40 (dd, <i>J</i> = 16.3, 8.6 Hz, 1H), 2.43 (d, <i>J</i> = 13.9 Hz, 1H), 2.34–2.21 (m, 1H), 2.03 (s, 3H), 2.00–1.53 (m, 12H), 1.50–1.21 (m, 12H), 1.16 (s, 3H), 0.89 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.81, 172.09, 170.56, 168.09, 162.28, 156.28, 150.07, 146.93, 136.32, 128.50, 128.13, 128.01, 120.88, 115.51, 85.40, 73.30, 71.82, 66.93, 61.98, 60.44, 60.13, 48.59, 46.38, 43.46, 40.78, 40.70, 39.39, 38.57, 36.74, 32.73, 30.61, 28.01, 27.89, 26.29, 25.52, 24.84, 23.40, 21.08, 18.19, 17.52, 14.19. ESI-MS (<i>m</i>/<i>z</i>): 776.8 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 776.3754 [M + H]<sup>+</sup>; calcd for C<sub>42</sub>H<sub>54</sub>N<sub>3</sub>O<sub>11</sub> 776.3753.</div><div class="NLM_p"><b>3b</b>. Synthesis of compound <b>3b</b> with method C yielded a white foamy solid. Yield, 79%; mp 123–125 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.39 (d, <i>J</i> = 1.7 Hz, 1H), 7.37–7.28 (m, 5H), 7.21 (d, <i>J</i> = 8.6 Hz, 1H), 6.28 (d, <i>J</i> = 9.7 Hz, 1H), 5.78 (s, 1H), 5.10 (d, <i>J</i> = 6.0 Hz, 3H), 4.59 (d, <i>J</i> = 6.3 Hz, 1H), 4.44 (dd, <i>J</i> = 8.5, 4.6 Hz, 1H), 4.31 (d, <i>J</i> = 11.0 Hz, 1H), 4.09 (dd, <i>J</i> = 12.2, 5.1 Hz, 2H), 4.02 (d, <i>J</i> = 9.7 Hz, 1H), 3.56 (t, <i>J</i> = 7.4 Hz, 1H), 3.42 (dd, <i>J</i> = 16.6, 9.0 Hz, 1H), 2.44 (d, <i>J</i> = 13.8 Hz, 1H), 2.32 (d, <i>J</i> = 9.3 Hz, 1H), 2.16 (dd, <i>J</i> = 11.5, 7.0 Hz, 2H), 2.06 (s, 3H), 2.04 (s, 2H), 1.98–1.60 (m, 11H), 1.52–1.21 (m, 7H), 1.17 (s, 3H), 0.91 (s, 1H), 0.90 (s, 3H), 0.88 (d, <i>J</i> = 2.4 Hz, 3H), 0.86 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.61, 170.96, 170.69, 168.16, 162.14, 150.02, 146.62, 136.23, 128.46, 128.09, 127.99, 120.61, 115.58, 85.48, 73.24, 71.63, 66.93, 61.82, 60.12, 57.50, 46.33, 43.36, 40.73, 40.67, 39.46, 38.61, 36.68, 32.77, 32.61, 31.23, 30.68, 27.91, 27.46, 26.18, 25.54, 24.83, 23.36, 21.51, 18.97, 17.50, 17.43. ESI-MS (<i>m</i>/<i>z</i>): 804.5 [M + H]<sup>+</sup>, 848.5 [M + HCOO]<sup>−</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 804.4064 [M + H]<sup>+</sup>; calcd for C<sub>44</sub>H<sub>58</sub>N<sub>3</sub>O<sub>11</sub> 804.4066.</div><div class="NLM_p"><b>3c</b>. Synthesis of compound <b>3c</b> with method C yielded a white foamy solid. Yield, 90%; mp 122–125 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.71 (dd, <i>J</i> = 9.7, 2.6 Hz, 1H), 7.39 (d, <i>J</i> = 1.7 Hz, 1H), 7.37–7.29 (m, 5H), 7.08 (d, <i>J</i> = 7.6 Hz, 1H), 6.27 (d, <i>J</i> = 9.8 Hz, 1H), 5.70 (t, <i>J</i> = 3.9 Hz, 1H), 5.11 (s, 2H), 5.09 (s, 1H), 4.56 (d, <i>J</i> = 6.5 Hz, 1H), 4.47 (dd, <i>J</i> = 14.4, 6.8 Hz, 1H), 4.30 (dd, <i>J</i> = 11.1, 3.4 Hz, 1H), 4.14–4.05 (m, 1H), 4.00 (dd, <i>J</i> = 7.4, 4.5 Hz, 2H), 3.81 (d, <i>J</i> = 3.5 Hz, 1H), 3.53 (dd, <i>J</i> = 11.8, 5.7 Hz, 1H), 3.40 (dd, <i>J</i> = 16.4, 8.9 Hz, 1H), 2.44 (d, <i>J</i> = 13.9 Hz, 1H), 2.15–1.96 (m, 6H), 1.83 (ddd, <i>J</i> = 22.4, 14.8, 6.9 Hz, 12H), 1.70–1.52 (m, 7H), 1.35 (ddd, <i>J</i> = 23.6, 12.8, 7.3 Hz, 7H), 1.17 (s, 3H), 0.93 (d, <i>J</i> = 6.0 Hz, 4H), 0.90 (s, 4H), 0.89 (s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.76, 172.08, 170.50, 168.27, 162.24, 156.34, 150.20, 146.72, 136.41, 128.65, 128.28, 128.18, 120.72, 115.78, 85.65, 73.43, 71.76, 67.11, 61.96, 60.19, 51.61, 46.46, 43.54, 41.46, 40.92, 40.83, 39.66, 38.73, 36.83, 32.97, 32.76, 30.76, 28.08, 27.57, 26.33, 25.67, 25.15, 24.98, 23.54, 22.71, 22.40, 21.68, 17.60. ESI-MS (<i>m</i>/<i>z</i>): 818.8 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 818.4223 [M + H]<sup>+</sup>; calcd for C<sub>45</sub>H<sub>60</sub>N<sub>3</sub>O<sub>11</sub> 818.4222.</div><div class="NLM_p"><b>3d</b>. Synthesis of compound <b>3d</b> with method C yielded a white foamy solid. Yield, 80%; mp 125–127 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (dd, <i>J</i> = 9.7, 2.5 Hz, 1H), 7.38 (d, <i>J</i> = 1.7 Hz, 1H), 7.37–7.27 (m, 6H), 7.19 (d, <i>J</i> = 8.3 Hz, 1H), 6.26 (d, <i>J</i> = 9.7 Hz, 1H), 5.73 (s, 1H), 5.11 (s, 3H), 4.57 (d, <i>J</i> = 6.2 Hz, 1H), 4.49 (dd, <i>J</i> = 8.3, 4.3 Hz, 1H), 4.30 (dd, <i>J</i> = 10.9, 3.2 Hz, 1H), 4.08 (t, <i>J</i> = 8.1 Hz, 1H), 4.00 (dd, <i>J</i> = 8.6, 4.4 Hz, 2H), 3.81 (d, <i>J</i> = 3.4 Hz, 1H), 3.53 (d, <i>J</i> = 7.1 Hz, 1H), 3.40 (dd, <i>J</i> = 16.8, 8.4 Hz, 1H), 2.44 (d, <i>J</i> = 11.9 Hz, 1H), 2.31 (s, 2H), 2.16 (m, 4H), 2.09–1.57 (m, 19H), 1.41 (m, 10H), 1.17 (m, 4H), 0.90 (m, 4H), 0.89–0.81 (m, 7H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.78, 171.01, 170.66, 168.19, 162.23, 156.31, 150.19, 146.76, 136.41, 128.62, 128.25, 128.15, 120.76, 115.72, 85.60, 73.42, 71.79, 67.07, 61.99, 60.24, 56.96, 46.45, 43.54, 40.91, 40.84, 39.62, 38.82, 37.99, 36.83, 32.92, 32.80, 31.05, 28.07, 27.56, 27.00, 26.30, 25.20, 24.99, 23.56, 21.66, 17.60, 15.71, 11.85. ESI-MS (<i>m</i>/<i>z</i>): 818.9 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 818.4221 [M + H]<sup>+</sup>; calcd for C<sub>45</sub>H<sub>60</sub>N<sub>3</sub>O<sub>11</sub> 818.4222.</div><div class="NLM_p"><b>3e</b>. Synthesis of compound <b>3e</b> with method C yielded a white foamy solid. Yield, 90%; mp 118–121 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (dd, <i>J</i> = 9.8, 2.5 Hz, 1H), 7.39 (s, 1H), 7.39–7.29 (m, 7H), 7.16 (ddd, <i>J</i> = 22.7, 14.6, 6.7 Hz, 6H), 6.27 (d, <i>J</i> = 9.8 Hz, 1H), 5.64 (s, 1H), 5.14 (d, <i>J</i> = 1.5 Hz, 2H), 5.10 (s, 1H), 4.81 (dd, <i>J</i> = 14.1, 6.6 Hz, 1H), 4.55 (d, <i>J</i> = 7.0 Hz, 1H), 4.32–4.23 (m, 1H), 4.09 (dd, <i>J</i> = 11.2, 7.1 Hz, 1H), 3.94 (d, <i>J</i> = 4.4 Hz, 1H), 3.84 (d, <i>J</i> = 4.0 Hz, 1H), 3.82–3.76 (m, 1H), 3.39–3.26 (m, 2H), 3.08 (ddd, <i>J</i> = 37.2, 14.1, 6.7 Hz, 3H), 2.38 (d, <i>J</i> = 13.8 Hz, 2H), 2.02 (dd, <i>J</i> = 19.3, 8.2 Hz, 7H), 1.90–1.48 (m, 15H), 1.44–1.17 (m, 10H), 1.12 (s, 4H), 0.88 (d, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.74, 170.86, 170.17, 168.23, 162.20, 150.19, 146.67, 136.46, 136.30, 129.33, 128.64, 128.39, 128.28, 128.19, 127.03, 120.68, 115.80, 85.67, 73.39, 72.09, 67.10, 61.94, 59.98, 53.48, 46.26, 40.92, 40.83, 39.66, 38.19, 36.79, 32.98, 30.72, 28.08, 27.03, 26.37, 25.66, 24.85, 23.36, 21.70, 17.59. ESI-MS (<i>m</i>/<i>z</i>): 852.3 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 852.4066 [M + H]<sup>+</sup>; calcd for C<sub>48</sub>H<sub>58</sub>N<sub>3</sub>O<sub>11</sub> 852.4066.</div><div class="NLM_p"><b>3f</b>. Synthesis of compound <b>3f</b> with method C yielded a light yellow foamy solid. Yield, 89%; mp 135–136 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.25 (s, 1H), 7.70 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.51 (d, <i>J</i> = 7.7 Hz, 1H), 7.47–7.27 (m, 8H), 7.10 (dt, <i>J</i> = 23.7, 7.3 Hz, 2H), 6.92 (s, 1H), 6.28 (d, <i>J</i> = 9.6 Hz, 1H), 5.49 (s, 1H), 5.15 (d, <i>J</i> = 6.4 Hz, 2H), 5.09 (s, 1H), 4.87 (dd, <i>J</i> = 13.3, 6.0 Hz, 1H), 4.52 (d, <i>J</i> = 7.3 Hz, 1H), 4.27 (dd, <i>J</i> = 11.0, 3.5 Hz, 1H), 4.13–4.05 (m, 1H), 3.80 (d, <i>J</i> = 3.5 Hz, 1H), 3.63 (dd, <i>J</i> = 60.8, 4.4 Hz, 1H), 3.43 (dd, <i>J</i> = 25.2, 5.4 Hz, 1H), 3.28 (dd, <i>J</i> = 35.3, 6.0 Hz, 2H), 3.19–3.11 (m, 1H), 3.10–3.03 (m, 1H), 2.37 (d, <i>J</i> = 14.8 Hz, 2H), 2.17 (s, 1H), 1.93 (ddd, <i>J</i> = 39.5, 23.3, 11.4 Hz, 9H), 1.72 (s, 6H), 1.61 (dd, <i>J</i> = 33.3, 11.5 Hz, 6H), 1.44–1.17 (m, 10H), 1.08 (s, 3H), 0.89 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.74 (d, <i>J</i> = 5.8 Hz), 171.34, 170.21, 168.30, 162.15, 156.41, 150.11, 146.55, 136.51, 136.02, 128.72, 128.41, 128.33, 127.95, 123.08, 122.15, 120.60, 119.48, 118.59, 115.82, 111.37, 110.08, 85.68, 73.41, 71.98, 67.16, 61.93, 59.96, 53.25, 46.12, 43.16, 40.92, 40.82, 39.67, 38.36, 36.77, 32.98, 32.53, 30.72, 29.82, 28.07, 27.44, 27.03, 26.31, 25.63, 24.83, 23.30, 21.70, 17.58. ESI-MS (<i>m</i>/<i>z</i>): 891.8 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 891.4175 [M + H]<sup>+</sup>; calcd for C<sub>50</sub>H<sub>59</sub>N<sub>4</sub>O<sub>11</sub> 891.4175.</div><div class="NLM_p"><b>3g</b>. Synthesis of compound <b>3g</b> with method C yielded a white foamy solid. Yield, 87%; mp 120–122 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.57 (s, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 7.72 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.59 (d, <i>J</i> = 8.7 Hz, 2H), 7.39 (d, <i>J</i> = 1.8 Hz, 1H), 7.38–7.29 (m, 9H), 6.28 (d, <i>J</i> = 10.2 Hz, 1H), 5.70 (s, 1H), 5.29 (s, 2H), 5.16–5.05 (m, 4H), 4.76 (d, <i>J</i> = 7.3 Hz, 1H), 4.34 (d, <i>J</i> = 10.6 Hz, 1H), 4.06 (ddd, <i>J</i> = 18.1, 14.9, 6.9 Hz, 4H), 3.85 (s, 1H), 2.51 (d, <i>J</i> = 13.0 Hz, 3H), 1.85 (d, <i>J</i> = 9.8 Hz, 7H), 1.25 (s, 3H), 1.22 (s, 4H), 1.10 (t, <i>J</i> = 7.3 Hz, 2H), 0.92 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.83, 171.16, 162.27, 156.46, 150.17, 146.77, 137.12, 136.31, 129.82, 128.67, 128.35, 128.17, 120.78, 119.95, 115.73, 85.63, 73.44, 71.02, 67.23, 61.98, 61.18, 46.69, 43.58, 40.91, 40.83, 39.66, 36.80, 32.93, 32.66, 30.73, 29.81, 28.08, 27.11, 26.32, 25.64, 25.06, 23.47, 23.39, 21.70, 17.60. ESI-MS (<i>m</i>/<i>z</i>): 824.3 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 824.3753 [M + H]<sup>+</sup>; calcd for C<sub>47</sub>H<sub>53</sub>N<sub>3</sub>O<sub>11</sub> 824.3753.</div><div class="NLM_p last"><b>3h</b>. Synthesis of compound <b>3h</b> with method C yielded a white foamy solid. Yield, 80%; mp 127–128 °C; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.20 (d, <i>J</i> = 3.5 Hz, 1H), 7.71 (dd, <i>J</i> = 9.7, 2.0 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 2H), 7.37 (d, <i>J</i> = 1.8 Hz, 1H), 7.33 (d, <i>J</i> = 5.9 Hz, 5H), 7.19 (d, <i>J</i> = 8.3 Hz, 2H), 6.26 (d, <i>J</i> = 9.6 Hz, 1H), 5.76 (s, 1H), 5.11 (s, 2H), 5.03 (s, 1H), 4.72 (d, <i>J</i> = 7.5 Hz, 1H), 4.28 (d, <i>J</i> = 10.8 Hz, 1H), 4.03 (td, <i>J</i> = 17.1, 11.1 Hz, 3H), 3.80 (d, <i>J</i> = 3.0 Hz, 1H), 3.55 (s, 3H), 3.42 (dd, <i>J</i> = 16.5, 8.8 Hz, 1H), 2.48 (s, 1H), 2.41–2.31 (m, 1H), 2.18 (dd, <i>J</i> = 22.8, 15.7 Hz, 2H), 2.03 (d, <i>J</i> = 9.1 Hz, 3H), 1.93–1.51 (m, 13H), 1.42 (s, 1H), 1.25 (s, 4H), 1.12 (s, 2H), 1.09 (s, 2H), 0.89 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 213.83, 171.16, 162.27, 156.46, 150.17, 146.77, 137.12, 136.31, 129.82, 128.67, 128.35, 128.17, 120.78, 119.95, 115.73, 85.63, 73.44, 71.02, 67.23, 61.98, 61.18, 46.69, 43.58, 40.91, 40.83, 39.66, 36.80, 32.93, 32.66, 30.73, 29.81, 28.08, 27.11, 26.32, 25.64, 25.06, 23.47, 23.39, 21.70, 17.60. ESI-MS (<i>m</i>/<i>z</i>): 838.8 [M + H]<sup>+</sup>. HR-ESI-MS (<i>m</i>/<i>z</i>): 838.3909 [M + H]<sup>+</sup>; calcd for C<sub>47</sub>H<sub>56</sub>N<sub>3</sub>O<sub>11</sub> 838.3909.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cell Lines</h3><div class="NLM_p last">Human breast cancer cell lines MCF-7, MDA-MB-231, and MDA-MB-435 were obtained from American Type Culture Collection (ATCC, Rockville, MD). Breast cancer cell lines were incubated in DMEM medium with 10% (v/v) fetal bovine serum and 1% (v/v) penicillin–streptomycin in a 5% CO<sub>2</sub> humidified atmosphere at 37 °C.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Animals</h3><div class="NLM_p last">Four- to six-week-old female BALB/C mice were purchased from Vital River Laboratory Animal Technology Co, Ltd. (Beijing, China). Kunming (KM) mice weighing 20–28 g were obtained from Guangdong Medical Experimental Animal Center (Guangzhou, China). All animal experiments were conducted in accordance with the ARRIVE guidelines and were approved by Experimental Animal Ethics Committee of Jinan University (Guangzhou, China).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> LC–MS/MS Methods</h3><div class="NLM_p last">Quantitation of the active forms <b>2a</b>–<b>h</b> were carried out by the Waters ACQUITY UPLC system equipped with a photodiode array detector (Milford, MA). Chromatographic separation was performed on an ACQUITY UPLC BEH column (2.1 mm × 100 mm, 1.7 μm; Waters). Elution was accomplished using a gradient of 0.1% formic acid in H<sub>2</sub>O (mobile phase A) versus MeOH (mobile phase B) at a flow rate of 0.40 mL/min. The gradient program was 5% B at 0–1.0 min, 25%–40% B at 1.0–2.0 min, 40%–70% B at 2.0–3.0 min, 70%–95% B at 3.0–3.5 min, 95%–90% B at 3.5–4.0 min, and 90%–5% B at 4.0–5.0 min. Data were collected in the positive mode using the electrospray ionization source (ESI) in full scan mode (200–1200 Da). The desolvation gas (N<sub>2</sub>) was 800 L/h and cone gas was 30 L/h. The desolvation and source temperature were 350 and 100 °C, respectively. An external reference leucine enkephalin (lock spray, <i>m</i>/<i>z</i> 556.2771) at the concentration of 2 ng/mL was infused with a flow rate of 5 μL/min to ensure mass accuracy throughout an entire experiment.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> rhFAPα-Mediated Hydrolysis of Prodrugs in Vitro</h3><div class="NLM_p last">Bufalin (2 μmol/L), as the internal standard, was added into the reaction buffer. The reaction buffer (0.2 mL per sample) was maintained at 37 °C and contained prodrug <b>2a</b> (40 μmol/L) and rhFAPα (0.45 μg/mL) for 6 h. Acetonitrile (0.6 mL) was added to the reaction buffer to terminate the reaction. The buffer was centrifuged at 18 000<i>g</i> for 15 min, and the supernatant was subjected to UPLC–MS/MS analysis. A standard curve was produced by using the peak area ratio between various concentrations of <b>2a</b> (0, 0.625–40 μmol/L) and bufalin (2 μmol/L). Peak areas of <b>2a</b> released from <b>3a</b> by rhFAPα were converted to concentrations, and the data were analyzed by GraphPad Prism. Other prodrugs <b>3b</b>–<b>h</b> were analyzed using the same experiment process as <b>3a</b>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Kinetic Analysis of rhFAPα Hydrolysis</h3><div class="NLM_p last">Various concentrations of prodrug <b>3a</b> (0.625–40 μmol/L) were incubated with rhFAPα (0.45 μg/mL) and an internal standard in 0.2 mL of phosphate buffer saline (PBS, pH 7.4) at 37 °C for 90 min. MeCN (0.6 mL) was added into the reaction buffer to terminate the reaction. The reaction buffer was centrifuged at 18 000<i>g</i> for 15 min, and the supernatant was subjected to LC–MS/MS analysis. <i>S</i><sub>50</sub> and <i>V</i><sub>max</sub> were calculated from the concentration plots with allosteric sigmoidal because Eadie–Hofstee plots of the data were indicative of autoactivation, and CL<sub>int</sub> was calculated from the ratio of <i>V</i><sub>max</sub> to <i>S</i><sub>50</sub>. Other prodrugs <b>3b</b>–<b>h</b> were analyzed using the same experimental process as was used for <b>3a</b>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Hydrolysis of Prodrug <b>3f</b> by 10% FBS, 10% Heat-Inactivated FBS, BMSCs, Rat Serum, Homogenates of Tumor and Heart</h3><div class="NLM_p last">Normal FBS was treated at 56 °C overnight to generate heat-inactivated FBS. Tumor and heart tissues were weighed and homogenized on ice containing PBS (pH 7.4) by using a mechanical tissue grinder. Internal standard bufalin (2 μmol/L) was added to the homogenates. The standard curves were constructed by adding <b>2f</b> (final concentration ranged from 0.625 to 40 μmol/L) to the corresponding reaction buffer. Prodrug <b>3f</b> (40 μmol/L) was incubated with normal 10% FBS, 10% heat-inactivated FBS, BMSCs, rat serum, homogenates of tumor or heart. The reaction was stopped by adding acetonitrile. The reaction buffers were centrifuged at 18 000<i>g</i> for 30 min, and the supernatant was subjected to LC–MS/MS analysis.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Generation of FAPα-Transfected Cells</h3><div class="NLM_p last">The human FAPα cDNA clone (catalog SC117372) and pCMV6-Entry vector (catalog PS100001) were obtained from Origene Technologies (Rockville, MD). Lipofectamine LTX reagent with PLUS reagent (catalog 15338-100) was obtained from Invitrogen (Carlsbad, CA). The human FAPα plasmids and the pCMV6-Entry vector were transfected into MDA-MB-231 to generate FAP-positive cells MDA-MB-231<sup>FAPα</sup> and negative control cells MDA-MB-231<sup>NC</sup> respectively according to the manufacturer’s instructions. After 48 h, cells were lysed for Western blot analysis to test the transfected efficiency.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Western Blotting</h3><div class="NLM_p last">Total cellular protein lysate was prepared as described previously.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Cell lysates were separated by SDS–PAGE and transferred to polyvinylidene fluoride (PVDF) membranes. Membranes were blocked and immunoblotted with antibody against FAPα (1:500, abcam, ab53066).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> MTT Assay</h3><div class="NLM_p last">10% heat-inactivated FBS was used in in vitro cytotoxicity assays in order to rule out of the disturbance of FAP activity in FBS. The cytotoxic effects of these compounds were detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as has been described previously.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Acute Toxicity Assay</h3><div class="NLM_p last">100 Kunming mice (22.0–28.0 g), half male and half female, were randomly divided into 10 groups (<i>n</i> = 10) and intravenously injected with <b>3f</b> (29.98, 34.07, 38.72, 44.00, and 50.00 μmol/kg) or arenobufagin (4.50, 5.27, 6.06, 6.96, and 8.00 μmol/kg) on day 1. The mice were observed continuously for 8 h after drug administration to detect any abnormal behavior, and the death rate of each group was recorded. Subsequently, the mice were observed intermittently for the next 2 weeks and sacrificed on the 14th day. The Bliss method was employed to calculate the LD<sub>50</sub> values of <b>3f</b> and arenobufagin.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Tumor Xenograft in Nude Mice</h3><div class="NLM_p last">MDA-MB-231 cells (1 × 10<sup>7</sup>) in 200 μL of Matrigel–PBS buffer (v:v = 1:1) were inoculated subcutaneously into the backs of female BABL/C mice. Each day after day 5, animals were intravenously administered <b>3f</b> dissolved in 5% HS15 at a concentration of 12 μmol/kg or arenobufagin dissolved in 5% HS15 at a concentration of 4 μmol/kg. Tumor size was assessed every 2 days by caliper. Tumor volume was calculated using the formula <i>v</i> = 0.5 × <i>a</i> × <i>b</i><sup>2</sup>, where <i>a</i> refers to the longer diameter and <i>b</i> to the shorter diameter of the tumor. The experiment was terminated on day 22. Animals were anesthetized, and hearts were rapidly collected and fixed in 4% paraformaldehyde for 24 h. Tumors were also collected, weighed, and photographed, then fixed in 4% paraformaldehyde. Both heart and tumor tissues were further examined by histologically and immunohistochemically (IHC).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Echocardiography</h3><div class="NLM_p last">Cardiac function of animals were recorded by transthoracic echocardiography using a Technos MPX ultrasound system (ESAOTE, Italy) with a 21 MHz imaging transducer, as described previously.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Briefly, animals were anesthetized with 1.5% isoflurane and placed in a supine position. The M-mode images were obtained from the parasternal short-axis view at the papillary muscle. The following parameters were measured: LVIDd, LVIDs, IVSd, IVSs. All the parameters were obtained from 6 samples per group.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Immunofluorescence Analysis</h3><div class="NLM_p last">The expression of FAPα in MDA-MB-231 xenograft tissues was assessed as described previously.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Tumor samples were snap frozen in OCT compound for storage and further processing. Fresh cryosections were fixed and blocked, followed by incubation with antibody against FAPα (1:50, abcam, ab53066) and secondary antibody. The distributions of FAPα were imaged using confocal microscope (Zeiss LSM700, Germany) with a ×20 lens, at the excitation wavelength of 488 nm.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Histopathological and Immunohistochemical Analysis</h3><div class="NLM_p last">All IHCs were performed as described previously.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> After tissues were fixed for 24 h and then embedded in paraffin, tissue sections (5 μm thick) were mounted on glass slides. For histological examination, heart, liver, spleen, lung, kidney, and femur sections were stained with hematoxylin–eosin (H&E). For proliferative index analysis, sections were incubated with anti-Ki67. For apoptotic analysis, sections were examined using the in situ cell death detection kit (Roche Diagnostic). The stained mice tissue sections in the current study were examined by a pathologist who was blind to the treatment conditions. Images were collected by using an Olympus DP2-SAL microscope. Proliferative index (%) and apoptosis (%) were analyzed by Image-Pro Plus software.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Assays for <span class="smallcaps smallerCapital">d</span>-Lactate Dehydrogenase (D-LDH)</h3><div class="NLM_p last">Before sacrifice, the blood of mice was collected by cardiac puncture and centrifuged at 3000 rpm for 20 min at 4 °C to obtain serum. Enzyme activities of D-LDH in serum were measured using an Amplite colorimetric <span class="smallcaps smallerCapital">d</span>-lactate dehydrogenase assay kit (AAT Bioquest) in accordance with the manufacturer’s protocol.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Statistical Analysis</h3><div class="NLM_p last">Results were presented as the mean ± SEM. Statistical analysis was conducted using GraphPad Prism 5 software with a one-way ANOVA with post hoc comparisons and Tukey’s test. <i>P</i> value of ≤0.05 was considered to indicate significant differences.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01755">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01755" class="ext-link">10.1021/acs.jmedchem.6b01755</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">(1) General methods, (2) additional experimental results, (3) <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and ESI-MS spectra of all compounds, and (4) HPLC data of <b>2a</b>–<b>h</b> and <b>3a</b>–<b>h</b> used in biological assays (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf">jm6b01755_si_001.pdf (11.63 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_002.csv">jm6b01755_si_002.csv (3.81 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01755" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen-Cai Ye</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2810-1001" title="Orcid link">http://orcid.org/0000-0002-2810-1001</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d2b1baabb7a5b192b5bfb3bbbefcb1bdbf"><span class="__cf_email__" data-cfemail="f5969d8c908296b59298949c99db969a98">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong-Mei Zhang</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9df9f0e7f5fcf3faaaadacddfbf2e5f0fcf4f1b3fef2f0"><span class="__cf_email__" data-cfemail="b4d0d9cedcd5dad3838485f4d2dbccd9d5ddd89ad7dbd9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei-Min Chen</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0292-7841" title="Orcid link">http://orcid.org/0000-0002-0292-7841</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#394d4e545a515c577953574c175c5d4c175a57"><span class="__cf_email__" data-cfemail="87f3f0eae4efe2e9c7ede9f2a9e2e3f2a9e4e9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Juan Deng</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Long-Hai Wang</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Kang Peng</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Bin Li</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mao-Hua Huang</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min-Feng Chen</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xue-Ping Lei</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming Qi</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Cen</span> - <span class="hlFld-Affiliation affiliation">Guangdong Province Key Laboratory
of Pharmacodynamic Constituents of TCM and New Drugs Research, College
of Pharmacy, Jinan University, Guangzhou 510632, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L.-J.D. and L.-H.W. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d89e3977-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Science and Technology Program of China (Grant 2012ZX09103101-053), the National Science Foundation of China (Grant 81573455), Guangdong Province (Grants S20120100008130, S2013050014183, and 2013CXZDA006), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant 20124401110008), the Program for New Century Excellent Talents in University (D.-M.Z.), and the Project Supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (D.-M.Z.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> Abbreviations Used</h2><tr><td class="NLM_term">FAPα</td><td class="NLM_def"><p class="first last">fibroblast activation protein α</p></td></tr><tr><td class="NLM_term">rhFAPα</td><td class="NLM_def"><p class="first last">recombinant human FAPα</p></td></tr><tr><td class="NLM_term">CAF</td><td class="NLM_def"><p class="first last">carcinoma-associated fibroblast</p></td></tr><tr><td class="NLM_term">Z-GP</td><td class="NLM_def"><p class="first last">N-terminal benzyloxycarbonyl blocked Gly-Pro</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">penicillin–streptomycin</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">Me<sub>2</sub>CO</td><td class="NLM_def"><p class="first last">acetone</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">median inhibitory concentration</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">IHC</td><td class="NLM_def"><p class="first last">immunohistochemistry</p></td></tr><tr><td class="NLM_term">IVSd</td><td class="NLM_def"><p class="first last">interventricular septal dimension in diastole</p></td></tr><tr><td class="NLM_term">IVSs</td><td class="NLM_def"><p class="first last">interventricular septal dimension in systole</p></td></tr><tr><td class="NLM_term">LVIDd</td><td class="NLM_def"><p class="first last">left ventricular internal dimension in diastole</p></td></tr><tr><td class="NLM_term">LVIDs</td><td class="NLM_def"><p class="first last">left ventricular internal dimension</p></td></tr><tr><td class="NLM_term">D-LDH</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-lactate dehydrogenase</p></td></tr><tr><td class="NLM_term">HS15</td><td class="NLM_def"><p class="first last">Solutol-HS15</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">IHC</td><td class="NLM_def"><p class="first last">immunohistochemically</p></td></tr><tr><td class="NLM_term">PVDF</td><td class="NLM_def"><p class="first last">polyvinylidene fluoride</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethanolamine</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popescu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Bufadienolides and their antitumor activity</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span><span class="refDoi"> DOI: 10.1039/c0np00032a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1039%2Fc0np00032a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=21416078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVGmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=953-969&author=H.+Gaoauthor=R.+Popescuauthor=B.+Koppauthor=Z.+Wang&title=Bufadienolides+and+their+antitumor+activity&doi=10.1039%2Fc0np00032a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Bufadienolides and their antitumor activity</span></div><div class="casAuthors">Gao, Huimin; Popescu, Ruxandra; Kopp, Brigitte; Wang, Zhimin</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">953-969</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1998 to July 2010.  Since 1998, a great no. of bufadienolides have been reported from plants, animals and plant cell suspensions, as well as from fungi and bacteria cultures.  This review summarizes both new bufadienolides and those obtained from new sources, together with data regarding the antitumor activity of bufadienolide derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8b9zxCMeCPLVg90H21EOLACvtfcHk0liQf9UcINZgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVGmsLw%253D&md5=099ca5f68c6967a59d7bf6b68f25d66d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1039%2Fc0np00032a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0np00032a%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DPopescu%26aufirst%3DR.%26aulast%3DKopp%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DBufadienolides%2520and%2520their%2520antitumor%2520activity%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2011%26volume%3D28%26spage%3D953%26epage%3D969%26doi%3D10.1039%2Fc0np00032a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Qi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokudo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1016/j.intimp.2010.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.intimp.2010.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=21185919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=342-349&author=F.+Qiauthor=A.+Liauthor=Y.+Inagakiauthor=N.+Kokudoauthor=S.+Tamuraauthor=M.+Nakataauthor=W.+Tang&title=Antitumor+activity+of+extracts+and+compounds+from+the+skin+of+the+toad+Bufo+bufo+gargarizans+Cantor&doi=10.1016%2Fj.intimp.2010.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor</span></div><div class="casAuthors">Qi, Fanghua; Li, Anyuan; Inagaki, Yoshinori; Kokudo, Norihiro; Tamura, Sumihito; Nakata, Munehiro; Tang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-349</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The skin of the toad Bufo bufo gargarizans Cantor is known to be rich in bufadienolides, peptides and alkaloids.  It has been found to be a source of some exts. and biol. active compds. with antitumor activity.  Cinobufacini (Huachansu), a Chinese medicine prepd. from the dried toad skin, has been widely used in clin. therapy for various cancers in China.  Bufadienolides, such as bufalin, cinobufagin, resibufogenin, and telocinobufagin, are the major active compds. derived from the toad skin.  They are the maker biol. active compds. of cinobufagin while the antitumor activity of cinobufagin may be due to this kind of components.  Exptl. research has suggested that cinobufacini and its active compds. (e.g. bufalin and cinobufagin) exhibit significant antitumor activity, including inhibition of cell proliferation, induction of cell differentiation, induction of apoptosis, disruption of the cell cycle, inhibition of cancer angiogenesis, reversal of multi-drug resistance, and regulation of the immune response.  Clin. data have indicated that cinobufacini may have effective anticancer activity with low toxicity and few side effects.  Data to date suggest it may also enhance quality of life for patients with cancer.  Thus, this review briefly summarizes recent studies on the anticancer activity of cinobufacini and some of its active compds. from the skin of the toad Bufo bufo gargarizans Cantor.  This might provide addnl. evidence for further study of the exts. and active compds. from the toad skin in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dk3gqndKDLVg90H21EOLACvtfcHk0liQf9UcINZgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGqs78%253D&md5=25624f3f7a5b628cfef4d3255842624c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DKokudo%26aufirst%3DN.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DNakata%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DAntitumor%2520activity%2520of%2520extracts%2520and%2520compounds%2520from%2520the%2520skin%2520of%2520the%2520toad%2520Bufo%2520bufo%2520gargarizans%2520Cantor%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2011%26volume%3D11%26spage%3D342%26epage%3D349%26doi%3D10.1016%2Fj.intimp.2010.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroiwa, Y.</span><span> </span><span class="NLM_article-title">Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=4634-4641&author=L.+Zhangauthor=K.+Nakayaauthor=T.+Yoshidaauthor=Y.+Kuroiwa&title=Induction+by+bufalin+of+differentiation+of+human+leukemia+cells+HL60%2C+U937%2C+and+ML1+toward+macrophage%2Fmonocyte-like+cells+and+its+potent+synergistic+effect+on+the+differentiation+of+human+leukemia+cells+in+combination+with+other+inducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNakaya%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKuroiwa%26aufirst%3DY.%26atitle%3DInduction%2520by%2520bufalin%2520of%2520differentiation%2520of%2520human%2520leukemia%2520cells%2520HL60%252C%2520U937%252C%2520and%2520ML1%2520toward%2520macrophage%252Fmonocyte-like%2520cells%2520and%2520its%2520potent%2520synergistic%2520effect%2520on%2520the%2520differentiation%2520of%2520human%2520leukemia%2520cells%2520in%2520combination%2520with%2520other%2520inducers%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D4634%26epage%3D4641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zhang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W. C.</span><span> </span><span class="NLM_article-title">Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span><span class="refDoi"> DOI: 10.1093/carcin/bgt060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fcarcin%2Fbgt060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=23393227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFCnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1331-1342&author=D.+M.+Zhangauthor=J.+S.+Liuauthor=L.+J.+Dengauthor=M.+F.+Chenauthor=A.+Yiuauthor=H.+H.+Caoauthor=H.+Y.+Tianauthor=K.+P.+Fungauthor=H.+Kuriharaauthor=J.+X.+Panauthor=W.+C.+Ye&title=Arenobufagin%2C+a+natural+bufadienolide+from+toad+venom%2C+induces+apoptosis+and+autophagy+in+human+hepatocellular+carcinoma+cells+through+inhibition+of+PI3K%2FAkt%2FmTOR+pathway&doi=10.1093%2Fcarcin%2Fbgt060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway</span></div><div class="casAuthors">Zhang, Dong-Mei; Liu, Jun-Shan; Deng, Li-Juan; Chen, Min-Feng; Yiu, Anita; Cao, Hui-Hui; Tian, Hai-Yan; Fung, Kwok-Pui; Kurihara, Hiroshi; Pan, Jing-Xuan; Ye, Wen-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1331-1342</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is a deadly form of cancer without effective chemotherapy so far.  Currently, only sorafenib, a multitargeted tyrosine kinase inhibitor, slightly improves survival in HCC patients.  In searching for natural anti-HCC components from toad venom, which is frequently used in the treatment of liver cancer in traditional Chinese medicine, we discovered that arenobufagin, a bufadienolide from toad venom, had potent antineoplastic activity against HCC HepG2 cells as well as corresponding multidrug-resistant HepG2/ADM cells.  We found that arenobufagin induced mitochondria-mediated apoptosis in HCC cells, with decreasing mitochondrial potential, as well as increasing Bax/Bcl-2 expression ratio, Bax translocation from cytosol to mitochondria.  Arenobufagin also induced autophagy in HepG2/ADM cells.  Autophagy-specific inhibitors (3-methyladenine, chloroquine and bafilomycin A1) or Beclin1 and Atg 5 small interfering RNAs (siRNAs) enhanced arenobufagin-induced apoptosis, indicating that arenobufagin-mediated autophagy may protect HepG2/ADM cells from undergoing apoptotic cell death.  In addn., we obsd. the inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway by arenobufagin.  Interestingly, inhibition of mTOR by rapamycin or siRNA duplexes augmented arenobufagin-induced apoptosis and autophagy.  Finally, arenobufagin inhibited the growth of HepG2/ADM xenograft tumors, which were assocd. with poly (ADP-ribose) polymerase cleavage, light chain 3-II activation and mTOR inhibition.  In summary, we first demonstrated the antineoplastic effect of arenobufagin on HCC cells both in vitro and in vivo.  We elucidated the underlying antineoplastic mechanisms of arenobufagin that involve cross talk between apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathway.  This study may provide a rationale for future clin. application using arenobufagin as a chemotherapeutic agent for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQohRZfmg9e7Vg90H21EOLACvtfcHk0ljSaNODdY7Q6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFCnsLo%253D&md5=76fcf6c0880a51fd8aba8681ba9e65c5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt060%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DDeng%26aufirst%3DL.%2BJ.%26aulast%3DChen%26aufirst%3DM.%2BF.%26aulast%3DYiu%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DH.%2BH.%26aulast%3DTian%26aufirst%3DH.%2BY.%26aulast%3DFung%26aufirst%3DK.%2BP.%26aulast%3DKurihara%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DJ.%2BX.%26aulast%3DYe%26aufirst%3DW.%2BC.%26atitle%3DArenobufagin%252C%2520a%2520natural%2520bufadienolide%2520from%2520toad%2520venom%252C%2520induces%2520apoptosis%2520and%2520autophagy%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%2520through%2520inhibition%2520of%2520PI3K%252FAkt%252FmTOR%2520pathway%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D1331%26epage%3D1342%26doi%3D10.1093%2Fcarcin%2Fbgt060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Deng, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. M.</span><span> </span><span class="NLM_article-title">Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">34258</span><span class="NLM_x">–</span> <span class="NLM_lpage">34275</span><span class="refDoi"> DOI: 10.18632/oncotarget.5545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.18632%2Foncotarget.5545" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=34258-34275&author=L.+J.+Dengauthor=Q.+L.+Pengauthor=L.+H.+Wangauthor=J.+Xuauthor=J.+S.+Liuauthor=Y.+J.+Liauthor=Z.+J.+Zhuoauthor=L.+L.+Baiauthor=L.+P.+Huauthor=W.+M.+Chenauthor=W.+C.+Yeauthor=D.+M.+Zhang&title=Arenobufagin+intercalates+with+DNA+leading+to+G2+cell+cycle+arrest+via+ATM%2FATR+pathway&doi=10.18632%2Foncotarget.5545"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5545%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%2BJ.%26aulast%3DPeng%26aufirst%3DQ.%2BL.%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DLi%26aufirst%3DY.%2BJ.%26aulast%3DZhuo%26aufirst%3DZ.%2BJ.%26aulast%3DBai%26aufirst%3DL.%2BL.%26aulast%3DHu%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DW.%2BM.%26aulast%3DYe%26aufirst%3DW.%2BC.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26atitle%3DArenobufagin%2520intercalates%2520with%2520DNA%2520leading%2520to%2520G2%2520cell%2520cycle%2520arrest%2520via%2520ATM%252FATR%2520pathway%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D34258%26epage%3D34275%26doi%3D10.18632%2Foncotarget.5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Meng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5309</span><span class="NLM_x">–</span> <span class="NLM_lpage">5318</span><span class="refDoi"> DOI: 10.1002/cncr.24602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fcncr.24602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=19701908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A280%3ADC%252BD1MjkslOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2009&pages=5309-5318&author=Z.+Mengauthor=P.+Yangauthor=Y.+Shenauthor=W.+Beiauthor=Y.+Zhangauthor=Y.+Geauthor=R.+A.+Newmanauthor=L.+Cohenauthor=L.+Liuauthor=B.+Thorntonauthor=D.+Z.+Changauthor=Z.+Liaoauthor=R.+Kurzrock&title=Pilot+study+of+huachansu+in+patients+with+hepatocellular+carcinoma%2C+nonsmall-cell+lung+cancer%2C+or+pancreatic+cancer&doi=10.1002%2Fcncr.24602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer</span></div><div class="casAuthors">Meng Zhiqiang; Yang Peiying; Shen Yehua; Bei Wenying; Zhang Ying; Ge Yongqian; Newman Robert A; Cohen Lorenzo; Liu Luming; Thornton Bob; Chang David Z; Liao Zongxing; Kurzrock Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5309-18</span>
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    </div><div class="casAbstract">BACKGROUND:  Huachansu, a Chinese medicine that comes from dried toad venom from the skin glands of Bufo gargarizans or B. melanostictus, has been used in the treatment of various cancers in China.  The authors conducted a pilot study, using a phase 1 trial design, of huachansu in patients with advanced cancer.  METHODS:  Huachansu was administered intravenously for 14 days followed by 7 days off (1 cycle).  Without significant adverse events or progressive disease, treatment continued beyond 2 cycles.  The dose of huachansu was escalated as follows with 3 patients per cohort: 10 (level 1), 20 (level 2), 40 (level 3), 60 (level 4), and 90 (level 5) mL/m(2).  RESULTS:  Fifteen patients (hepatocellular cancer, n = 11; nonsmall cell lung cancer, n = 2; pancreatic cancer, n = 2) were enrolled in the trial, and no dose-limiting toxicities (DLTs) were found.  Eleven patients had no drug-related toxicity greater than grade 1.  Six (40%) had stable disease (median duration, 6.0 months; range, 3.5-11.1 months).  One of these patients (with hepatocellular cancer) had 20% regression (duration, 11 months) (dose level 1).  Quality of life improved for patients with stable disease.  Plasma bufalin concentration reached maximal levels at the end of the 2-hour infusion and was proportional to the amount of drug being administered (0.81-3.38 ng/mL).  CONCLUSIONS:  No DLT was observed with the use of huachansu at doses up to 8x higher than typically used in China.  Six patients had prolonged stable disease or minor tumor shrinkage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF23-pyDO1PP_I8Jvzw4xCfW6udTcc2eYQskv2Asa_PLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjkslOisg%253D%253D&md5=6f702604b4b8fcd75c86c867e2c74672</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fcncr.24602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.24602%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DBei%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DNewman%26aufirst%3DR.%2BA.%26aulast%3DCohen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DThornton%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DD.%2BZ.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DPilot%2520study%2520of%2520huachansu%2520in%2520patients%2520with%2520hepatocellular%2520carcinoma%252C%2520nonsmall-cell%2520lung%2520cancer%252C%2520or%2520pancreatic%2520cancer%26jtitle%3DCancer%26date%3D2009%26volume%3D115%26spage%3D5309%26epage%3D5318%26doi%3D10.1002%2Fcncr.24602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Qin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. R.</span><span> </span><span class="NLM_article-title">Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5210</span><span class="NLM_x">–</span> <span class="NLM_lpage">5216</span><span class="refDoi"> DOI: 10.3748/wjg.14.5210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.3748%2Fwjg.14.5210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=18777599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVCltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5210-5216&author=T.+J.+Qinauthor=X.+H.+Zhaoauthor=J.+Yunauthor=L.+X.+Zhangauthor=Z.+P.+Ruanauthor=B.+R.+Pan&title=Efficacy+and+safety+of+gemcitabine-oxaliplatin+combined+with+huachansu+in+patients+with+advanced+gallbladder+carcinoma&doi=10.3748%2Fwjg.14.5210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma</span></div><div class="casAuthors">Qin, Tian-Jie; Zhao, Xin-Han; Yun, Jun; Zhang, Ling-Xiao; Ruan, Zhi-Ping; Pan, Bo-Rong</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5210-5216</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">To evaluate the efficacy and safety of gemcitabine-oxaliplatin (GEMOX) combined with huachansu (cinobufagin) injection treatment in patients with locally advanced or metastatic gallbladder carcinoma (GBC), and to assess the quality of life (QOL) of such patients.  Twenty-five patients with locally advanced or metastatic GBC were treated with i.v. gemcitabine (1000 mg/m2) over 30 min on days 1 and 8, 2 h infusion of oxaliplatin (120 mg/m2) on day 1, and 2-3 h infusion of huachansu (20 mL/m2) on days -3-11, every 3-4 wk.  Treatment was continued until occurrence of unacceptable toxicity or disease progression.  QOL of patients was assessed by the EORTC QLQ-C30 at baseline, at the end of the first, third and sixth chemotherapy cycles, and 1 mo after the treatment.  Among the 25 patients with a median age of 64 years (range 42-78 years), 23 were evaluable in the study.  A total of 137 cycles of therapy were performed and the median cycle was 5 (range 1-8) per patient.  Out of the 23 patients whose response could be evaluated, 8 partial responses (PR) were obsd. (34.8%), while 7 patients (30.4%) demonstrated a stable disease (SD).  The disease control rate was 65.2%.  Progression of cancer was obsd. in 8 (34.8%) patients.  The median progression-free and overall survival time was 5.8 mo (95% CI: 4.5-7.1 mo) and 10.5 mo, resp.  The therapy was well tolerated, with moderate myelosuppression as the main toxicity.  Anemia grade 2 was seen in 16.0%, neutropenia grade 3 in 8.0% and thrombocytopenia grade 3 in 24.0% of patients, resp.  Non-hematol. toxicity ranged from mild to moderate.  No death occurred due to toxicity.  The QOL of patients was improved after chemotherapy, and the scores of QOL were increased by 10 to 20 points.  GEMOX combined with huachansu (cinobufagin) injection is well tolerated, effective, thus improving the QOL of patients with advanced GBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXTNC0gWd2j7Vg90H21EOLACvtfcHk0lgvyWaQPqmgTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVCltQ%253D%253D&md5=f8a22209a1dc13f09007e324927b50bf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3748%2Fwjg.14.5210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.14.5210%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DT.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BH.%26aulast%3DYun%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%2BX.%26aulast%3DRuan%26aufirst%3DZ.%2BP.%26aulast%3DPan%26aufirst%3DB.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520gemcitabine-oxaliplatin%2520combined%2520with%2520huachansu%2520in%2520patients%2520with%2520advanced%2520gallbladder%2520carcinoma%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D14%26spage%3D5210%26epage%3D5216%26doi%3D10.3748%2Fwjg.14.5210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, B.</span><span> </span><span class="NLM_article-title">Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer</span> <span class="citation_source-journal">Zhongxiyi Jiehe Xuebao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.3736/jcim20030311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.3736%2Fjcim20030311" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=184-186&author=Z.+Chenauthor=X.+F.+Zhaiauthor=Y.+H.+Suauthor=X.+Y.+Wanauthor=J.+Liauthor=J.+M.+Xieauthor=B.+Gao&title=Clinical+observation+of+cinobufacini+injection+used+to+treat+moderate+and+advanced+primary+liver+cancer&doi=10.3736%2Fjcim20030311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3736%2Fjcim20030311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3736%252Fjcim20030311%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZhai%26aufirst%3DX.%2BF.%26aulast%3DSu%26aufirst%3DY.%2BH.%26aulast%3DWan%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DJ.%2BM.%26aulast%3DGao%26aufirst%3DB.%26atitle%3DClinical%2520observation%2520of%2520cinobufacini%2520injection%2520used%2520to%2520treat%2520moderate%2520and%2520advanced%2520primary%2520liver%2520cancer%26jtitle%3DZhongxiyi%2520Jiehe%2520Xuebao%26date%3D2003%26volume%3D1%26spage%3D184%26epage%3D186%26doi%3D10.3736%2Fjcim20030311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span> </span><span class="NLM_article-title">A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">479</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2014.12.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.ijpharm.2014.12.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=25545797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFygurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=479&publication_year=2015&pages=52-62&author=W.+Liauthor=X.+Linauthor=Z.+Yangauthor=W.+Zhangauthor=T.+Renauthor=F.+Quauthor=Y.+Wangauthor=N.+Zhangauthor=X.+Tang&title=A+bufadienolide-loaded+submicron+emulsion+for+oral+administration%3A+stability%2C+antitumor+efficacy+and+toxicity&doi=10.1016%2Fj.ijpharm.2014.12.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A bufadienolide-loaded submicron emulsion for oral administration: Stability, antitumor efficacy and toxicity</span></div><div class="casAuthors">Li, Wanqiu; Lin, Xia; Yang, Zhenhua; Zhang, Wei; Ren, Tianyang; Qu, Fengming; Wang, Yanjiao; Zhang, Ning; Tang, Xing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">479</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-62</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was to develop an alternative submicron emulsion contg. three bufadienolides for oral administration and evaluate its preclin. stability, efficacy, and toxicity.  The bufadienolide-loaded oral submicron emulsion (BU-OE) was prepd. by high-pressure homogenization.  The storage stability, in vitro cytotoxicity, in vivo antitumor efficacy, acute toxicity, and long-term toxicity of BU-OE were investigated in detail to evaluate the formulation.  The stability study suggested that BU-OE was stable at room temp. and could be stored for at least 18 mo at 6 ± 2 °C.  The cytotoxicity test revealed that BU-OE had marked cytotoxic activities against cancer cells, but no evident inhibitory effects on normal cells.  Likewise, BU-OE exhibited significant antitumor efficacy against Hep G2, HCT-8, and EC9706 cell lines and a slight inhibitory effect on BGC 803 cell line in nude mice, while comparable antitumor activity with fluorouracil injection.  The LD50 of BU-OE in mice was 29.4 mg/kg (male) and 22.8 mg/kg (female), resp.  As for the long-term toxicity, BU-OE showed no apparent toxic effects except minor cardiotoxic effects which were reversible.  In conclusion, submicron emulsion is a suitable delivery system for oral administration of bufadienolides, with satisfactory stability, superior antitumor efficacy and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNHt7kPFPtW7Vg90H21EOLACvtfcHk0lgvyWaQPqmgTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFygurfJ&md5=1a95b56387d660fcdcdcd54a1574a7e5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2014.12.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2014.12.054%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DT.%26aulast%3DQu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DA%2520bufadienolide-loaded%2520submicron%2520emulsion%2520for%2520oral%2520administration%253A%2520stability%252C%2520antitumor%2520efficacy%2520and%2520toxicity%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2015%26volume%3D479%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.ijpharm.2014.12.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Xie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C. S.</span><span> </span><span class="NLM_article-title">Cardiac toxicity of resibufogenin: electrophysiological evidence</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=289-297&author=J.+T.+Xieauthor=L.+Deyauthor=J.+A.+Wuauthor=T.+K.+Lowellauthor=C.+S.+Yuan&title=Cardiac+toxicity+of+resibufogenin%3A+electrophysiological+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%2BT.%26aulast%3DDey%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.%2BA.%26aulast%3DLowell%26aufirst%3DT.%2BK.%26aulast%3DYuan%26aufirst%3DC.%2BS.%26atitle%3DCardiac%2520toxicity%2520of%2520resibufogenin%253A%2520electrophysiological%2520evidence%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2001%26volume%3D22%26spage%3D289%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kostakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byard, R. W.</span><span> </span><span class="NLM_article-title">Sudden death associated with intravenous injection of toad extract</span> <span class="citation_source-journal">Forensic Sci. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e5</span><span class="refDoi"> DOI: 10.1016/j.forsciint.2009.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.forsciint.2009.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=19303230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlKgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2009&pages=e1-e5&author=C.+Kostakisauthor=R.+W.+Byard&title=Sudden+death+associated+with+intravenous+injection+of+toad+extract&doi=10.1016%2Fj.forsciint.2009.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sudden death associated with intravenous injection of toad extract</span></div><div class="casAuthors">Kostakis, Chris; Byard, Roger W.</div><div class="citationInfo"><span class="NLM_cas:title">Forensic Science International</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">e1-e5</span>CODEN:
                <span class="NLM_cas:coden">FSINDR</span>;
        ISSN:<span class="NLM_cas:issn">0379-0738</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A 24-yr-old male died suddenly following the i.v. injection of what was believed to be the ring-derivate amphetamine ecstasy' (MDMA).  Toxicol. analyses of the victim's blood and the injected material, however, failed to reveal MDMA, but showed instead low levels of bufotenine, a tryptamine deriv. alkaloid found in the secretions of various toads.  In addn., resibufogenin, cinobufagin and bufalin, bufadienolides that are also found in toad venom, were identified in the injected material.  While these substances also occur in certain South American plants, the finding of paracetamol, promethazine and diclofenac would be in keeping with ingredients found in the traditional Chinese herbal product Chan Su that derives from the skin glands and secretions of toads and that is often adulterated with std. pharmaceutical drugs.  This case demonstrates the problems that users and sellers may encounter from the unknown compn. of street drugs and herbal medicines, and the danger that may be incurred from the injection of such materials.  It also shows the difficulties that may be assocd. with attempting to identify low levels of org. toxins in postmortem specimens necessitating a targeted screening approach guided by information obtained at the death scene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwVQWldP8dZLVg90H21EOLACvtfcHk0lh7MjjK_sAxtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKgsb0%253D&md5=f2891ed18d8b1e88ab924a2cf77b3e27</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.forsciint.2009.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.forsciint.2009.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DKostakis%26aufirst%3DC.%26aulast%3DByard%26aufirst%3DR.%2BW.%26atitle%3DSudden%2520death%2520associated%2520with%2520intravenous%2520injection%2520of%2520toad%2520extract%26jtitle%3DForensic%2520Sci.%2520Int.%26date%3D2009%26volume%3D188%26spage%3De1%26epage%3De5%26doi%3D10.1016%2Fj.forsciint.2009.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cunha-Filho, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resck, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalcanti, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessoa, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, M. L.</span><span> </span><span class="NLM_article-title">Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion</span> <span class="citation_source-journal">Toxicon</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1016/j.toxicon.2010.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.toxicon.2010.03.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=339-348&author=G.+A.+Cunha-Filhoauthor=I.+S.+Resckauthor=B.+C.+Cavalcantiauthor=C.+O.+Pessoaauthor=M.+O.+Moraesauthor=J.+R.+Ferreiraauthor=F.+A.+Rodriguesauthor=M.+L.+Dos+Santos&title=Cytotoxic+profile+of+natural+and+some+modified+bufadienolides+from+toad+Rhinella+schneideri+parotoid+gland+secretion&doi=10.1016%2Fj.toxicon.2010.03.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2010.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2010.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DCunha-Filho%26aufirst%3DG.%2BA.%26aulast%3DResck%26aufirst%3DI.%2BS.%26aulast%3DCavalcanti%26aufirst%3DB.%2BC.%26aulast%3DPessoa%26aufirst%3DC.%2BO.%26aulast%3DMoraes%26aufirst%3DM.%2BO.%26aulast%3DFerreira%26aufirst%3DJ.%2BR.%26aulast%3DRodrigues%26aufirst%3DF.%2BA.%26aulast%3DDos%2BSantos%26aufirst%3DM.%2BL.%26atitle%3DCytotoxic%2520profile%2520of%2520natural%2520and%2520some%2520modified%2520bufadienolides%2520from%2520toad%2520Rhinella%2520schneideri%2520parotoid%2520gland%2520secretion%26jtitle%3DToxicon%26date%3D2010%26volume%3D56%26spage%3D339%26epage%3D348%26doi%3D10.1016%2Fj.toxicon.2010.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. H.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships study of cytotoxic bufalin 3-nitrogen-containing-ester derivatives</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1016/j.steroids.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.steroids.2013.02.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=508-512&author=B.+Maauthor=Z.+Y.+Xiaoauthor=Y.+J.+Chenauthor=M.+Leiauthor=Y.+H.+Mengauthor=D.+A.+Guoauthor=X.+Liuauthor=L.+H.+Hu&title=Synthesis+and+structure-activity+relationships+study+of+cytotoxic+bufalin+3-nitrogen-containing-ester+derivatives&doi=10.1016%2Fj.steroids.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DY.%2BH.%26aulast%3DGuo%26aufirst%3DD.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%2BH.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520study%2520of%2520cytotoxic%2520bufalin%25203-nitrogen-containing-ester%2520derivatives%26jtitle%3DSteroids%26date%3D2013%26volume%3D78%26spage%3D508%26epage%3D512%26doi%3D10.1016%2Fj.steroids.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span> </span><span class="NLM_article-title">New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8947</span><span class="NLM_x">–</span> <span class="NLM_lpage">8955</span><span class="refDoi"> DOI: 10.1016/j.tet.2005.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.tet.2005.07.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=8947-8955&author=M.+Yeauthor=J.+Hanauthor=D.+Anauthor=G.+Tuauthor=D.+Guo&title=New+cytotoxic+bufadienolides+from+the+biotransformation+of+resibufogenin+by+Mucor+polymorphosporus&doi=10.1016%2Fj.tet.2005.07.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DD.%26aulast%3DTu%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DNew%2520cytotoxic%2520bufadienolides%2520from%2520the%2520biotransformation%2520of%2520resibufogenin%2520by%2520Mucor%2520polymorphosporus%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D8947%26epage%3D8955%26doi%3D10.1016%2Fj.tet.2005.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hayes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piggott, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capon, R. J.</span><span> </span><span class="NLM_article-title">Microbial biotransformation as a source of chemical diversity in cane toad steroid toxins</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1790</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.bmcl.2009.01.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1790-1792&author=R.+A.+Hayesauthor=A.+M.+Piggottauthor=K.+Dalleauthor=R.+J.+Capon&title=Microbial+biotransformation+as+a+source+of+chemical+diversity+in+cane+toad+steroid+toxins&doi=10.1016%2Fj.bmcl.2009.01.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.064%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DR.%2BA.%26aulast%3DPiggott%26aufirst%3DA.%2BM.%26aulast%3DDalle%26aufirst%3DK.%26aulast%3DCapon%26aufirst%3DR.%2BJ.%26atitle%3DMicrobial%2520biotransformation%2520as%2520a%2520source%2520of%2520chemical%2520diversity%2520in%2520cane%2520toad%2520steroid%2520toxins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1790%26epage%3D1792%26doi%3D10.1016%2Fj.bmcl.2009.01.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span> </span><span class="NLM_article-title">Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2004.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.jsbmb.2004.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=15261311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVSqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=87-98&author=M.+Yeauthor=G.+Quauthor=H.+Guoauthor=D.+Guo&title=Novel+cytotoxic+bufadienolides+derived+from+bufalin+by+microbial+hydroxylation+and+their+structure-activity+relationships&doi=10.1016%2Fj.jsbmb.2004.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships</span></div><div class="casAuthors">Ye, Min; Qu, Guiqin; Guo, Hongzhu; Guo, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Microbial transformation was used to prep. novel cytotoxic bufadienolides.  Twelve products (3-14) were obtained from bufalin (1) by the fungus Mucor spinosus.  Their structures were elucidated by high-resoln. mass spectroscopy (HR-MS) and extensive NMR techniques, including 1H NMR, 13C NMR, DEPT, 1H-1H correlation spectroscopy (COSY), two dimensional nuclear Overhauser effect correlation spectroscopy (NOESY), heteronuclear multiple quantum coherence (HMQC), and heteronuclear multiple bond coherence (HMBC).  Compds. 3, 4, 9 and 11-14 are new mono- or dihydroxylated derivs. of bufalin with novel oxy-functionalities at C-1β, C-7β, C-11β, C-12β and C-16α positions.  The in vitro cytotoxic activities against human cancer cell lines of 3-14, together with 16 biotransformed products derived from cinobufagin (15-30) were detd. by the MTT method, and their structure-activity relationships (SAR) were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSGHkcJYCvgLVg90H21EOLACvtfcHk0lh7MjjK_sAxtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVSqs7s%253D&md5=57932cdcf2b9219963cf66d1cdf640a3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2004.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2004.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DNovel%2520cytotoxic%2520bufadienolides%2520derived%2520from%2520bufalin%2520by%2520microbial%2520hydroxylation%2520and%2520their%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D91%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.jsbmb.2004.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Engineering enzymatically activated "molecular grenades" for cancer</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span><span class="refDoi"> DOI: 10.18632/oncotarget.562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.18632%2Foncotarget.562" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=666-667&author=S.+R.+Denmeadeauthor=J.+T.+Isaacs&title=Engineering+enzymatically+activated+%22molecular+grenades%22+for+cancer&doi=10.18632%2Foncotarget.562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.562%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DEngineering%2520enzymatically%2520activated%2520%2522molecular%2520grenades%2522%2520for%2520cancer%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D666%26epage%3D667%26doi%3D10.18632%2Foncotarget.562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span><span class="refDoi"> DOI: 10.1073/pnas.87.18.7235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1073%2Fpnas.87.18.7235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=2402505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers&doi=10.1073%2Fpnas.87.18.7235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span></div><div class="casAuthors">Garin-Chesa, Pilar; Old, Lloyd J.; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7235-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The F19 antigen is a cell surface glycoprotein (mol. wt. 95,000) of human sarcomas and proliferating cultured fibroblasts that is absent from resting fibroblasts in normal adult tissues.  Normal and malignant epithelial cells are also F19-.  The present immunohistochem. study describes induction of F19 in the reactive mesenchyme of epithelial tumors.  F19+ fibroblasts were found in primary and metastatic carcinomas, including colorectal, breast, ovarian, bladder, and lung carcinomas.  The stroma of benign colorectal adenomas, fibrocystic disease, and fibroadenomas of breast, benign prostate hyperplasia, bladder carcinomas, and benign ovarian tumors showed no or only moderate nos. of F19+ fibroblasts.  Anal. of dermal incision wounds revealed that F19 was strongly induced during scar formation.  Comparison of F19 with the extracellular matrix protein tenascin, a putative marker of tumor mesenchyme, showed a cellular staining pattern for F19 vs. the extracellular matrix pattern for tenascin and widespread expression of tenascin in F19- normal tissues and benign tumors.  The F19+ phenotype may correlate with specialized fibroblast functions in wound healing and malignant tumor growth.  Because of its abundance in tumor mesenchyme, F19 may serve as a target for antibodies labeled with radioisotopes or toxic agents, or inflammatogenic antibodies, in carcinoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_KYVTgRj8LVg90H21EOLACvtfcHk0lhCh2KGm2Zcjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D&md5=957bd13237f20c4f1e95a7a1b2204081</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.87.18.7235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.87.18.7235%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239%26doi%3D10.1073%2Fpnas.87.18.7235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Scanlan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Moncasi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">5657</span><span class="NLM_x">–</span> <span class="NLM_lpage">5661</span><span class="refDoi"> DOI: 10.1073/pnas.91.12.5657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1073%2Fpnas.91.12.5657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=7911242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADyaK2cXlsFajtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5657-5661&author=M.+J.+Scanlanauthor=B.+K.+Rajauthor=B.+Calvoauthor=P.+Garin-Chesaauthor=M.+P.+Sanz-Moncasiauthor=J.+H.+Healeyauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Molecular+cloning+of+fibroblast+activation+protein+alpha%2C+a+member+of+the+serine+protease+family+selectively+expressed+in+stromal+fibroblasts+of+epithelial+cancers&doi=10.1073%2Fpnas.91.12.5657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers</span></div><div class="casAuthors">Scanlan, Matthew J.; Raj, B. K. Mohan; Calvo, Benjamin; Garin-Chesa, Pilar; Sanz-Moncasi, M. Pilar; Healey, John H.; Old, Lloyd J.; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5657-61</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The human fibroblast activation protein α (FAPα) is a Mr 95,000 cell surface antigen selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas.  Normal adult tissues are generally FAPα-, but some fetal mesenchymal tissues transiently express the mol.  Because of its restricted normal tissue distribution and abundant expression in the stroma of over 90% of breast, colorectal, and lung carcinomas, FAPα is under clin. evaluation as a target for immunodetection and immunotherapy of epithelial cancers.  In the present study, the authors have isolated a full-length cDNA for FAPα through expression cloning in COS-1 cells.  The FAPα cDNA codes for a type II integral membrane protein with a large extracellular domain, transmembrane segment, and short cytoplasmic tail.  FAPα shows 48% amino acid sequence identity to the T-cell activation antigen CD26, a membrane-bound protein with dipeptidyl peptidase IV (DPPIV) activity; however, unlike FAPα, CD26 is widely expressed in normal tissues.  Three catalytic domains shared by DPPIV homologues in different species and by other serine proteases are conserved in FAPα.  Immunochem. anal. of COS-1 cells coexpressing FAPα and CD26 revealed that the two mols. form heteromeric cell surface complexes, suggesting that a previously identified FAPα-assocd. Mr 105,000 protein of cultured fibroblasts and growth factor-stimulated melanocytes, FAPβ, is identical to CD26.  In vivo coexpression of FAPα and CD26 is found in reactive fibroblasts of healing wounds but not in tumor stromal fibroblasts or sarcomas (FAPα+/CD26-).  The putative serine protease activity of FAPα and its in vivo induction pattern may indicate a role for this mol. in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_I5dna-9X1bVg90H21EOLACvtfcHk0lhCh2KGm2Zcjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsFajtbg%253D&md5=c5597e9614f4c0bf3961a946d6980719</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.12.5657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.12.5657%26sid%3Dliteratum%253Aachs%26aulast%3DScanlan%26aufirst%3DM.%2BJ.%26aulast%3DRaj%26aufirst%3DB.%2BK.%26aulast%3DCalvo%26aufirst%3DB.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DSanz-Moncasi%26aufirst%3DM.%2BP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DMolecular%2520cloning%2520of%2520fibroblast%2520activation%2520protein%2520alpha%252C%2520a%2520member%2520of%2520the%2520serine%2520protease%2520family%2520selectively%2520expressed%2520in%2520stromal%2520fibroblasts%2520of%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D5657%26epage%3D5661%26doi%3D10.1073%2Fpnas.91.12.5657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissil, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pure, E.</span><span> </span><span class="NLM_article-title">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3613</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span><span class="refDoi"> DOI: 10.1172/JCI38988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1172%2FJCI38988" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3613-3625&author=A.+M.+Santosauthor=J.+Jungauthor=N.+Azizauthor=J.+L.+Kissilauthor=E.+Pure&title=Targeting+fibroblast+activation+protein+inhibits+tumor+stromagenesis+and+growth+in+mice&doi=10.1172%2FJCI38988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1172%2FJCI38988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38988%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKissil%26aufirst%3DJ.%2BL.%26aulast%3DPure%26aufirst%3DE.%26atitle%3DTargeting%2520fibroblast%2520activation%2520protein%2520inhibits%2520tumor%2520stromagenesis%2520and%2520growth%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3613%26epage%3D3625%26doi%3D10.1172%2FJCI38988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salakian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnands, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span> </span><span class="NLM_article-title">Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">19441</span><span class="NLM_x">–</span> <span class="NLM_lpage">19444</span><span class="refDoi"> DOI: 10.1074/jbc.C500092200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1074%2Fjbc.C500092200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19441-19444&author=K.+Aertgeertsauthor=I.+Levinauthor=L.+H.+Shiauthor=G.+P.+Snellauthor=A.+Jenningsauthor=G.+S.+Prasadauthor=Y.+M.+Zhangauthor=M.+L.+Krausauthor=S.+Salakianauthor=V.+Sridharauthor=R.+Wijnandsauthor=M.+G.+Tennant&title=Structural+and+kinetic+analysis+of+the+substrate+specificity+of+human+fibroblast+activation+protein+%CE%B1&doi=10.1074%2Fjbc.C500092200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500092200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500092200%26sid%3Dliteratum%253Aachs%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DLevin%26aufirst%3DI.%26aulast%3DShi%26aufirst%3DL.%2BH.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DSalakian%26aufirst%3DS.%26aulast%3DSridhar%26aufirst%3DV.%26aulast%3DWijnands%26aufirst%3DR.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26atitle%3DStructural%2520and%2520kinetic%2520analysis%2520of%2520the%2520substrate%2520specificity%2520of%2520human%2520fibroblast%2520activation%2520protein%2520%25CE%25B1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19441%26epage%3D19444%26doi%3D10.1074%2Fjbc.C500092200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netto, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span><span class="refDoi"> DOI: 10.1002/pros.22847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fpros.22847" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1308-1319&author=W.+N.+Brennenauthor=D.+M.+Rosenauthor=A.+Chauxauthor=G.+J.+Nettoauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Pharmacokinetics+and+toxicology+of+a+fibroblast+activation+protein+%28FAP%29-activated+prodrug+in+murine+xenograft+models+of+human+cancer&doi=10.1002%2Fpros.22847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fpros.22847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22847%26sid%3Dliteratum%253Aachs%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DChaux%26aufirst%3DA.%26aulast%3DNetto%26aufirst%3DG.%2BJ.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DPharmacokinetics%2520and%2520toxicology%2520of%2520a%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529-activated%2520prodrug%2520in%2520murine%2520xenograft%2520models%2520of%2520human%2520cancer%26jtitle%3DProstate%26date%3D2014%26volume%3D74%26spage%3D1308%26epage%3D1319%26doi%3D10.1002%2Fpros.22847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Akinboye, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakare, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1002/pros.23162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fpros.23162" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=703-714&author=E.+S.+Akinboyeauthor=W.+N.+Brennenauthor=D.+M.+Rosenauthor=O.+Bakareauthor=S.+R.+Denmeade&title=Iterative+design+of+emetine-based+prodrug+targeting+fibroblast+activation+protein+%28FAP%29+and+dipeptidyl+peptidase+IV+DPPIV+using+a+tandem+enzymatic+activation+strategy&doi=10.1002%2Fpros.23162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fpros.23162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.23162%26sid%3Dliteratum%253Aachs%26aulast%3DAkinboye%26aufirst%3DE.%2BS.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DBakare%26aufirst%3DO.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DIterative%2520design%2520of%2520emetine-based%2520prodrug%2520targeting%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520dipeptidyl%2520peptidase%2520IV%2520DPPIV%2520using%2520a%2520tandem%2520enzymatic%2520activation%2520strategy%26jtitle%3DProstate%26date%3D2016%26volume%3D76%26spage%3D703%26epage%3D714%26doi%3D10.1002%2Fpros.23162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug</span> <span class="citation_source-journal">J. Natl. Cancer I.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1320</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1093/jnci/djs336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fjnci%2Fdjs336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=22911669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCqtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2012&pages=1320-1334&author=W.+N.+Brennenauthor=D.+M.+Rosenauthor=H.+Wangauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Targeting+carcinoma-associated+fibroblasts+within+the+tumor+stroma+with+a+fibroblast+activation+protein-activated+prodrug&doi=10.1093%2Fjnci%2Fdjs336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug</span></div><div class="casAuthors">Brennen, W. Nathaniel; Rosen, D. Marc; Wang, Hao; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1320-1334</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Fibroblasts undergo a morphol. transformation to a reactive phenotype in the tumor microenvironment characterized by the expression of proteins such as fibroblast activation protein (FAP), a post-prolyl endopeptidase with expression largely restricted to carcinoma-assocd. fibroblasts.  Thapsigargin (TG) is a highly toxic natural plant product that triggers a rise in intracellular calcium levels and apoptosis.  FAP is therefore a provocative target for the activation of prodrugs consisting of a FAP-specific peptide coupled to a potent cytotoxic analog of TG.  The efficacy of FAP-activated peptidyl-TG prodrugs was tested in vitro in cell proliferation assays and effects on intracellular calcium in human cancer cell lines.  The effects of FAP-activated prodrugs on tumor growth and host toxicity were tested in Balb-C nude MCF-7 and LNCaP xenograft mice (n = 9-11 per group).  P values were calcd. using permutation tests based on 50 000 permutations.  Mixed effects models were used to account for correlations among replicate measures.  All statistical tests were two-sided.  FAP-activated prodrugs killed human cancer cells at low nanomolar concns. (MCF-7 cells: IC50 = 3.5nM).  Amino acid-12ADT analogs from FAP-cleaved prodrugs, but not uncleaved prodrugs, produced a rapid rise in intracellular calcium within minutes of exposure.  Immunohistochem. anal. of xenografts exposed to FAP-prodrugs documented stromal-selective cell death of fibroblasts, pericytes, and endothelial cells of sufficient magnitude to inhibit growth of MCF-7 and LNCaP xenografts with minimal systemic toxicity, whereas non-FAP cleavable prodrugs were inactive.  MCF-7 and LNCaP xenografts treated with a FAP-activated prodrug had maximal treated-to-control tumor vol. ratios of 0.36 (treated: mean = 0.206mm3, 95% CI = 0.068 to 0.344mm3; control: mean = 0.580mm3, 95% CI = 0.267 to 0.893mm3) and 0.24 (treated: mean = 0.131mm3, 95% CI = 0.09 to 0.180mm3; control: mean = 0.543mm3, 95% CI = 0.173 to 0.913mm3), resp., on day 21 after therapy.  This study validates the proteolytic activity of FAP as a target for the activation of a systemically delivered cytotoxic prodrug and demonstrates that targeted killing of cells within the stromal compartment of the tumor microenvironment can produce a therapeutic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8_szDQo-aLVg90H21EOLACvtfcHk0lhuAuSeKwMwLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCqtr7L&md5=5e2568f8d80d92daa0f8902adfe6d557</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjs336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjs336%26sid%3Dliteratum%253Aachs%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DTargeting%2520carcinoma-associated%2520fibroblasts%2520within%2520the%2520tumor%2520stroma%2520with%2520a%2520fibroblast%2520activation%2520protein-activated%2520prodrug%26jtitle%3DJ.%2520Natl.%2520Cancer%2520I.%26date%3D2012%26volume%3D104%26spage%3D1320%26epage%3D1334%26doi%3D10.1093%2Fjnci%2Fdjs336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1378</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-1170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1158%2F1535-7163.MCT-08-1170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=19417147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jslGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1378-1386&author=A.+M.+LeBeauauthor=W.+N.+Brennenauthor=S.+Aggarwalauthor=S.+R.+Denmeade&title=Targeting+the+cancer+stroma+with+a+fibroblast+activation+protein-activated+promelittin+protoxin&doi=10.1158%2F1535-7163.MCT-08-1170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin</span></div><div class="casAuthors">LeBeau Aaron M; Brennen W Nathaniel; Aggarwal Saurabh; Denmeade Samuel R</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1378-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fibroblast-Activation Protein-α (FAP) is a membrane-bound serine protease that is expressed on the surface of reactive stromal fibroblasts present within the majority of human epithelial tumors but is not expressed by normal tissues.  FAP is a postprolyl peptidase that differs from other dipeptidyl prolyl peptidases such as diprolylpeptidase 4 in that it also has gelatinase and collagenase endopeptidase activity.  Therefore, FAP represents a potential pan-tumor target whose enzymatic activity can be exploited for the intratumoral activation of prodrugs and protoxins.  To evaluate FAP as a tumor-specific target, putative FAP-selective peptide protoxins were constructed through modification of the prodomain of melittin, a 26 amino acid amphipathic cytolytic peptide that is the main toxic component in the venom of the common European honeybee Apis milefera.  Melittin is synthesized as promelittin, containing a 22 amino acid NH(2)-terminal prodomain rich in the amino acids proline and alanine.  In this study, peptides containing truncated melittin prodomain sequences were tested on erythrocytes to determine the optimal prodomain length for inhibiting cytolytic activity.  Once optimized, modified promelittin peptides were generated in which previously identified FAP substrate sequences were introduced into the prodomain.  Peptide protoxins were identified that were efficiently activated by FAP and selectively toxic to FAP-expressing cell lines with an IC(50) value in the low micromolar range that is similar to melittin.  Intratumoral injection of an FAP-activated protoxin produced significant lysis and growth inhibition of human breast and prostate cancer xenografts with minimal toxicity to the host animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU7D_2lNRo3L5XHngOXiV_fW6udTcc2eYg0JhWj_WgKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jslGiuw%253D%253D&md5=3f5a2d4bc4a6632784309d09ea3c39b7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1170%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DTargeting%2520the%2520cancer%2520stroma%2520with%2520a%2520fibroblast%2520activation%2520protein-activated%2520promelittin%2520protoxin%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1378%26epage%3D1386%26doi%3D10.1158%2F1535-7163.MCT-08-1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span> </span><span class="NLM_article-title">Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.bcp.2012.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=22305746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Olu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1251-1260&author=M.+Liauthor=S.+Wuauthor=Z.+Liuauthor=W.+Zhangauthor=J.+Xuauthor=Y.+Wangauthor=J.+Liuauthor=D.+Zhangauthor=H.+Tianauthor=Y.+Liauthor=W.+Ye&title=Arenobufagin%2C+a+bufadienolide+compound+from+toad+venom%2C+inhibits+VEGF-mediated+angiogenesis+through+suppression+of+VEGFR-2+signaling+pathway&doi=10.1016%2Fj.bcp.2012.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway</span></div><div class="casAuthors">Li, Manmei; Wu, Shuai; Liu, Zhong; Zhang, Wei; Xu, Jing; Wang, Ying; Liu, Junshan; Zhang, Dongmei; Tian, Haiyan; Li, Yaolan; Ye, Wencai</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1251-1260</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Angiogenesis is crucial for carcinogenesis and other angiogenic processes.  Arenobufagin, one of the major components of toad venom, is a traditional Chinese medicine used for cancer therapy.  It inhibits cell growth in several cancer cell lines.  However, little is known about arenobufagin's anti-angiogenic activity.  In this study, we showed that arenobufagin inhibited vascular endothelial growth factor (VEGF)-induced viability, migration, invasion and tube formation in human umbilical vein endothelial cells (HUVECs) in vitro.  Arenobufagin also suppressed sprouting formation from VEGF-treated aortic rings in an ex vivo model.  Furthermore, we found that arenobufagin blocked angiogenesis in a matrigel plugs assay.  Computer simulations suggested that arenobufagin interacted with the ATP-binding sites of VEGFR-2 by docking.  In addn., arenobufagin inhibited VEGF-induced VEGFR-2 auto-phosphorylation and suppressed the activity of VEGFR-2-mediated signaling cascades.  Taken together, our findings demonstrate that arenobufagin is a specific inhibitor of VEGF-mediated angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzhWOnk2ZnP7Vg90H21EOLACvtfcHk0linPUU7wqbgRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Olu7Y%253D&md5=27ce325f99dfad8e9432c9f39bed29ba</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DArenobufagin%252C%2520a%2520bufadienolide%2520compound%2520from%2520toad%2520venom%252C%2520inhibits%2520VEGF-mediated%2520angiogenesis%2520through%2520suppression%2520of%2520VEGFR-2%2520signaling%2520pathway%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1251%26epage%3D1260%26doi%3D10.1016%2Fj.bcp.2012.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span><span class="refDoi"> DOI: 10.1016/j.febslet.2006.01.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.febslet.2006.01.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=1581-1586&author=C.+Y.+Edosadaauthor=C.+Quanauthor=T.+Tranauthor=V.+Phamauthor=C.+Wiesmannauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Peptide+substrate+profiling+defines+fibroblast+activation+protein+as+an+endopeptidase+of+strict+Gly%282%29-Pro%281%29-cleaving+specificity&doi=10.1016%2Fj.febslet.2006.01.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2006.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2006.01.087%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DPeptide%2520substrate%2520profiling%2520defines%2520fibroblast%2520activation%2520protein%2520as%2520an%2520endopeptidase%2520of%2520strict%2520Gly%25282%2529-Pro%25281%2529-cleaving%2520specificity%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D1581%26epage%3D1586%26doi%3D10.1016%2Fj.febslet.2006.01.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1093/jb/mvr017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fjb%2Fmvr017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=21288888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVaqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2011&pages=685-692&author=C.+H.+Huangauthor=C.+S.+Suenauthor=C.+T.+Linauthor=C.+H.+Chienauthor=H.+Y.+Leeauthor=K.+M.+Chungauthor=T.+Y.+Tsaiauthor=W.+T.+Jiaangauthor=M.+J.+Hwangauthor=X.+Chen&title=Cleavage-site+specificity+of+prolyl+endopeptidase+FAP+investigated+with+a+full-length+protein+substrate&doi=10.1093%2Fjb%2Fmvr017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate</span></div><div class="casAuthors">Huang, Chih-Hsiang; Suen, Ching-Shu; Lin, Ching-Ting; Chien, Chia-Hui; Lee, Hsin-Ying; Chung, Kuei-Min; Tsai, Ting-Yueh; Jiaang, Weir-Tong; Hwang, Ming-Jing; Chen, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAP) is a prolyl-cleaving endopeptidase proposed as an anti-cancer drug target.  It is necessary to define its cleavage-site specificity to facilitate the identification of its in vivo substrates and to understand its biol. functions.  We found that the previously identified substrate of FAP, α2-anti-plasmin (α2-AP), is not a robust substrate in vitro.  Instead, an intracellular protein, SPRY2, is cleavable by FAP and more suitable for investigation of its substrate specificity in the context of the full-length globular protein.  FAP prefers uncharged residues, including small or bulky hydrophobic amino acids, but not charged amino acids, esp. acidic residue at P1', P3 and P4 sites.  Mol. modeling anal. shows that the substrate-binding site of FAP is surrounded by multiple tyrosine residues and some neg. charged residues, which may exhibit a low preference for substrates with acidic residues.  This provides an explanation why FAP cannot cleave interleukins, which have a glutamate at either P4 or P2', despite their P3-P2-P1 sites being identical to SPRY2 or α-AP.  Our study provided new information on FAP cleavage-site specificity, which differs from the data obtained by profiling with a peptide library or with the denatured protein, gelatin, as the substrate.  Furthermore, our study suggests that neg. charged residues should be avoided when designing FAP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRyKb4ZKvcxLVg90H21EOLACvtfcHk0linPUU7wqbgRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVaqsrk%253D&md5=e0abef970e8f795da1acd48d2dee6a43</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvr017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvr017%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DSuen%26aufirst%3DC.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BT.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DChung%26aufirst%3DK.%2BM.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26aulast%3DHwang%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DCleavage-site%2520specificity%2520of%2520prolyl%2520endopeptidase%2520FAP%2520investigated%2520with%2520a%2520full-length%2520protein%2520substrate%26jtitle%3DJ.%2520Biochem.%26date%3D2011%26volume%3D149%26spage%3D685%26epage%3D692%26doi%3D10.1093%2Fjb%2Fmvr017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5158</span><span class="refDoi"> DOI: 10.1021/bi900257m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900257m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtF2rsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5149-5158&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=S.+Terzyanauthor=V.+J.+Christiansenauthor=P.+A.+McKee&title=Using+substrate+specificity+of+antiplasmin-cleaving+enzyme+for+fibroblast+activation+protein+inhibitor+design&doi=10.1021%2Fbi900257m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Using Substrate Specificity of Antiplasmin-Cleaving Enzyme for Fibroblast Activation Protein Inhibitor Design</span></div><div class="casAuthors">Lee, Kyung N.; Jackson, Kenneth W.; Terzyan, Simon; Christiansen, Victoria J.; McKee, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5149-5158</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Circulating antiplasmin-cleaving enzyme (APCE), a prolyl-specific serine proteinase, is essentially identical to membrane-inserted fibroblast activation protein (FAP) that is transiently expressed during epithelial-derived cancer growth.  Human precursive α2-antiplasmin (Met-α2AP), the only known physiol. substrate for APCE, is cleaved N-terminally to Asn-α2AP that is rapidly crosslinked to fibrin and protects it from digestion by plasmin.  Identifying a specific inhibitor of APCE/FAP continues to be intensely pursued.  Recombinant FAP cleavage of peptide libraries of short amino acid sequences surrounding the scissile bond, -Pro12-Asn13-, indicated that P2 Gly and P1 Pro are required, just as we found for APCE.  We examd. cleavage of P4-P4' peptides, using 19 amino acid substitutions at each position and selected ones in P8-P5.  Km values detd. for peptide substrates showed that P7 Arg has the highest affinity for APCE.  Peptide cleavage rate increased with Arg in P6 rather than P5 or native P7.  Placing Arg in P4 or P8 reduced cleavage rates dramatically.  Cleavage of substrates with extended peptide sequences before or after the scissile bond showed endopeptidase to be superior to dipeptidase activity for APCE.  A substrate analog inhibitor, Phe-Arg-(8-amino-3,6-dioxaoctanoic acid)-Gly-[r]-fluoropyrrolidide, inhibited APCE with a Ki of 54 μM but not dipeptidyl peptidase IV even at 2 mM.  The inhibitor also blocked cleavage of Met-α2AP with an IC50 of 91 μM.  Replacing Arg with Gly at the same distance from fluoropyrrolidide as P7 Arg is from P1 Pro reduced its inhibition of APCE ∼10-fold.  Results indicate that Arg at P5, P6, or P7 distances from P1 enhances affinity and efficiency of substrates or inhibitors toward APCE or FAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFclagXGtiPLVg90H21EOLACvtfcHk0lj4BjlBUysZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtF2rsbg%253D&md5=2e9f547f3a5fcf510b0d8f2863958426</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi900257m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900257m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DUsing%2520substrate%2520specificity%2520of%2520antiplasmin-cleaving%2520enzyme%2520for%2520fibroblast%2520activation%2520protein%2520inhibitor%2520design%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D5149%26epage%3D5158%26doi%3D10.1021%2Fbi900257m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hutzler, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, T. S.</span><span> </span><span class="NLM_article-title">Atypical kinetic profiles in drug metabolism reactions</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1124/dmd.30.4.355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1124%2Fdmd.30.4.355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=11901086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Ols7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=355-362&author=J.+M.+Hutzlerauthor=T.+S.+Tracy&title=Atypical+kinetic+profiles+in+drug+metabolism+reactions&doi=10.1124%2Fdmd.30.4.355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical kinetic profiles in drug metabolism reactions</span></div><div class="casAuthors">Hutzler, J. Matthew; Tracy, Timothy S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-362</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The cytochrome P 450 enzymes are involved in the biotransformation of both xenobiotic and endobiotic hydrophobic compds., implicated in the bioactivation of certain procarcinogens (e.g., benzo[a]pyrene), and responsible for many metab.-based drug-drug interactions.  Consequently, the goal of drug metab. and toxicol. labs is to not only to det. the P 450 isoform contribution to the metab. of a given compd. but also to understand the various factors that effect the activity and behavior of these isoforms.  Classically, metab. of a particular compd. is described kinetically using the Michaelis-Menten equation, which yields a hyperbolic rate profile and ests. of maximal reaction velocity (Vmax) and apparent Km.  It is evident, however, that for some drugs the kinetic profile is better described by a non-Michaelis-Menten or atypical kinetic model.  Atypical kinetic profiles are proposed to fall into five categories, i.e., activation, autoactivation, substrate inhibition, partial inhibition, and biphasic metab.  Each of these categories is described with some specific examples.  The implications of atypical kinetics with respect to in vitro-in vivo correlations are discussed, as well as artifactual sources of atypical kinetic profiles and in vivo observations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOBfZ77w9Wu7Vg90H21EOLACvtfcHk0lj4BjlBUysZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Ols7s%253D&md5=b98944bf901e233b623303c6d09fae15</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.4.355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.4.355%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DTracy%26aufirst%3DT.%2BS.%26atitle%3DAtypical%2520kinetic%2520profiles%2520in%2520drug%2520metabolism%2520reactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D355%26epage%3D362%26doi%3D10.1124%2Fdmd.30.4.355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kole, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topaloglu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span><span class="refDoi"> DOI: 10.1021/bi701921b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi701921b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1076-1086&author=S.+Aggarwalauthor=W.+N.+Brennenauthor=T.+P.+Koleauthor=E.+Schneiderauthor=O.+Topalogluauthor=M.+Yatesauthor=R.+J.+Cotterauthor=S.+R.+Denmeade&title=Fibroblast+activation+protein+peptide+substrates+identified+from+human+collagen+I+derived+gelatin+cleavage+sites&doi=10.1021%2Fbi701921b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi701921b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701921b%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DKole%26aufirst%3DT.%2BP.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DTopaloglu%26aufirst%3DO.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DFibroblast%2520activation%2520protein%2520peptide%2520substrates%2520identified%2520from%2520human%2520collagen%2520I%2520derived%2520gelatin%2520cleavage%2520sites%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D1076%26epage%3D1086%26doi%3D10.1021%2Fbi701921b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Fricker, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastreich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Automated drawing of structural molecular formulas under constraints</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1078</span><span class="refDoi"> DOI: 10.1021/ci049958u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci049958u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVyrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=1065-1078&author=P.+C.+Frickerauthor=M.+Gastreichauthor=M.+Rarey&title=Automated+drawing+of+structural+molecular+formulas+under+constraints&doi=10.1021%2Fci049958u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Automated Drawing of Structural Molecular Formulas under Constraints</span></div><div class="casAuthors">Fricker, Patrick C.; Gastreich, Marcus; Rarey, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1065-1078</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present a new algorithm for automated drawing of 2D structural formulas of mols.  The algorithm is based on the classical scheme of a drawing queue placing the mol. fragments in a sequential way.  We extend the concept of so-called prefabricated units developed for complex ring systems to automatically created drawing units for chains and rings which will then be assembled in a sequential fashion.  The approach is fast and can be naturally extended to the problem of drawing mols. with common core structures.  Further on, we present an algorithm that allows the drawing of 2D structural formulas under directional constraints assigned to a subset of bonds.  Since no numerical optimization is necessary, the algorithm creates drawings of small org. mols. on the order of 500 structures per s.  The new algorithm is relevant for all kinds of prediction and anal. software presenting a large no. of probably similar mol. structures to the user of the software.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgX0puSSdKbVg90H21EOLACvtfcHk0lh91kGOrJq8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVyrtLk%253D&md5=79d40a22b8fe66858694a695d69a5da5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fci049958u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049958u%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DP.%2BC.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DAutomated%2520drawing%2520of%2520structural%2520molecular%2520formulas%2520under%2520constraints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D1065%26epage%3D1078%26doi%3D10.1021%2Fci049958u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Stierand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">From modeling to medicinal chemistry: automatic generation of two-dimensional complex diagrams</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1002/cmdc.200700010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fcmdc.200700010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=853-860&author=K.+Stierandauthor=M.+Rarey&title=From+modeling+to+medicinal+chemistry%3A+automatic+generation+of+two-dimensional+complex+diagrams&doi=10.1002%2Fcmdc.200700010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700010%26sid%3Dliteratum%253Aachs%26aulast%3DStierand%26aufirst%3DK.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DFrom%2520modeling%2520to%2520medicinal%2520chemistry%253A%2520automatic%2520generation%2520of%2520two-dimensional%2520complex%2520diagrams%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D853%26epage%3D860%26doi%3D10.1002%2Fcmdc.200700010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Stierand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maass, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Molecular complexes at a glance: automated generation of two-dimensional complex diagrams</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1710</span><span class="NLM_x">–</span> <span class="NLM_lpage">1716</span><span class="refDoi"> DOI: 10.1093/bioinformatics/btl150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fbioinformatics%2Fbtl150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=1710-1716&author=K.+Stierandauthor=P.+C.+Maassauthor=M.+Rarey&title=Molecular+complexes+at+a+glance%3A+automated+generation+of+two-dimensional+complex+diagrams&doi=10.1093%2Fbioinformatics%2Fbtl150"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtl150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtl150%26sid%3Dliteratum%253Aachs%26aulast%3DStierand%26aufirst%3DK.%26aulast%3DMaass%26aufirst%3DP.%2BC.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DMolecular%2520complexes%2520at%2520a%2520glance%253A%2520automated%2520generation%2520of%2520two-dimensional%2520complex%2520diagrams%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26spage%3D1710%26epage%3D1716%26doi%3D10.1093%2Fbioinformatics%2Fbtl150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Stierand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Drawing the PDB: protein-ligand complexes in two dimensions</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1021/ml100164p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100164p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=540-545&author=K.+Stierandauthor=M.+Rarey&title=Drawing+the+PDB%3A+protein-ligand+complexes+in+two+dimensions&doi=10.1021%2Fml100164p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Drawing the PCB: Protein-Ligand Complexes in Two Dimensions</span></div><div class="casAuthors">Stierand, Katrin; Rarey, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">540-545</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two-dimensional representation of mols. is a popular communication medium in chem. and the assocd. scientific fields.  Computational methods for drawing small mols. with and without manual investigation are well-established and widely spread in terms of numerous software tools.  Concerning the planar depiction of mol. complexes, there is considerably less choice.  We developed the software PoseView, which automatically generates two-dimensional diagrams of macromol. complexes, showing the ligand, the interactions, and the interacting residues.  All depicted mols. are drawn on an at. level as structure diagrams; thus, the output plots are clearly structured and easily readable for the scientist.  We tested the performance of PoseView in a large-scale application on nearly all drug-like complexes of the PDB (approx. 200000 complexes); for more than 92% of the complexes considered for drawing, a layout could be computed.  In the following, we will present the results of this application study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG4AYcqSlSGbVg90H21EOLACvtfcHk0lh91kGOrJq8gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtr3M&md5=bb61ee7c42e86e5a931b370255a894a7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fml100164p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100164p%26sid%3Dliteratum%253Aachs%26aulast%3DStierand%26aufirst%3DK.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DDrawing%2520the%2520PDB%253A%2520protein-ligand%2520complexes%2520in%2520two%2520dimensions%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D540%26epage%3D545%26doi%3D10.1021%2Fml100164p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Tran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnasamy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Restifo, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. A.</span><span> </span><span class="NLM_article-title">Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span><span class="refDoi"> DOI: 10.1084/jem.20130110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1084%2Fjem.20130110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=1125-1135&author=E.+Tranauthor=D.+Chinnasamyauthor=Z.+Yuauthor=R.+A.+Morganauthor=C.+C.+Leeauthor=N.+P.+Restifoauthor=S.+A.+Rosenberg&title=Immune+targeting+of+fibroblast+activation+protein+triggers+recognition+of+multipotent+bone+marrow+stromal+cells+and+cachexia&doi=10.1084%2Fjem.20130110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1084%2Fjem.20130110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20130110%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DE.%26aulast%3DChinnasamy%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26aulast%3DRosenberg%26aufirst%3DS.%2BA.%26atitle%3DImmune%2520targeting%2520of%2520fibroblast%2520activation%2520protein%2520triggers%2520recognition%2520of%2520multipotent%2520bone%2520marrow%2520stromal%2520cells%2520and%2520cachexia%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D1125%26epage%3D1135%26doi%3D10.1084%2Fjem.20130110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2008.07241.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1111%2Fj.1365-2141.2008.07241.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=18510677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2008&pages=827-830&author=S.+Baeauthor=C.+W.+Parkauthor=H.+K.+Sonauthor=H.+K.+Juauthor=D.+Paikauthor=C.+J.+Jeonauthor=G.+Y.+Kohauthor=J.+Kimauthor=H.+Kim&title=Fibroblast+activation+protein+alpha+identifies+mesenchymal+stromal+cells+from+human+bone+marrow&doi=10.1111%2Fj.1365-2141.2008.07241.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow</span></div><div class="casAuthors">Bae, Sohyun; Park, Chae Woon; Son, Hye Kyung; Ju, Hye Kyung; Paik, Donggi; Jeon, Choon-Ju; Koh, Gou Young; Kim, Jaeseob; Kim, Hoeon</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mesenchymal stromal cells (MSCs) have gained widespread popularity in cell therapy, but their development into clin. products has been impeded by the scarcity of cell-specific markers.  We previously explored transcriptome and membrane proteome of MSCs, from which fibroblast activation protein α (FAP) was recognized as a prime surface marker candidate.  The present study showed that FAP was constitutively expressed on MSCs, but not on other cells.  FAP immunoselection yielded homogeneous MSCs from cryopreserved bone marrow (BM).  These results suggest that FAP serves as a surface protein marker that can singly define MSCs from BM and possibly from other sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomL8KTuYNoSrVg90H21EOLACvtfcHk0lhUDLTEC0fZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK&md5=9df43578ca2dba65fe288a3e48c2e5ba</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2008.07241.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2008.07241.x%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%2BW.%26aulast%3DSon%26aufirst%3DH.%2BK.%26aulast%3DJu%26aufirst%3DH.%2BK.%26aulast%3DPaik%26aufirst%3DD.%26aulast%3DJeon%26aufirst%3DC.%2BJ.%26aulast%3DKoh%26aufirst%3DG.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520identifies%2520mesenchymal%2520stromal%2520cells%2520from%2520human%2520bone%2520marrow%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D142%26spage%3D827%26epage%3D830%26doi%3D10.1111%2Fj.1365-2141.2008.07241.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3783</span><span class="NLM_x">–</span> <span class="NLM_lpage">3788</span><span class="refDoi"> DOI: 10.1182/blood-2003-12-4240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1182%2Fblood-2003-12-4240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=3783-3788&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=K.+H.+Chungauthor=P.+A.+McKee&title=A+novel+plasma+proteinase+potentiates+alpha2-antiplasmin+inhibition+of+fibrin+digestion&doi=10.1182%2Fblood-2003-12-4240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-12-4240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-12-4240%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DChung%26aufirst%3DK.%2BH.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520plasma%2520proteinase%2520potentiates%2520alpha2-antiplasmin%2520inhibition%2520of%2520fibrin%2520digestion%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D3783%26epage%3D3788%26doi%3D10.1182%2Fblood-2003-12-4240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span><span class="refDoi"> DOI: 10.1182/blood-2005-08-3452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1182%2Fblood-2005-08-3452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=1397-1404&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=C.+S.+Leeauthor=J.+G.+Chunauthor=P.+A.+McKee&title=Antiplasmin-cleaving+enzyme+is+a+soluble+form+of+fibroblast+activation+protein&doi=10.1182%2Fblood-2005-08-3452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-08-3452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-08-3452%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChun%26aufirst%3DJ.%2BG.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DAntiplasmin-cleaving%2520enzyme%2520is%2520a%2520soluble%2520form%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D1397%26epage%3D1404%26doi%3D10.1182%2Fblood-2005-08-3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Jia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span> </span><span class="NLM_article-title">FAP-alpha (Fibroblast activation protein-alpha) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway</span> <span class="citation_source-journal">BMC Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/1471-2121-15-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1186%2F1471-2121-15-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=24885257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=16&author=J.+Jiaauthor=T.+A.+Martinauthor=L.+Yeauthor=W.+G.+Jiang&title=FAP-alpha+%28Fibroblast+activation+protein-alpha%29+is+involved+in+the+control+of+human+breast+cancer+cell+line+growth+and+motility+via+the+FAK+pathway&doi=10.1186%2F1471-2121-15-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway</span></div><div class="casAuthors">Jia, Jun; Martin, Tracey Amanda; Ye, Lin; Jiang, Wen Guo</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">BCBMAY</span>;
        ISSN:<span class="NLM_cas:issn">1471-2121</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Fibroblast Activation Protein alpha (FAP-α) or seprase is an integral membrane serine peptidase.  Previous work has not satisfactorily explained both the suppression and promotion effects that have been obsd. in cancer.  The purpose of this work was to investigate the role of FAP-α in human breast cancer.  Expression of FAP-α was characterized in primary tumor samples and in cell lines, along with the effects of FAP-α expression on in vitro growth, invasion, attachment and migration.  Furthermore the potential interaction of FAP-α with other signalling pathways was investigated.  Results: FAP-α was significantly increased in patients with poor outcome and survival.  In vitro results showed that breast cancer cells over expressing FAP-α had increased growth ability and impaired migratory ability.  The growth of MDA-MB-231 cells and the adhesion and invasion ability of both MCF-7 cells and MDA-MB-231 cells were not dramatically influenced by FAP-α expression.  Over-expression of FAP-α resulted in a redn. of phosphorylated focal adhesion kinase (FAK) level in both cells cultured in normal media and serum-free media.  An inhibitor to FAK restored the reduced motility ability of both MCF-7exp cells and MDA-MB-231exp cells and prevented the change in phosphorylated FAK levels.  However, inhibitors to PI3K, ERK, PLCY, NWASP, ARP2/3, and ROCK had no influence this.  Conclusions: FAP-α in significantly assocd. with poor outcome in patients with breast cancer.  In vitro, FAP-α promotes proliferation and inhibits migration of breast cancer cells, potentially by regulating the FAK pathway.  These results suggest FAP-α could be a target for future therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0YeU4O0xHbVg90H21EOLACvtfcHk0lhUDLTEC0fZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFSisr8%253D&md5=efeaff2ac55fdf9b14eace3fb29920e3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1186%2F1471-2121-15-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2121-15-16%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DT.%2BA.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DFAP-alpha%2520%2528Fibroblast%2520activation%2520protein-alpha%2529%2520is%2520involved%2520in%2520the%2520control%2520of%2520human%2520breast%2520cancer%2520cell%2520line%2520growth%2520and%2520motility%2520via%2520the%2520FAK%2520pathway%26jtitle%3DBMC%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D16%26doi%3D10.1186%2F1471-2121-15-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span> </span><span class="NLM_article-title">Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5734</span><span class="NLM_x">–</span> <span class="NLM_lpage">5743</span><span class="refDoi"> DOI: 10.1021/jm400881m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400881m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5734-5743&author=J.+Liuauthor=D.+Zhangauthor=Y.+Liauthor=W.+Chenauthor=Z.+Ruanauthor=L.+Dengauthor=L.+Wangauthor=H.+Tianauthor=A.+Yiuauthor=C.+Fanauthor=H.+Luoauthor=S.+Liuauthor=Y.+Wangauthor=G.+Xiaoauthor=L.+Chenauthor=W.+Ye&title=Discovery+of+bufadienolides+as+a+novel+class+of+ClC-3+chloride+channel+activators+with+antitumor+activities&doi=10.1021%2Fjm400881m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm400881m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400881m%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DYiu%26aufirst%3DA.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520bufadienolides%2520as%2520a%2520novel%2520class%2520of%2520ClC-3%2520chloride%2520channel%2520activators%2520with%2520antitumor%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5734%26epage%3D5743%26doi%3D10.1021%2Fjm400881m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Zhou, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P. Q.</span><span> </span><span class="NLM_article-title">Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats</span> <span class="citation_source-journal">J. Poteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2908</span><span class="refDoi"> DOI: 10.1021/pr050456l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr050456l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyrsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2901-2908&author=S.+G.+Zhouauthor=S.+F.+Zhouauthor=H.+Q.+Huangauthor=J.+W.+Chenauthor=M.+Huangauthor=P.+Q.+Liu&title=Proteomic+analysis+of+hypertrophied+myocardial+protein+patterns+in+renovascularly+hypertensive+and+spontaneously+hypertensive+rats&doi=10.1021%2Fpr050456l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic Analysis of Hypertrophied Myocardial Protein Patterns in Renovascularly Hypertensive and Spontaneously Hypertensive Rats</span></div><div class="casAuthors">Zhou, Si-Gui; Zhou, Shu-Feng; Huang, He-Qing; Chen, Jian-Wen; Huang, Min; Liu, Pei-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2901-2908</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cardiac protein profiles of spontaneously hypertensive and renovascularly hypertensive hypertrophy showed a significant alteration compared with normal hearts.  Most proteins with significant modulations in their expressions belong to the category of metabolic and stress-related proteins.  Among these proteins, glutathione-S-transferase mu2 and short-chain acyl-CoA dehydrogenase may be two candidate proteins assocd. with left ventricular hypertrophy in spontaneously hypertensive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxVJ6ioM5x1rVg90H21EOLACvtfcHk0liO5CuFC3gQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyrsbbL&md5=f5ceb1c46fb3190a26bfdff83c1bde7c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fpr050456l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr050456l%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%2BG.%26aulast%3DZhou%26aufirst%3DS.%2BF.%26aulast%3DHuang%26aufirst%3DH.%2BQ.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DP.%2BQ.%26atitle%3DProteomic%2520analysis%2520of%2520hypertrophied%2520myocardial%2520protein%2520patterns%2520in%2520renovascularly%2520hypertensive%2520and%2520spontaneously%2520hypertensive%2520rats%26jtitle%3DJ.%2520Poteome%2520Res.%26date%3D2006%26volume%3D5%26spage%3D2901%26epage%3D2908%26doi%3D10.1021%2Fpr050456l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yu, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span> </span><span class="NLM_article-title">Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of egf receptor in vitro and in vivo</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">32990</span><span class="NLM_x">–</span> <span class="NLM_lpage">33003</span><span class="refDoi"> DOI: 10.18632/oncotarget.8843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.18632%2Foncotarget.8843" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=32990-33003&author=X.+W.+Yuauthor=S.+Linauthor=H.+Z.+Duauthor=R.+P.+Zhaoauthor=S.+Y.+Fengauthor=B.+Y.+Yuauthor=L.+Y.+Zhangauthor=R.+M.+Liauthor=C.+M.+Qianauthor=X.+J.+Luoauthor=S.+T.+Yuanauthor=L.+Sun&title=Synergistic+combination+of+DT-13+and+topotecan+inhibits+human+gastric+cancer+via+myosin+IIA-induced+endocytosis+of+egf+receptor+in+vitro+and+in+vivo&doi=10.18632%2Foncotarget.8843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8843%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%2BW.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DH.%2BZ.%26aulast%3DZhao%26aufirst%3DR.%2BP.%26aulast%3DFeng%26aufirst%3DS.%2BY.%26aulast%3DYu%26aufirst%3DB.%2BY.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DR.%2BM.%26aulast%3DQian%26aufirst%3DC.%2BM.%26aulast%3DLuo%26aufirst%3DX.%2BJ.%26aulast%3DYuan%26aufirst%3DS.%2BT.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DSynergistic%2520combination%2520of%2520DT-13%2520and%2520topotecan%2520inhibits%2520human%2520gastric%2520cancer%2520via%2520myosin%2520IIA-induced%2520endocytosis%2520of%2520egf%2520receptor%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D32990%26epage%3D33003%26doi%3D10.18632%2Foncotarget.8843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Anchen Fu, Hongbo Wang, Taotao Huo, Xinwei Li, Wei Fu, Rongqin Huang, <span class="NLM_string-name hlFld-ContribAuthor">Zhijuan Cao</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Chemiluminescence Probe for Sensitive Detection of Fibroblast Activation Protein-Alpha In Vitro and in Living Systems. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (16)
                                     , 6501-6507. <a href="https://doi.org/10.1021/acs.analchem.1c00413" title="DOI URL">https://doi.org/10.1021/acs.analchem.1c00413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.1c00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.1c00413%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DA%252BNovel%252BChemiluminescence%252BProbe%252Bfor%252BSensitive%252BDetection%252Bof%252BFibroblast%252BActivation%252BProtein-Alpha%252BIn%252BVitro%252Band%252Bin%252BLiving%252BSystems%26aulast%3DFu%26aufirst%3DAnchen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28012021%26date%3D09042021%26date%3D19042021%26volume%3D93%26issue%3D16%26spage%3D6501%26epage%3D6507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yibo Zhou, Keyi Yin, Hao Dong, Sheng Yang, JunBin Li, Jinqiu Luo, Yi Li, <span class="NLM_string-name hlFld-ContribAuthor">Ronghua Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Long-Lasting Bioluminescence Imaging of the Fibroblast Activation Protein by an Amphiphilic Block Copolymer-Based Probe. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (8)
                                     , 3726-3732. <a href="https://doi.org/10.1021/acs.analchem.0c03638" title="DOI URL">https://doi.org/10.1021/acs.analchem.0c03638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.0c03638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.0c03638%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DLong-Lasting%252BBioluminescence%252BImaging%252Bof%252Bthe%252BFibroblast%252BActivation%252BProtein%252Bby%252Ban%252BAmphiphilic%252BBlock%252BCopolymer-Based%252BProbe%26aulast%3DZhou%26aufirst%3DYibo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26082020%26date%3D04022021%26date%3D18022021%26volume%3D93%26issue%3D8%26spage%3D3726%26epage%3D3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kibrom Gebreheiwot Bedane, Lukas Brieger, Carsten Strohmann, Ean-Jeong Seo, Thomas Efferth, <span class="NLM_string-name hlFld-ContribAuthor">Michael Spiteller</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic Bufadienolides from the Leaves of Melianthus major. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2020,</strong> <em>83 </em>
                                    (7)
                                     , 2122-2128. <a href="https://doi.org/10.1021/acs.jnatprod.0c00060" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c00060%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DCytotoxic%252BBufadienolides%252Bfrom%252Bthe%252BLeaves%252Bof%252BMelianthus%252Bmajor%26aulast%3DBedane%26aufirst%3DKibrom%2BGebreheiwot%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16012020%26date%3D14072020%26volume%3D83%26issue%3D7%26spage%3D2122%26epage%3D2128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nan Ma, Zhi-Min Zhang, Jun-Seok Lee, Ke Cheng, Ligen Lin, Dong-Mei Zhang, Piliang Hao, Ke Ding, Wen-Cai Ye, <span class="NLM_string-name hlFld-ContribAuthor">Zhengqiu Li</span>. </span><span class="cited-content_cbyCitation_article-title">Affinity-Based Protein Profiling Reveals Cellular Targets of Photoreactive Anticancer Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (12)
                                     , 2546-2552. <a href="https://doi.org/10.1021/acschembio.9b00784" title="DOI URL">https://doi.org/10.1021/acschembio.9b00784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00784%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAffinity-Based%252BProtein%252BProfiling%252BReveals%252BCellular%252BTargets%252Bof%252BPhotoreactive%252BAnticancer%252BInhibitors%26aulast%3DMa%26aufirst%3DNan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01102019%26date%3D14112019%26date%3D26112019%26date%3D19112019%26volume%3D14%26issue%3D12%26spage%3D2546%26epage%3D2552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chuanle Zhu, Hao Zeng, Chi Liu, Fulin Chen, <span class="NLM_string-name hlFld-ContribAuthor">Huanfeng Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Intermolecular [4 + 2] Annulation Enabled by Internal Oxidant-Promoted C(sp3)–H Functionalization: Access to 3-Trifluoromethylated 3-Hydroxy-cyclohexan-1-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (12)
                                     , 4900-4904. <a href="https://doi.org/10.1021/acs.orglett.9b01817" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01817%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BIntermolecular%252B%25255B4%252B%25252B%252B2%25255D%252BAnnulation%252BEnabled%252Bby%252BInternal%252BOxidant-Promoted%252BC%252528sp3%252529%2525E2%252580%252593H%252BFunctionalization%25253A%252BAccess%252Bto%252B3-Trifluoromethylated%252B3-Hydroxy-cyclohexan-1-ones%26aulast%3DZhu%26aufirst%3DChuanle%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25052019%26date%3D12062019%26volume%3D21%26issue%3D12%26spage%3D4900%26epage%3D4904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fan Feng, Xi Chen, Guojie Li, Song Liang, Zhangyong Hong, <span class="NLM_string-name hlFld-ContribAuthor">He-Fang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Afterglow Resonance Energy Transfer Inhibition for Fibroblast Activation Protein-α Assay. </span><span class="cited-content_cbyCitation_journal-name">ACS Sensors</span><span> <strong>2018,</strong> <em>3 </em>
                                    (9)
                                     , 1846-1854. <a href="https://doi.org/10.1021/acssensors.8b00680" title="DOI URL">https://doi.org/10.1021/acssensors.8b00680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssensors.8b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssensors.8b00680%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sensors%26atitle%3DAfterglow%252BResonance%252BEnergy%252BTransfer%252BInhibition%252Bfor%252BFibroblast%252BActivation%252BProtein-%2525CE%2525B1%252BAssay%26aulast%3DFeng%26aufirst%3DFan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20072018%26date%3D06092018%26date%3D18092018%26date%3D06092018%26volume%3D3%26issue%3D9%26spage%3D1846%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhi-Wen Liu, Jian Zhang, Song-Tao Li, Ming-Qun Liu, Xiao-Jun Huang, Yun-Lin Ao, Chun-Lin Fan, Dong-Mei Zhang, Qing-Wen Zhang, Wen-Cai Ye, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Qi Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ervadivamines A and B, Two Unusual Trimeric Monoterpenoid Indole Alkaloids from Ervatamia divaricata. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (17)
                                     , 10613-10618. <a href="https://doi.org/10.1021/acs.joc.8b01371" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01371%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DErvadivamines%252BA%252Band%252BB%25252C%252BTwo%252BUnusual%252BTrimeric%252BMonoterpenoid%252BIndole%252BAlkaloids%252Bfrom%252BErvatamia%252Bdivaricata%26aulast%3DLiu%26aufirst%3DZhi-Wen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07062018%26date%3D26072018%26date%3D17072018%26volume%3D83%26issue%3D17%26spage%3D10613%26epage%3D10618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samira  Yazdanparast</span>, <span class="hlFld-ContribAuthor ">Ali  Benvidi</span>, <span class="hlFld-ContribAuthor ">Saleheh  Abbasi</span>, <span class="hlFld-ContribAuthor ">Seyyed Kazem  Sabbagh</span>. </span><span class="cited-content_cbyCitation_article-title">Monitoring the mechanism of anti-cancer agents to inhibit colorectal cancer cell proliferation: Enzymatic biosensing of glucose combined with molecular docking. </span><span class="cited-content_cbyCitation_journal-name">Enzyme and Microbial Technology</span><span> <strong>2021,</strong> <em>148 </em>, 109804. <a href="https://doi.org/10.1016/j.enzmictec.2021.109804" title="DOI URL">https://doi.org/10.1016/j.enzmictec.2021.109804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.enzmictec.2021.109804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.enzmictec.2021.109804%26sid%3Dliteratum%253Aachs%26jtitle%3DEnzyme%2520and%2520Microbial%2520Technology%26atitle%3DMonitoring%252Bthe%252Bmechanism%252Bof%252Banti-cancer%252Bagents%252Bto%252Binhibit%252Bcolorectal%252Bcancer%252Bcell%252Bproliferation%25253A%252BEnzymatic%252Bbiosensing%252Bof%252Bglucose%252Bcombined%252Bwith%252Bmolecular%252Bdocking%26aulast%3DYazdanparast%26aufirst%3DSamira%26date%3D2021%26volume%3D148%26spage%3D109804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Luo</span>, <span class="hlFld-ContribAuthor ">Wenjie  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Tan</span>, <span class="hlFld-ContribAuthor ">Quan  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Surface Modified Persistent Luminescence Probes for Biosensing and Bioimaging: A Review. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1009-1021. <a href="https://doi.org/10.1002/cjoc.202000583" title="DOI URL">https://doi.org/10.1002/cjoc.202000583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202000583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202000583%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DSurface%252BModified%252BPersistent%252BLuminescence%252BProbes%252Bfor%252BBiosensing%252Band%252BBioimaging%25253A%252BA%252BReview%26aulast%3DLuo%26aufirst%3DQiang%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D4%26spage%3D1009%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baobao  Chen</span>, <span class="hlFld-ContribAuthor ">Chuanhao  Wang</span>, <span class="hlFld-ContribAuthor ">Jianjiang  Ma</span>, <span class="hlFld-ContribAuthor ">Haijun  Ma</span>, <span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Yazhao  Zhu</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Chuan  Luo</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Yuelin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-peptide substituted arenobufagin derivatives as potent antitumor agents with low cardiotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2021,</strong> <em>166 </em>, 108772. <a href="https://doi.org/10.1016/j.steroids.2020.108772" title="DOI URL">https://doi.org/10.1016/j.steroids.2020.108772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2020.108772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2020.108772%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DDiscovery%252Bof%252B3-peptide%252Bsubstituted%252Barenobufagin%252Bderivatives%252Bas%252Bpotent%252Bantitumor%252Bagents%252Bwith%252Blow%252Bcardiotoxicity%26aulast%3DChen%26aufirst%3DBaobao%26date%3D2021%26volume%3D166%26spage%3D108772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W Nathaniel  Brennen</span>, <span class="hlFld-ContribAuthor ">Daniel L  J Thorek</span>, <span class="hlFld-ContribAuthor ">Wen  Jiang</span>, <span class="hlFld-ContribAuthor ">Timothy E  Krueger</span>, <span class="hlFld-ContribAuthor ">Lizamma  Antony</span>, <span class="hlFld-ContribAuthor ">Samuel R  Denmeade</span>, <span class="hlFld-ContribAuthor ">John T  Isaacs</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Immunotherapy</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 155-175. <a href="https://doi.org/10.2217/imt-2020-0066" title="DOI URL">https://doi.org/10.2217/imt-2020-0066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/imt-2020-0066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fimt-2020-0066%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunotherapy%26atitle%3DOvercoming%252Bstromal%252Bbarriers%252Bto%252Bimmuno-oncological%252Bresponses%252Bvia%252Bfibroblast%252Bactivation%252Bprotein-targeted%252Btherapy%26aulast%3DBrennen%26aufirst%3DW%25C2%25A0Nathaniel%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D155%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Juan  Deng</span>, <span class="hlFld-ContribAuthor ">Yu-He  Lei</span>, <span class="hlFld-ContribAuthor ">Jing-Yu  Quan</span>, <span class="hlFld-ContribAuthor ">Bao-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Dong-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Yan  Tian</span>, <span class="hlFld-ContribAuthor ">Ye  Chen</span>, <span class="hlFld-ContribAuthor ">En-Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Cai  Ye</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Ning</span>, <span class="hlFld-ContribAuthor ">Lin-Zhong  Yu</span>, <span class="hlFld-ContribAuthor ">Jun-Shan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">1β–OH–arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2021,</strong> <em>266 </em>, 113443. <a href="https://doi.org/10.1016/j.jep.2020.113443" title="DOI URL">https://doi.org/10.1016/j.jep.2020.113443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2020.113443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2020.113443%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3D1%2525CE%2525B2%2525E2%252580%252593OH%2525E2%252580%252593arenobufagin%252Binduces%252Bmitochondrial%252Bapoptosis%252Bin%252Bhepatocellular%252Bcarcinoma%252Bthrough%252Bthe%252Bsuppression%252Bof%252BmTOR%252Bsignaling%252Bpathway%26aulast%3DDeng%26aufirst%3DLi-Juan%26date%3D2021%26volume%3D266%26spage%3D113443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Teng</span>, <span class="hlFld-ContribAuthor ">Beiyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongyue  Yuan</span>, <span class="hlFld-ContribAuthor ">Zheng  Kuang</span>, <span class="hlFld-ContribAuthor ">Zhuodong  Chai</span>, <span class="hlFld-ContribAuthor ">Lianjie  Ren</span>, <span class="hlFld-ContribAuthor ">Chao  Qin</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaopeng  Han</span>, <span class="hlFld-ContribAuthor ">Lifang  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein-α-adaptive micelles deliver anti-cancer drugs and reprogram stroma fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale</span><span> <strong>2020,</strong> <em>12 </em>
                                    (46)
                                     , 23756-23767. <a href="https://doi.org/10.1039/D0NR04465B" title="DOI URL">https://doi.org/10.1039/D0NR04465B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NR04465B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NR04465B%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%26atitle%3DFibroblast%252Bactivation%252Bprotein-%2525CE%2525B1-adaptive%252Bmicelles%252Bdeliver%252Banti-cancer%252Bdrugs%252Band%252Breprogram%252Bstroma%252Bfibrosis%26aulast%3DTeng%26aufirst%3DChao%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D46%26spage%3D23756%26epage%3D23767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Juan  Deng</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Qi</span>, <span class="hlFld-ContribAuthor ">Jun-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Sheng  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Jun  Hu</span>, <span class="hlFld-ContribAuthor ">Yu-He  Lei</span>, <span class="hlFld-ContribAuthor ">Ren-Wang  Jiang</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>, <span class="hlFld-ContribAuthor ">Qi  Qi</span>, <span class="hlFld-ContribAuthor ">Hai-Yan  Tian</span>, <span class="hlFld-ContribAuthor ">Wei-Li  Han</span>, <span class="hlFld-ContribAuthor ">Bao-Jian  Wu</span>, <span class="hlFld-ContribAuthor ">Jia-Xu  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Cai  Ye</span>, <span class="hlFld-ContribAuthor ">Dong-Mei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2020,</strong> <em>887 </em>, 173379. <a href="https://doi.org/10.1016/j.ejphar.2020.173379" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173379%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DMolecular%252Bmechanisms%252Bof%252Bbufadienolides%252Band%252Btheir%252Bnovel%252Bstrategies%252Bfor%252Bcancer%252Btreatment%26aulast%3DDeng%26aufirst%3DLi-Juan%26date%3D2020%26volume%3D887%26spage%3D173379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kibrom Gebreheiwot  Bedane</span>, <span class="hlFld-ContribAuthor ">Lukas  Brieger</span>, <span class="hlFld-ContribAuthor ">Carsten  Strohmann</span>, <span class="hlFld-ContribAuthor ">Ean-Jeong  Seo</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>, <span class="hlFld-ContribAuthor ">Michael  Spiteller</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic bufadienolides from the leaves of a medicinal plant Melianthus comosus collected in South Africa. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104102. <a href="https://doi.org/10.1016/j.bioorg.2020.104102" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCytotoxic%252Bbufadienolides%252Bfrom%252Bthe%252Bleaves%252Bof%252Ba%252Bmedicinal%252Bplant%252BMelianthus%252Bcomosus%252Bcollected%252Bin%252BSouth%252BAfrica%26aulast%3DBedane%26aufirst%3DKibrom%2BGebreheiwot%26date%3D2020%26volume%3D102%26spage%3D104102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li‐Juan  Deng</span>, <span class="hlFld-ContribAuthor ">Ming  Qi</span>, <span class="hlFld-ContribAuthor ">Nan  Li</span>, <span class="hlFld-ContribAuthor ">Yu‐He  Lei</span>, <span class="hlFld-ContribAuthor ">Dong‐Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia‐Xu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Natural products and their derivatives: Promising modulators of tumor immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Leukocyte Biology</span><span> <strong>2020,</strong> <em>108 </em>
                                    (2)
                                     , 493-508. <a href="https://doi.org/10.1002/JLB.3MR0320-444R" title="DOI URL">https://doi.org/10.1002/JLB.3MR0320-444R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/JLB.3MR0320-444R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2FJLB.3MR0320-444R%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Leukocyte%2520Biology%26atitle%3DNatural%252Bproducts%252Band%252Btheir%252Bderivatives%25253A%252BPromising%252Bmodulators%252Bof%252Btumor%252Bimmunotherapy%26aulast%3DDeng%26aufirst%3DLi%25E2%2580%2590Juan%26date%3D2020%26date%3D2020%26volume%3D108%26issue%3D2%26spage%3D493%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Petr  Bušek</span>, <span class="hlFld-ContribAuthor ">Aleksi  Šedo</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (7)
                                     , 140409. <a href="https://doi.org/10.1016/j.bbapap.2020.140409" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140409%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DMolecular%252Brecognition%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bfor%252Bdiagnostic%252Band%252Btherapeutic%252Bapplications%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2020%26volume%3D1868%26issue%3D7%26spage%3D140409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue-  Zhong</span>, <span class="hlFld-ContribAuthor ">Chao-  Zhao</span>, <span class="hlFld-ContribAuthor ">Wen-Yu  Wu</span>, <span class="hlFld-ContribAuthor ">Tian-Yuan  Fan</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Min-  Chen</span>, <span class="hlFld-ContribAuthor ">Jin-Ao  Duan</span>, <span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Total synthesis, chemical modification and structure-activity relationship of bufadienolides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112038. <a href="https://doi.org/10.1016/j.ejmech.2020.112038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTotal%252Bsynthesis%25252C%252Bchemical%252Bmodification%252Band%252Bstructure-activity%252Brelationship%252Bof%252Bbufadienolides%26aulast%3DZhong%26aufirst%3DYue-%26date%3D2020%26volume%3D189%26spage%3D112038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cao</span>, <span class="hlFld-ContribAuthor ">Wu</span>, <span class="hlFld-ContribAuthor ">Pan</span>, <span class="hlFld-ContribAuthor ">Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Profile and Multicomponent Quantitative Analysis for the Quality Evaluation of Toad Venom from Different Origins. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (19)
                                     , 3595. <a href="https://doi.org/10.3390/molecules24193595" title="DOI URL">https://doi.org/10.3390/molecules24193595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24193595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24193595%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DChemical%252BProfile%252Band%252BMulticomponent%252BQuantitative%252BAnalysis%252Bfor%252Bthe%252BQuality%252BEvaluation%252Bof%252BToad%252BVenom%252Bfrom%252BDifferent%252BOrigins%26aulast%3DCao%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D19%26spage%3D3595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhao</span>, <span class="hlFld-ContribAuthor ">Li-Jian  Chen</span>, <span class="hlFld-ContribAuthor ">Kai-Chao  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu-Shi  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-lin  Liu</span>, <span class="hlFld-ContribAuthor ">Xiu-Ping  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Autofluorescence-free chemo/biosensing in complex matrixes based on persistent luminescence nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">TrAC Trends in Analytical Chemistry</span><span> <strong>2019,</strong> <em>118 </em>, 65-72. <a href="https://doi.org/10.1016/j.trac.2019.05.025" title="DOI URL">https://doi.org/10.1016/j.trac.2019.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trac.2019.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trac.2019.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DTrAC%2520Trends%2520in%2520Analytical%2520Chemistry%26atitle%3DAutofluorescence-free%252Bchemo%25252Fbiosensing%252Bin%252Bcomplex%252Bmatrixes%252Bbased%252Bon%252Bpersistent%252Bluminescence%252Bnanoparticles%26aulast%3DZhao%26aufirst%3DXu%26date%3D2019%26volume%3D118%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huannan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoren  Cao</span>, <span class="hlFld-ContribAuthor ">Xiongbing  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yi</span>, <span class="hlFld-ContribAuthor ">Jun  Xia</span>, <span class="hlFld-ContribAuthor ">Jilan  Chen</span>, <span class="hlFld-ContribAuthor ">Lan  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Medicine Reports</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.3892/mmr.2019.10452" title="DOI URL">https://doi.org/10.3892/mmr.2019.10452</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/mmr.2019.10452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fmmr.2019.10452%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Medicine%2520Reports%26atitle%3DBufadienolides%252Binduce%252Bapoptosis%252Band%252Bautophagy%252Bby%252Binhibiting%252Bthe%252BAKT%252Bsignaling%252Bpathway%252Bin%252Bmelanoma%252BA%2525E2%252580%252591375%252Bcells%26aulast%3DLi%26aufirst%3DHuannan%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Deng</span>, <span class="hlFld-ContribAuthor ">Hai-Yan  Tian</span>, <span class="hlFld-ContribAuthor ">Zhi-Xiong  Ruan</span>, <span class="hlFld-ContribAuthor ">Hui-Hui  Cao</span>, <span class="hlFld-ContribAuthor ">Wen-Cai  Ye</span>, <span class="hlFld-ContribAuthor ">Dong-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Ling  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2019,</strong> <em>134 </em>, 362-371. <a href="https://doi.org/10.1016/j.fitote.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.fitote.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DAnti-tumor%252Beffects%252Band%252B3D-quantitative%252Bstructure-activity%252Brelationship%252Banalysis%252Bof%252Bbufadienolides%252Bfrom%252Btoad%252Bvenom%26aulast%3DLiu%26aufirst%3DJun-Shan%26date%3D2019%26volume%3D134%26spage%3D362%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Hou</span>, <span class="hlFld-ContribAuthor ">Zhi-Xing  Huang</span>, <span class="hlFld-ContribAuthor ">Hong-Gui  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Lin</span>, <span class="hlFld-ContribAuthor ">Dong-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qun-Long  Peng</span>, <span class="hlFld-ContribAuthor ">Hui  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Qun  Chang</span>, <span class="hlFld-ContribAuthor ">Long-Hai  Wang</span>, <span class="hlFld-ContribAuthor ">Zhe  Yao</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (20)
                                     , 3391-3394. <a href="https://doi.org/10.1016/j.bmcl.2018.08.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.08.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.08.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHybrids%252Bof%252Barenobufagin%252Band%252Bbenzoisoselenazol%252Breducing%252Bthe%252Bcardiotoxicity%252Bof%252Barenobufagin%26aulast%3DHou%26aufirst%3DWen%26date%3D2018%26volume%3D28%26issue%3D20%26spage%3D3391%26epage%3D3394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen  Puré</span>, <span class="hlFld-ContribAuthor ">Rachel  Blomberg</span>. </span><span class="cited-content_cbyCitation_article-title">Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2018,</strong> <em>37 </em>
                                    (32)
                                     , 4343-4357. <a href="https://doi.org/10.1038/s41388-018-0275-3" title="DOI URL">https://doi.org/10.1038/s41388-018-0275-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-018-0275-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-018-0275-3%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DPro-tumorigenic%252Broles%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bin%252Bcancer%25253A%252Bback%252Bto%252Bthe%252Bbasics%26aulast%3DPur%25C3%25A9%26aufirst%3DEllen%26date%3D2018%26date%3D2018%26volume%3D37%26issue%3D32%26spage%3D4343%26epage%3D4357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design strategy of FAPα-activated tripeptide arenobufagin prodrugs: (a) A; (b) V; (c) L; (d) I; (e) F; (f) W; (g) <i>p</i>-aminobenzoic acid; (h) <i>p</i>-aminophenylacetic acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthetic route to FAPα-activated tripeptide arenobufagin prodrugs. Reagents and conditions: (i) <i>N</i>-Cbz-amino acid, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDCI), 1-hydroxybenzotriazole (HOBt), DMAP, DCM, rt, 8–16 h; (ii) Et<sub>3</sub>SiH, PdCl<sub>2</sub>, triethanolamine (TEA), DCM, rt, 20–50 min; (iii) <i>N</i>-Cbz-Gly-<span class="smallcaps smallerCapital">l</span>-Pro, EDCI, HOBt, TEA, rt, 40–90 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of compounds <b>2a</b>–<b>h</b> and <b>3a</b>–<b>h</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Prodrugs <b>3a</b>–<b>h</b> are hydrolyzed by rhFAPα: (A) evaluation of the hydrolytic efficiency of <b>3a</b>–<b>h</b> by rhFAPα; (B) TAL blocks the hydrolysis of <b>3e</b> and <b>3f</b>; (C) kinetic profiles for <b>3a</b>–<b>f</b> and <b>3h</b> reactions mediated by rhFAPα enzyme. Data are shown as the mean ± SEM from three independent experiments. Statistical analysis was conducted using GraphPad Prism 5 software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking analysis of the interactions of <b>3a</b>, <b>3e</b>, or <b>3f</b> with FAPα. <b>3a</b> (A), <b>3e</b> (B), and <b>3f</b> (C) are docked with FAPα in a three-dimensional view (left). Red dashed lines: hydrogen bonds. Details of the interaction of <b>3a</b> (A), <b>3e</b> (B), or <b>3f</b> (C) with FAPα in a two-dimensional view (right). Black dashed lines: hydrogen bonds. Green dashed lines with dots: π interactions including π–π stacking and π–cation interactions. Green full lines: hydrophobic contacts. The FAPα structure was obtained from the Protein Data Bank (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68">1Z68</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Expression of FAPα in MDA-MB-231 xenograft tissues. Immunofluorescence analysis was conducted with anti-FAPα antibody (green). Representative figure was shown. Original magnification: 40×. Scale bar: 20 μm. (B) The FAPα plasmids and the pCMV6-Entry vector were transfected into MDA-MB-231 cells. The expression of FAPα in these MDA-MB-231 cells was tested by Western blot with the indicated antibody. β-Actin was used as a loading control. (C) <b>3f</b> was hydrolyzed by 10% FBS, 10% heat-inactivated FBS, rat serum, BMSCs, homogenates of heart and tumor. Each column represents the mean ± SEM of three independent samples. Statistical analysis was conducted using GraphPad Prism 5 software.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Anticancer activity of <b>3f</b> and arenobufagin in a MDA-MB-231 xenograft model. (A) Growth curves of subcutaneous xenografts of MDA-MB-231 (<i>n</i> = 6). (B) Tumor weights of MDA-MB-231 xenografts. (C) Stable body weight curves of treated mice (<i>n</i> = 6). (D) IHC was conducted with anti-Ki67 antibody. Representative figures of the Ki67 staining are shown (left), and quantitation of Ki67 indices was calculated using Image-Pro Plus 6.0 software (right). (E) IHC was conducted with Tunel staining. These stained mice tissue sections were examined by a pathologist who was blind to the treatment conditions. Representative figures were shown (left), and quantitation of apoptotic cells (%) was calculated using Image-Pro Plus 6.0 software (right). Original magnification: 40×. Scale bar: 100 μm. Each column represents the mean ± SEM (<i>n</i> = 6). Statistical analysis was conducted using GraphPad Prism 5 software with a one-way ANOVA with post hoc comparisons and Tukey’s test: (∗) <i>P</i> < 0.05 versus the 5% Solutol-HS15 (HS15) control; (∗∗) <i>P</i> < 0.01 versus the 5% Solutol-HS15 (HS15) control; (∗∗∗) <i>P</i> < 0.001 versus the 5% Solutol-HS15 (HS15) control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/medium/jm-2016-017552_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of <b>3f</b> and arenobufagin on cardiac function in the left ventricles of MDA-MB-231 tumor-bearing mice. (A) Analysis of cardiac morphology and function of mice by echocardiography after 22 days drug administration. Representative figures for echocardiography (top) and LVIDd, LVIDs, IVSd, and IVSs were calculated (<i>n</i> = 6) (bottom). (B) Representative images of morphological changes of myocardial cells observed by HE staining. Original magnification: 40×. Scale bar: 100 μm. (C) Effect of <b>3f</b> and arenobufagin on serum levels of LDH. Each column represents the mean ± SEM. Statistical analysis was conducted using GraphPad Prism 5 software with a one-way ANOVA with post hoc comparisons and Tukey’s test: (∗) <i>P</i> < 0.05 versus the 5% HS15 control; (#) <i>P</i> < 0.05 versus the arenobufagin group alone (<i>n</i> = 6). These stained mice tissue sections were examined by a pathologist who was blind to the treatment conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.6b01755/20170707/images/large/jm-2016-017552_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01755&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popescu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Bufadienolides and their antitumor activity</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span><span class="refDoi"> DOI: 10.1039/c0np00032a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1039%2Fc0np00032a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=21416078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVGmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=953-969&author=H.+Gaoauthor=R.+Popescuauthor=B.+Koppauthor=Z.+Wang&title=Bufadienolides+and+their+antitumor+activity&doi=10.1039%2Fc0np00032a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Bufadienolides and their antitumor activity</span></div><div class="casAuthors">Gao, Huimin; Popescu, Ruxandra; Kopp, Brigitte; Wang, Zhimin</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">953-969</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1998 to July 2010.  Since 1998, a great no. of bufadienolides have been reported from plants, animals and plant cell suspensions, as well as from fungi and bacteria cultures.  This review summarizes both new bufadienolides and those obtained from new sources, together with data regarding the antitumor activity of bufadienolide derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8b9zxCMeCPLVg90H21EOLACvtfcHk0liwoWPQxDxKRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVGmsLw%253D&md5=099ca5f68c6967a59d7bf6b68f25d66d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1039%2Fc0np00032a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0np00032a%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DPopescu%26aufirst%3DR.%26aulast%3DKopp%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DBufadienolides%2520and%2520their%2520antitumor%2520activity%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2011%26volume%3D28%26spage%3D953%26epage%3D969%26doi%3D10.1039%2Fc0np00032a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Qi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokudo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1016/j.intimp.2010.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.intimp.2010.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=21185919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=342-349&author=F.+Qiauthor=A.+Liauthor=Y.+Inagakiauthor=N.+Kokudoauthor=S.+Tamuraauthor=M.+Nakataauthor=W.+Tang&title=Antitumor+activity+of+extracts+and+compounds+from+the+skin+of+the+toad+Bufo+bufo+gargarizans+Cantor&doi=10.1016%2Fj.intimp.2010.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor</span></div><div class="casAuthors">Qi, Fanghua; Li, Anyuan; Inagaki, Yoshinori; Kokudo, Norihiro; Tamura, Sumihito; Nakata, Munehiro; Tang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-349</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The skin of the toad Bufo bufo gargarizans Cantor is known to be rich in bufadienolides, peptides and alkaloids.  It has been found to be a source of some exts. and biol. active compds. with antitumor activity.  Cinobufacini (Huachansu), a Chinese medicine prepd. from the dried toad skin, has been widely used in clin. therapy for various cancers in China.  Bufadienolides, such as bufalin, cinobufagin, resibufogenin, and telocinobufagin, are the major active compds. derived from the toad skin.  They are the maker biol. active compds. of cinobufagin while the antitumor activity of cinobufagin may be due to this kind of components.  Exptl. research has suggested that cinobufacini and its active compds. (e.g. bufalin and cinobufagin) exhibit significant antitumor activity, including inhibition of cell proliferation, induction of cell differentiation, induction of apoptosis, disruption of the cell cycle, inhibition of cancer angiogenesis, reversal of multi-drug resistance, and regulation of the immune response.  Clin. data have indicated that cinobufacini may have effective anticancer activity with low toxicity and few side effects.  Data to date suggest it may also enhance quality of life for patients with cancer.  Thus, this review briefly summarizes recent studies on the anticancer activity of cinobufacini and some of its active compds. from the skin of the toad Bufo bufo gargarizans Cantor.  This might provide addnl. evidence for further study of the exts. and active compds. from the toad skin in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dk3gqndKDLVg90H21EOLACvtfcHk0ljoMo-50kPI0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGqs78%253D&md5=25624f3f7a5b628cfef4d3255842624c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DKokudo%26aufirst%3DN.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DNakata%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DAntitumor%2520activity%2520of%2520extracts%2520and%2520compounds%2520from%2520the%2520skin%2520of%2520the%2520toad%2520Bufo%2520bufo%2520gargarizans%2520Cantor%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2011%26volume%3D11%26spage%3D342%26epage%3D349%26doi%3D10.1016%2Fj.intimp.2010.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroiwa, Y.</span><span> </span><span class="NLM_article-title">Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=4634-4641&author=L.+Zhangauthor=K.+Nakayaauthor=T.+Yoshidaauthor=Y.+Kuroiwa&title=Induction+by+bufalin+of+differentiation+of+human+leukemia+cells+HL60%2C+U937%2C+and+ML1+toward+macrophage%2Fmonocyte-like+cells+and+its+potent+synergistic+effect+on+the+differentiation+of+human+leukemia+cells+in+combination+with+other+inducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNakaya%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKuroiwa%26aufirst%3DY.%26atitle%3DInduction%2520by%2520bufalin%2520of%2520differentiation%2520of%2520human%2520leukemia%2520cells%2520HL60%252C%2520U937%252C%2520and%2520ML1%2520toward%2520macrophage%252Fmonocyte-like%2520cells%2520and%2520its%2520potent%2520synergistic%2520effect%2520on%2520the%2520differentiation%2520of%2520human%2520leukemia%2520cells%2520in%2520combination%2520with%2520other%2520inducers%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D4634%26epage%3D4641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zhang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W. C.</span><span> </span><span class="NLM_article-title">Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span><span class="refDoi"> DOI: 10.1093/carcin/bgt060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fcarcin%2Fbgt060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=23393227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFCnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1331-1342&author=D.+M.+Zhangauthor=J.+S.+Liuauthor=L.+J.+Dengauthor=M.+F.+Chenauthor=A.+Yiuauthor=H.+H.+Caoauthor=H.+Y.+Tianauthor=K.+P.+Fungauthor=H.+Kuriharaauthor=J.+X.+Panauthor=W.+C.+Ye&title=Arenobufagin%2C+a+natural+bufadienolide+from+toad+venom%2C+induces+apoptosis+and+autophagy+in+human+hepatocellular+carcinoma+cells+through+inhibition+of+PI3K%2FAkt%2FmTOR+pathway&doi=10.1093%2Fcarcin%2Fbgt060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway</span></div><div class="casAuthors">Zhang, Dong-Mei; Liu, Jun-Shan; Deng, Li-Juan; Chen, Min-Feng; Yiu, Anita; Cao, Hui-Hui; Tian, Hai-Yan; Fung, Kwok-Pui; Kurihara, Hiroshi; Pan, Jing-Xuan; Ye, Wen-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1331-1342</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is a deadly form of cancer without effective chemotherapy so far.  Currently, only sorafenib, a multitargeted tyrosine kinase inhibitor, slightly improves survival in HCC patients.  In searching for natural anti-HCC components from toad venom, which is frequently used in the treatment of liver cancer in traditional Chinese medicine, we discovered that arenobufagin, a bufadienolide from toad venom, had potent antineoplastic activity against HCC HepG2 cells as well as corresponding multidrug-resistant HepG2/ADM cells.  We found that arenobufagin induced mitochondria-mediated apoptosis in HCC cells, with decreasing mitochondrial potential, as well as increasing Bax/Bcl-2 expression ratio, Bax translocation from cytosol to mitochondria.  Arenobufagin also induced autophagy in HepG2/ADM cells.  Autophagy-specific inhibitors (3-methyladenine, chloroquine and bafilomycin A1) or Beclin1 and Atg 5 small interfering RNAs (siRNAs) enhanced arenobufagin-induced apoptosis, indicating that arenobufagin-mediated autophagy may protect HepG2/ADM cells from undergoing apoptotic cell death.  In addn., we obsd. the inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway by arenobufagin.  Interestingly, inhibition of mTOR by rapamycin or siRNA duplexes augmented arenobufagin-induced apoptosis and autophagy.  Finally, arenobufagin inhibited the growth of HepG2/ADM xenograft tumors, which were assocd. with poly (ADP-ribose) polymerase cleavage, light chain 3-II activation and mTOR inhibition.  In summary, we first demonstrated the antineoplastic effect of arenobufagin on HCC cells both in vitro and in vivo.  We elucidated the underlying antineoplastic mechanisms of arenobufagin that involve cross talk between apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathway.  This study may provide a rationale for future clin. application using arenobufagin as a chemotherapeutic agent for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQohRZfmg9e7Vg90H21EOLACvtfcHk0lgYRMab7cFjAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFCnsLo%253D&md5=76fcf6c0880a51fd8aba8681ba9e65c5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt060%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DDeng%26aufirst%3DL.%2BJ.%26aulast%3DChen%26aufirst%3DM.%2BF.%26aulast%3DYiu%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DH.%2BH.%26aulast%3DTian%26aufirst%3DH.%2BY.%26aulast%3DFung%26aufirst%3DK.%2BP.%26aulast%3DKurihara%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DJ.%2BX.%26aulast%3DYe%26aufirst%3DW.%2BC.%26atitle%3DArenobufagin%252C%2520a%2520natural%2520bufadienolide%2520from%2520toad%2520venom%252C%2520induces%2520apoptosis%2520and%2520autophagy%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%2520through%2520inhibition%2520of%2520PI3K%252FAkt%252FmTOR%2520pathway%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D1331%26epage%3D1342%26doi%3D10.1093%2Fcarcin%2Fbgt060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Deng, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. M.</span><span> </span><span class="NLM_article-title">Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">34258</span><span class="NLM_x">–</span> <span class="NLM_lpage">34275</span><span class="refDoi"> DOI: 10.18632/oncotarget.5545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.18632%2Foncotarget.5545" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=34258-34275&author=L.+J.+Dengauthor=Q.+L.+Pengauthor=L.+H.+Wangauthor=J.+Xuauthor=J.+S.+Liuauthor=Y.+J.+Liauthor=Z.+J.+Zhuoauthor=L.+L.+Baiauthor=L.+P.+Huauthor=W.+M.+Chenauthor=W.+C.+Yeauthor=D.+M.+Zhang&title=Arenobufagin+intercalates+with+DNA+leading+to+G2+cell+cycle+arrest+via+ATM%2FATR+pathway&doi=10.18632%2Foncotarget.5545"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5545%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%2BJ.%26aulast%3DPeng%26aufirst%3DQ.%2BL.%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BS.%26aulast%3DLi%26aufirst%3DY.%2BJ.%26aulast%3DZhuo%26aufirst%3DZ.%2BJ.%26aulast%3DBai%26aufirst%3DL.%2BL.%26aulast%3DHu%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DW.%2BM.%26aulast%3DYe%26aufirst%3DW.%2BC.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26atitle%3DArenobufagin%2520intercalates%2520with%2520DNA%2520leading%2520to%2520G2%2520cell%2520cycle%2520arrest%2520via%2520ATM%252FATR%2520pathway%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D34258%26epage%3D34275%26doi%3D10.18632%2Foncotarget.5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Meng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5309</span><span class="NLM_x">–</span> <span class="NLM_lpage">5318</span><span class="refDoi"> DOI: 10.1002/cncr.24602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fcncr.24602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=19701908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A280%3ADC%252BD1MjkslOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2009&pages=5309-5318&author=Z.+Mengauthor=P.+Yangauthor=Y.+Shenauthor=W.+Beiauthor=Y.+Zhangauthor=Y.+Geauthor=R.+A.+Newmanauthor=L.+Cohenauthor=L.+Liuauthor=B.+Thorntonauthor=D.+Z.+Changauthor=Z.+Liaoauthor=R.+Kurzrock&title=Pilot+study+of+huachansu+in+patients+with+hepatocellular+carcinoma%2C+nonsmall-cell+lung+cancer%2C+or+pancreatic+cancer&doi=10.1002%2Fcncr.24602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer</span></div><div class="casAuthors">Meng Zhiqiang; Yang Peiying; Shen Yehua; Bei Wenying; Zhang Ying; Ge Yongqian; Newman Robert A; Cohen Lorenzo; Liu Luming; Thornton Bob; Chang David Z; Liao Zongxing; Kurzrock Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5309-18</span>
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    </div><div class="casAbstract">BACKGROUND:  Huachansu, a Chinese medicine that comes from dried toad venom from the skin glands of Bufo gargarizans or B. melanostictus, has been used in the treatment of various cancers in China.  The authors conducted a pilot study, using a phase 1 trial design, of huachansu in patients with advanced cancer.  METHODS:  Huachansu was administered intravenously for 14 days followed by 7 days off (1 cycle).  Without significant adverse events or progressive disease, treatment continued beyond 2 cycles.  The dose of huachansu was escalated as follows with 3 patients per cohort: 10 (level 1), 20 (level 2), 40 (level 3), 60 (level 4), and 90 (level 5) mL/m(2).  RESULTS:  Fifteen patients (hepatocellular cancer, n = 11; nonsmall cell lung cancer, n = 2; pancreatic cancer, n = 2) were enrolled in the trial, and no dose-limiting toxicities (DLTs) were found.  Eleven patients had no drug-related toxicity greater than grade 1.  Six (40%) had stable disease (median duration, 6.0 months; range, 3.5-11.1 months).  One of these patients (with hepatocellular cancer) had 20% regression (duration, 11 months) (dose level 1).  Quality of life improved for patients with stable disease.  Plasma bufalin concentration reached maximal levels at the end of the 2-hour infusion and was proportional to the amount of drug being administered (0.81-3.38 ng/mL).  CONCLUSIONS:  No DLT was observed with the use of huachansu at doses up to 8x higher than typically used in China.  Six patients had prolonged stable disease or minor tumor shrinkage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF23-pyDO1PP_I8Jvzw4xCfW6udTcc2eYuOZmIVINJ-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjkslOisg%253D%253D&md5=6f702604b4b8fcd75c86c867e2c74672</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fcncr.24602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.24602%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DBei%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DNewman%26aufirst%3DR.%2BA.%26aulast%3DCohen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DThornton%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DD.%2BZ.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DPilot%2520study%2520of%2520huachansu%2520in%2520patients%2520with%2520hepatocellular%2520carcinoma%252C%2520nonsmall-cell%2520lung%2520cancer%252C%2520or%2520pancreatic%2520cancer%26jtitle%3DCancer%26date%3D2009%26volume%3D115%26spage%3D5309%26epage%3D5318%26doi%3D10.1002%2Fcncr.24602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Qin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. R.</span><span> </span><span class="NLM_article-title">Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5210</span><span class="NLM_x">–</span> <span class="NLM_lpage">5216</span><span class="refDoi"> DOI: 10.3748/wjg.14.5210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.3748%2Fwjg.14.5210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=18777599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVCltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5210-5216&author=T.+J.+Qinauthor=X.+H.+Zhaoauthor=J.+Yunauthor=L.+X.+Zhangauthor=Z.+P.+Ruanauthor=B.+R.+Pan&title=Efficacy+and+safety+of+gemcitabine-oxaliplatin+combined+with+huachansu+in+patients+with+advanced+gallbladder+carcinoma&doi=10.3748%2Fwjg.14.5210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma</span></div><div class="casAuthors">Qin, Tian-Jie; Zhao, Xin-Han; Yun, Jun; Zhang, Ling-Xiao; Ruan, Zhi-Ping; Pan, Bo-Rong</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5210-5216</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">To evaluate the efficacy and safety of gemcitabine-oxaliplatin (GEMOX) combined with huachansu (cinobufagin) injection treatment in patients with locally advanced or metastatic gallbladder carcinoma (GBC), and to assess the quality of life (QOL) of such patients.  Twenty-five patients with locally advanced or metastatic GBC were treated with i.v. gemcitabine (1000 mg/m2) over 30 min on days 1 and 8, 2 h infusion of oxaliplatin (120 mg/m2) on day 1, and 2-3 h infusion of huachansu (20 mL/m2) on days -3-11, every 3-4 wk.  Treatment was continued until occurrence of unacceptable toxicity or disease progression.  QOL of patients was assessed by the EORTC QLQ-C30 at baseline, at the end of the first, third and sixth chemotherapy cycles, and 1 mo after the treatment.  Among the 25 patients with a median age of 64 years (range 42-78 years), 23 were evaluable in the study.  A total of 137 cycles of therapy were performed and the median cycle was 5 (range 1-8) per patient.  Out of the 23 patients whose response could be evaluated, 8 partial responses (PR) were obsd. (34.8%), while 7 patients (30.4%) demonstrated a stable disease (SD).  The disease control rate was 65.2%.  Progression of cancer was obsd. in 8 (34.8%) patients.  The median progression-free and overall survival time was 5.8 mo (95% CI: 4.5-7.1 mo) and 10.5 mo, resp.  The therapy was well tolerated, with moderate myelosuppression as the main toxicity.  Anemia grade 2 was seen in 16.0%, neutropenia grade 3 in 8.0% and thrombocytopenia grade 3 in 24.0% of patients, resp.  Non-hematol. toxicity ranged from mild to moderate.  No death occurred due to toxicity.  The QOL of patients was improved after chemotherapy, and the scores of QOL were increased by 10 to 20 points.  GEMOX combined with huachansu (cinobufagin) injection is well tolerated, effective, thus improving the QOL of patients with advanced GBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXTNC0gWd2j7Vg90H21EOLACvtfcHk0lg2D1PpdwgLyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVCltQ%253D%253D&md5=f8a22209a1dc13f09007e324927b50bf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3748%2Fwjg.14.5210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.14.5210%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DT.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BH.%26aulast%3DYun%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%2BX.%26aulast%3DRuan%26aufirst%3DZ.%2BP.%26aulast%3DPan%26aufirst%3DB.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520gemcitabine-oxaliplatin%2520combined%2520with%2520huachansu%2520in%2520patients%2520with%2520advanced%2520gallbladder%2520carcinoma%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D14%26spage%3D5210%26epage%3D5216%26doi%3D10.3748%2Fwjg.14.5210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, B.</span><span> </span><span class="NLM_article-title">Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer</span> <span class="citation_source-journal">Zhongxiyi Jiehe Xuebao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.3736/jcim20030311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.3736%2Fjcim20030311" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=184-186&author=Z.+Chenauthor=X.+F.+Zhaiauthor=Y.+H.+Suauthor=X.+Y.+Wanauthor=J.+Liauthor=J.+M.+Xieauthor=B.+Gao&title=Clinical+observation+of+cinobufacini+injection+used+to+treat+moderate+and+advanced+primary+liver+cancer&doi=10.3736%2Fjcim20030311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3736%2Fjcim20030311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3736%252Fjcim20030311%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZhai%26aufirst%3DX.%2BF.%26aulast%3DSu%26aufirst%3DY.%2BH.%26aulast%3DWan%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DJ.%2BM.%26aulast%3DGao%26aufirst%3DB.%26atitle%3DClinical%2520observation%2520of%2520cinobufacini%2520injection%2520used%2520to%2520treat%2520moderate%2520and%2520advanced%2520primary%2520liver%2520cancer%26jtitle%3DZhongxiyi%2520Jiehe%2520Xuebao%26date%3D2003%26volume%3D1%26spage%3D184%26epage%3D186%26doi%3D10.3736%2Fjcim20030311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span> </span><span class="NLM_article-title">A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">479</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2014.12.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.ijpharm.2014.12.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=25545797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFygurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=479&publication_year=2015&pages=52-62&author=W.+Liauthor=X.+Linauthor=Z.+Yangauthor=W.+Zhangauthor=T.+Renauthor=F.+Quauthor=Y.+Wangauthor=N.+Zhangauthor=X.+Tang&title=A+bufadienolide-loaded+submicron+emulsion+for+oral+administration%3A+stability%2C+antitumor+efficacy+and+toxicity&doi=10.1016%2Fj.ijpharm.2014.12.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A bufadienolide-loaded submicron emulsion for oral administration: Stability, antitumor efficacy and toxicity</span></div><div class="casAuthors">Li, Wanqiu; Lin, Xia; Yang, Zhenhua; Zhang, Wei; Ren, Tianyang; Qu, Fengming; Wang, Yanjiao; Zhang, Ning; Tang, Xing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">479</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-62</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was to develop an alternative submicron emulsion contg. three bufadienolides for oral administration and evaluate its preclin. stability, efficacy, and toxicity.  The bufadienolide-loaded oral submicron emulsion (BU-OE) was prepd. by high-pressure homogenization.  The storage stability, in vitro cytotoxicity, in vivo antitumor efficacy, acute toxicity, and long-term toxicity of BU-OE were investigated in detail to evaluate the formulation.  The stability study suggested that BU-OE was stable at room temp. and could be stored for at least 18 mo at 6 ± 2 °C.  The cytotoxicity test revealed that BU-OE had marked cytotoxic activities against cancer cells, but no evident inhibitory effects on normal cells.  Likewise, BU-OE exhibited significant antitumor efficacy against Hep G2, HCT-8, and EC9706 cell lines and a slight inhibitory effect on BGC 803 cell line in nude mice, while comparable antitumor activity with fluorouracil injection.  The LD50 of BU-OE in mice was 29.4 mg/kg (male) and 22.8 mg/kg (female), resp.  As for the long-term toxicity, BU-OE showed no apparent toxic effects except minor cardiotoxic effects which were reversible.  In conclusion, submicron emulsion is a suitable delivery system for oral administration of bufadienolides, with satisfactory stability, superior antitumor efficacy and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNHt7kPFPtW7Vg90H21EOLACvtfcHk0liyatHa40FwnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFygurfJ&md5=1a95b56387d660fcdcdcd54a1574a7e5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2014.12.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2014.12.054%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DT.%26aulast%3DQu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DX.%26atitle%3DA%2520bufadienolide-loaded%2520submicron%2520emulsion%2520for%2520oral%2520administration%253A%2520stability%252C%2520antitumor%2520efficacy%2520and%2520toxicity%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2015%26volume%3D479%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.ijpharm.2014.12.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Xie, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C. S.</span><span> </span><span class="NLM_article-title">Cardiac toxicity of resibufogenin: electrophysiological evidence</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=289-297&author=J.+T.+Xieauthor=L.+Deyauthor=J.+A.+Wuauthor=T.+K.+Lowellauthor=C.+S.+Yuan&title=Cardiac+toxicity+of+resibufogenin%3A+electrophysiological+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%2BT.%26aulast%3DDey%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.%2BA.%26aulast%3DLowell%26aufirst%3DT.%2BK.%26aulast%3DYuan%26aufirst%3DC.%2BS.%26atitle%3DCardiac%2520toxicity%2520of%2520resibufogenin%253A%2520electrophysiological%2520evidence%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2001%26volume%3D22%26spage%3D289%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kostakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byard, R. W.</span><span> </span><span class="NLM_article-title">Sudden death associated with intravenous injection of toad extract</span> <span class="citation_source-journal">Forensic Sci. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e5</span><span class="refDoi"> DOI: 10.1016/j.forsciint.2009.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.forsciint.2009.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=19303230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlKgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2009&pages=e1-e5&author=C.+Kostakisauthor=R.+W.+Byard&title=Sudden+death+associated+with+intravenous+injection+of+toad+extract&doi=10.1016%2Fj.forsciint.2009.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sudden death associated with intravenous injection of toad extract</span></div><div class="casAuthors">Kostakis, Chris; Byard, Roger W.</div><div class="citationInfo"><span class="NLM_cas:title">Forensic Science International</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">e1-e5</span>CODEN:
                <span class="NLM_cas:coden">FSINDR</span>;
        ISSN:<span class="NLM_cas:issn">0379-0738</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A 24-yr-old male died suddenly following the i.v. injection of what was believed to be the ring-derivate amphetamine ecstasy' (MDMA).  Toxicol. analyses of the victim's blood and the injected material, however, failed to reveal MDMA, but showed instead low levels of bufotenine, a tryptamine deriv. alkaloid found in the secretions of various toads.  In addn., resibufogenin, cinobufagin and bufalin, bufadienolides that are also found in toad venom, were identified in the injected material.  While these substances also occur in certain South American plants, the finding of paracetamol, promethazine and diclofenac would be in keeping with ingredients found in the traditional Chinese herbal product Chan Su that derives from the skin glands and secretions of toads and that is often adulterated with std. pharmaceutical drugs.  This case demonstrates the problems that users and sellers may encounter from the unknown compn. of street drugs and herbal medicines, and the danger that may be incurred from the injection of such materials.  It also shows the difficulties that may be assocd. with attempting to identify low levels of org. toxins in postmortem specimens necessitating a targeted screening approach guided by information obtained at the death scene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwVQWldP8dZLVg90H21EOLACvtfcHk0lhNSvscEqlODg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKgsb0%253D&md5=f2891ed18d8b1e88ab924a2cf77b3e27</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.forsciint.2009.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.forsciint.2009.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DKostakis%26aufirst%3DC.%26aulast%3DByard%26aufirst%3DR.%2BW.%26atitle%3DSudden%2520death%2520associated%2520with%2520intravenous%2520injection%2520of%2520toad%2520extract%26jtitle%3DForensic%2520Sci.%2520Int.%26date%3D2009%26volume%3D188%26spage%3De1%26epage%3De5%26doi%3D10.1016%2Fj.forsciint.2009.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cunha-Filho, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resck, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalcanti, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessoa, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, M. L.</span><span> </span><span class="NLM_article-title">Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion</span> <span class="citation_source-journal">Toxicon</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1016/j.toxicon.2010.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.toxicon.2010.03.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2010&pages=339-348&author=G.+A.+Cunha-Filhoauthor=I.+S.+Resckauthor=B.+C.+Cavalcantiauthor=C.+O.+Pessoaauthor=M.+O.+Moraesauthor=J.+R.+Ferreiraauthor=F.+A.+Rodriguesauthor=M.+L.+Dos+Santos&title=Cytotoxic+profile+of+natural+and+some+modified+bufadienolides+from+toad+Rhinella+schneideri+parotoid+gland+secretion&doi=10.1016%2Fj.toxicon.2010.03.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2010.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2010.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DCunha-Filho%26aufirst%3DG.%2BA.%26aulast%3DResck%26aufirst%3DI.%2BS.%26aulast%3DCavalcanti%26aufirst%3DB.%2BC.%26aulast%3DPessoa%26aufirst%3DC.%2BO.%26aulast%3DMoraes%26aufirst%3DM.%2BO.%26aulast%3DFerreira%26aufirst%3DJ.%2BR.%26aulast%3DRodrigues%26aufirst%3DF.%2BA.%26aulast%3DDos%2BSantos%26aufirst%3DM.%2BL.%26atitle%3DCytotoxic%2520profile%2520of%2520natural%2520and%2520some%2520modified%2520bufadienolides%2520from%2520toad%2520Rhinella%2520schneideri%2520parotoid%2520gland%2520secretion%26jtitle%3DToxicon%26date%3D2010%26volume%3D56%26spage%3D339%26epage%3D348%26doi%3D10.1016%2Fj.toxicon.2010.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L. H.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships study of cytotoxic bufalin 3-nitrogen-containing-ester derivatives</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1016/j.steroids.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.steroids.2013.02.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=508-512&author=B.+Maauthor=Z.+Y.+Xiaoauthor=Y.+J.+Chenauthor=M.+Leiauthor=Y.+H.+Mengauthor=D.+A.+Guoauthor=X.+Liuauthor=L.+H.+Hu&title=Synthesis+and+structure-activity+relationships+study+of+cytotoxic+bufalin+3-nitrogen-containing-ester+derivatives&doi=10.1016%2Fj.steroids.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DY.%2BH.%26aulast%3DGuo%26aufirst%3DD.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%2BH.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520study%2520of%2520cytotoxic%2520bufalin%25203-nitrogen-containing-ester%2520derivatives%26jtitle%3DSteroids%26date%3D2013%26volume%3D78%26spage%3D508%26epage%3D512%26doi%3D10.1016%2Fj.steroids.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span> </span><span class="NLM_article-title">New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8947</span><span class="NLM_x">–</span> <span class="NLM_lpage">8955</span><span class="refDoi"> DOI: 10.1016/j.tet.2005.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.tet.2005.07.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=8947-8955&author=M.+Yeauthor=J.+Hanauthor=D.+Anauthor=G.+Tuauthor=D.+Guo&title=New+cytotoxic+bufadienolides+from+the+biotransformation+of+resibufogenin+by+Mucor+polymorphosporus&doi=10.1016%2Fj.tet.2005.07.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DD.%26aulast%3DTu%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DNew%2520cytotoxic%2520bufadienolides%2520from%2520the%2520biotransformation%2520of%2520resibufogenin%2520by%2520Mucor%2520polymorphosporus%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D8947%26epage%3D8955%26doi%3D10.1016%2Fj.tet.2005.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hayes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piggott, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capon, R. J.</span><span> </span><span class="NLM_article-title">Microbial biotransformation as a source of chemical diversity in cane toad steroid toxins</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1790</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.bmcl.2009.01.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1790-1792&author=R.+A.+Hayesauthor=A.+M.+Piggottauthor=K.+Dalleauthor=R.+J.+Capon&title=Microbial+biotransformation+as+a+source+of+chemical+diversity+in+cane+toad+steroid+toxins&doi=10.1016%2Fj.bmcl.2009.01.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.064%26sid%3Dliteratum%253Aachs%26aulast%3DHayes%26aufirst%3DR.%2BA.%26aulast%3DPiggott%26aufirst%3DA.%2BM.%26aulast%3DDalle%26aufirst%3DK.%26aulast%3DCapon%26aufirst%3DR.%2BJ.%26atitle%3DMicrobial%2520biotransformation%2520as%2520a%2520source%2520of%2520chemical%2520diversity%2520in%2520cane%2520toad%2520steroid%2520toxins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1790%26epage%3D1792%26doi%3D10.1016%2Fj.bmcl.2009.01.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span> </span><span class="NLM_article-title">Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2004.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.jsbmb.2004.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=15261311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVSqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=87-98&author=M.+Yeauthor=G.+Quauthor=H.+Guoauthor=D.+Guo&title=Novel+cytotoxic+bufadienolides+derived+from+bufalin+by+microbial+hydroxylation+and+their+structure-activity+relationships&doi=10.1016%2Fj.jsbmb.2004.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships</span></div><div class="casAuthors">Ye, Min; Qu, Guiqin; Guo, Hongzhu; Guo, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Microbial transformation was used to prep. novel cytotoxic bufadienolides.  Twelve products (3-14) were obtained from bufalin (1) by the fungus Mucor spinosus.  Their structures were elucidated by high-resoln. mass spectroscopy (HR-MS) and extensive NMR techniques, including 1H NMR, 13C NMR, DEPT, 1H-1H correlation spectroscopy (COSY), two dimensional nuclear Overhauser effect correlation spectroscopy (NOESY), heteronuclear multiple quantum coherence (HMQC), and heteronuclear multiple bond coherence (HMBC).  Compds. 3, 4, 9 and 11-14 are new mono- or dihydroxylated derivs. of bufalin with novel oxy-functionalities at C-1β, C-7β, C-11β, C-12β and C-16α positions.  The in vitro cytotoxic activities against human cancer cell lines of 3-14, together with 16 biotransformed products derived from cinobufagin (15-30) were detd. by the MTT method, and their structure-activity relationships (SAR) were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSGHkcJYCvgLVg90H21EOLACvtfcHk0li9CflrTOjCGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVSqs7s%253D&md5=57932cdcf2b9219963cf66d1cdf640a3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2004.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2004.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DNovel%2520cytotoxic%2520bufadienolides%2520derived%2520from%2520bufalin%2520by%2520microbial%2520hydroxylation%2520and%2520their%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D91%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.jsbmb.2004.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Engineering enzymatically activated "molecular grenades" for cancer</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span><span class="refDoi"> DOI: 10.18632/oncotarget.562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.18632%2Foncotarget.562" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=666-667&author=S.+R.+Denmeadeauthor=J.+T.+Isaacs&title=Engineering+enzymatically+activated+%22molecular+grenades%22+for+cancer&doi=10.18632%2Foncotarget.562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.562%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DEngineering%2520enzymatically%2520activated%2520%2522molecular%2520grenades%2522%2520for%2520cancer%26jtitle%3DOncotarget%26date%3D2012%26volume%3D3%26spage%3D666%26epage%3D667%26doi%3D10.18632%2Foncotarget.562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span><span class="refDoi"> DOI: 10.1073/pnas.87.18.7235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1073%2Fpnas.87.18.7235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=2402505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers&doi=10.1073%2Fpnas.87.18.7235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span></div><div class="casAuthors">Garin-Chesa, Pilar; Old, Lloyd J.; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7235-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The F19 antigen is a cell surface glycoprotein (mol. wt. 95,000) of human sarcomas and proliferating cultured fibroblasts that is absent from resting fibroblasts in normal adult tissues.  Normal and malignant epithelial cells are also F19-.  The present immunohistochem. study describes induction of F19 in the reactive mesenchyme of epithelial tumors.  F19+ fibroblasts were found in primary and metastatic carcinomas, including colorectal, breast, ovarian, bladder, and lung carcinomas.  The stroma of benign colorectal adenomas, fibrocystic disease, and fibroadenomas of breast, benign prostate hyperplasia, bladder carcinomas, and benign ovarian tumors showed no or only moderate nos. of F19+ fibroblasts.  Anal. of dermal incision wounds revealed that F19 was strongly induced during scar formation.  Comparison of F19 with the extracellular matrix protein tenascin, a putative marker of tumor mesenchyme, showed a cellular staining pattern for F19 vs. the extracellular matrix pattern for tenascin and widespread expression of tenascin in F19- normal tissues and benign tumors.  The F19+ phenotype may correlate with specialized fibroblast functions in wound healing and malignant tumor growth.  Because of its abundance in tumor mesenchyme, F19 may serve as a target for antibodies labeled with radioisotopes or toxic agents, or inflammatogenic antibodies, in carcinoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_KYVTgRj8LVg90H21EOLACvtfcHk0lhs5CiAS-hGkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D&md5=957bd13237f20c4f1e95a7a1b2204081</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.87.18.7235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.87.18.7235%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239%26doi%3D10.1073%2Fpnas.87.18.7235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Scanlan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Moncasi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">5657</span><span class="NLM_x">–</span> <span class="NLM_lpage">5661</span><span class="refDoi"> DOI: 10.1073/pnas.91.12.5657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1073%2Fpnas.91.12.5657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=7911242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADyaK2cXlsFajtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5657-5661&author=M.+J.+Scanlanauthor=B.+K.+Rajauthor=B.+Calvoauthor=P.+Garin-Chesaauthor=M.+P.+Sanz-Moncasiauthor=J.+H.+Healeyauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Molecular+cloning+of+fibroblast+activation+protein+alpha%2C+a+member+of+the+serine+protease+family+selectively+expressed+in+stromal+fibroblasts+of+epithelial+cancers&doi=10.1073%2Fpnas.91.12.5657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers</span></div><div class="casAuthors">Scanlan, Matthew J.; Raj, B. K. Mohan; Calvo, Benjamin; Garin-Chesa, Pilar; Sanz-Moncasi, M. Pilar; Healey, John H.; Old, Lloyd J.; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5657-61</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The human fibroblast activation protein α (FAPα) is a Mr 95,000 cell surface antigen selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas.  Normal adult tissues are generally FAPα-, but some fetal mesenchymal tissues transiently express the mol.  Because of its restricted normal tissue distribution and abundant expression in the stroma of over 90% of breast, colorectal, and lung carcinomas, FAPα is under clin. evaluation as a target for immunodetection and immunotherapy of epithelial cancers.  In the present study, the authors have isolated a full-length cDNA for FAPα through expression cloning in COS-1 cells.  The FAPα cDNA codes for a type II integral membrane protein with a large extracellular domain, transmembrane segment, and short cytoplasmic tail.  FAPα shows 48% amino acid sequence identity to the T-cell activation antigen CD26, a membrane-bound protein with dipeptidyl peptidase IV (DPPIV) activity; however, unlike FAPα, CD26 is widely expressed in normal tissues.  Three catalytic domains shared by DPPIV homologues in different species and by other serine proteases are conserved in FAPα.  Immunochem. anal. of COS-1 cells coexpressing FAPα and CD26 revealed that the two mols. form heteromeric cell surface complexes, suggesting that a previously identified FAPα-assocd. Mr 105,000 protein of cultured fibroblasts and growth factor-stimulated melanocytes, FAPβ, is identical to CD26.  In vivo coexpression of FAPα and CD26 is found in reactive fibroblasts of healing wounds but not in tumor stromal fibroblasts or sarcomas (FAPα+/CD26-).  The putative serine protease activity of FAPα and its in vivo induction pattern may indicate a role for this mol. in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_I5dna-9X1bVg90H21EOLACvtfcHk0lhs5CiAS-hGkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsFajtbg%253D&md5=c5597e9614f4c0bf3961a946d6980719</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.12.5657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.12.5657%26sid%3Dliteratum%253Aachs%26aulast%3DScanlan%26aufirst%3DM.%2BJ.%26aulast%3DRaj%26aufirst%3DB.%2BK.%26aulast%3DCalvo%26aufirst%3DB.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DSanz-Moncasi%26aufirst%3DM.%2BP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DMolecular%2520cloning%2520of%2520fibroblast%2520activation%2520protein%2520alpha%252C%2520a%2520member%2520of%2520the%2520serine%2520protease%2520family%2520selectively%2520expressed%2520in%2520stromal%2520fibroblasts%2520of%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D5657%26epage%3D5661%26doi%3D10.1073%2Fpnas.91.12.5657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissil, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pure, E.</span><span> </span><span class="NLM_article-title">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3613</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span><span class="refDoi"> DOI: 10.1172/JCI38988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1172%2FJCI38988" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3613-3625&author=A.+M.+Santosauthor=J.+Jungauthor=N.+Azizauthor=J.+L.+Kissilauthor=E.+Pure&title=Targeting+fibroblast+activation+protein+inhibits+tumor+stromagenesis+and+growth+in+mice&doi=10.1172%2FJCI38988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1172%2FJCI38988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38988%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKissil%26aufirst%3DJ.%2BL.%26aulast%3DPure%26aufirst%3DE.%26atitle%3DTargeting%2520fibroblast%2520activation%2520protein%2520inhibits%2520tumor%2520stromagenesis%2520and%2520growth%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3613%26epage%3D3625%26doi%3D10.1172%2FJCI38988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salakian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnands, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span> </span><span class="NLM_article-title">Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">19441</span><span class="NLM_x">–</span> <span class="NLM_lpage">19444</span><span class="refDoi"> DOI: 10.1074/jbc.C500092200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1074%2Fjbc.C500092200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19441-19444&author=K.+Aertgeertsauthor=I.+Levinauthor=L.+H.+Shiauthor=G.+P.+Snellauthor=A.+Jenningsauthor=G.+S.+Prasadauthor=Y.+M.+Zhangauthor=M.+L.+Krausauthor=S.+Salakianauthor=V.+Sridharauthor=R.+Wijnandsauthor=M.+G.+Tennant&title=Structural+and+kinetic+analysis+of+the+substrate+specificity+of+human+fibroblast+activation+protein+%CE%B1&doi=10.1074%2Fjbc.C500092200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C500092200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C500092200%26sid%3Dliteratum%253Aachs%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DLevin%26aufirst%3DI.%26aulast%3DShi%26aufirst%3DL.%2BH.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DSalakian%26aufirst%3DS.%26aulast%3DSridhar%26aufirst%3DV.%26aulast%3DWijnands%26aufirst%3DR.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26atitle%3DStructural%2520and%2520kinetic%2520analysis%2520of%2520the%2520substrate%2520specificity%2520of%2520human%2520fibroblast%2520activation%2520protein%2520%25CE%25B1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19441%26epage%3D19444%26doi%3D10.1074%2Fjbc.C500092200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netto, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span><span class="refDoi"> DOI: 10.1002/pros.22847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fpros.22847" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=1308-1319&author=W.+N.+Brennenauthor=D.+M.+Rosenauthor=A.+Chauxauthor=G.+J.+Nettoauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Pharmacokinetics+and+toxicology+of+a+fibroblast+activation+protein+%28FAP%29-activated+prodrug+in+murine+xenograft+models+of+human+cancer&doi=10.1002%2Fpros.22847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fpros.22847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22847%26sid%3Dliteratum%253Aachs%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DChaux%26aufirst%3DA.%26aulast%3DNetto%26aufirst%3DG.%2BJ.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DPharmacokinetics%2520and%2520toxicology%2520of%2520a%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529-activated%2520prodrug%2520in%2520murine%2520xenograft%2520models%2520of%2520human%2520cancer%26jtitle%3DProstate%26date%3D2014%26volume%3D74%26spage%3D1308%26epage%3D1319%26doi%3D10.1002%2Fpros.22847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Akinboye, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakare, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1002/pros.23162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fpros.23162" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=703-714&author=E.+S.+Akinboyeauthor=W.+N.+Brennenauthor=D.+M.+Rosenauthor=O.+Bakareauthor=S.+R.+Denmeade&title=Iterative+design+of+emetine-based+prodrug+targeting+fibroblast+activation+protein+%28FAP%29+and+dipeptidyl+peptidase+IV+DPPIV+using+a+tandem+enzymatic+activation+strategy&doi=10.1002%2Fpros.23162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fpros.23162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.23162%26sid%3Dliteratum%253Aachs%26aulast%3DAkinboye%26aufirst%3DE.%2BS.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DBakare%26aufirst%3DO.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DIterative%2520design%2520of%2520emetine-based%2520prodrug%2520targeting%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520dipeptidyl%2520peptidase%2520IV%2520DPPIV%2520using%2520a%2520tandem%2520enzymatic%2520activation%2520strategy%26jtitle%3DProstate%26date%3D2016%26volume%3D76%26spage%3D703%26epage%3D714%26doi%3D10.1002%2Fpros.23162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug</span> <span class="citation_source-journal">J. Natl. Cancer I.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1320</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1093/jnci/djs336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fjnci%2Fdjs336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=22911669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCqtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2012&pages=1320-1334&author=W.+N.+Brennenauthor=D.+M.+Rosenauthor=H.+Wangauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Targeting+carcinoma-associated+fibroblasts+within+the+tumor+stroma+with+a+fibroblast+activation+protein-activated+prodrug&doi=10.1093%2Fjnci%2Fdjs336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug</span></div><div class="casAuthors">Brennen, W. Nathaniel; Rosen, D. Marc; Wang, Hao; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1320-1334</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Fibroblasts undergo a morphol. transformation to a reactive phenotype in the tumor microenvironment characterized by the expression of proteins such as fibroblast activation protein (FAP), a post-prolyl endopeptidase with expression largely restricted to carcinoma-assocd. fibroblasts.  Thapsigargin (TG) is a highly toxic natural plant product that triggers a rise in intracellular calcium levels and apoptosis.  FAP is therefore a provocative target for the activation of prodrugs consisting of a FAP-specific peptide coupled to a potent cytotoxic analog of TG.  The efficacy of FAP-activated peptidyl-TG prodrugs was tested in vitro in cell proliferation assays and effects on intracellular calcium in human cancer cell lines.  The effects of FAP-activated prodrugs on tumor growth and host toxicity were tested in Balb-C nude MCF-7 and LNCaP xenograft mice (n = 9-11 per group).  P values were calcd. using permutation tests based on 50 000 permutations.  Mixed effects models were used to account for correlations among replicate measures.  All statistical tests were two-sided.  FAP-activated prodrugs killed human cancer cells at low nanomolar concns. (MCF-7 cells: IC50 = 3.5nM).  Amino acid-12ADT analogs from FAP-cleaved prodrugs, but not uncleaved prodrugs, produced a rapid rise in intracellular calcium within minutes of exposure.  Immunohistochem. anal. of xenografts exposed to FAP-prodrugs documented stromal-selective cell death of fibroblasts, pericytes, and endothelial cells of sufficient magnitude to inhibit growth of MCF-7 and LNCaP xenografts with minimal systemic toxicity, whereas non-FAP cleavable prodrugs were inactive.  MCF-7 and LNCaP xenografts treated with a FAP-activated prodrug had maximal treated-to-control tumor vol. ratios of 0.36 (treated: mean = 0.206mm3, 95% CI = 0.068 to 0.344mm3; control: mean = 0.580mm3, 95% CI = 0.267 to 0.893mm3) and 0.24 (treated: mean = 0.131mm3, 95% CI = 0.09 to 0.180mm3; control: mean = 0.543mm3, 95% CI = 0.173 to 0.913mm3), resp., on day 21 after therapy.  This study validates the proteolytic activity of FAP as a target for the activation of a systemically delivered cytotoxic prodrug and demonstrates that targeted killing of cells within the stromal compartment of the tumor microenvironment can produce a therapeutic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8_szDQo-aLVg90H21EOLACvtfcHk0lihUSfoDKg1Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCqtr7L&md5=5e2568f8d80d92daa0f8902adfe6d557</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjs336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjs336%26sid%3Dliteratum%253Aachs%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DRosen%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DTargeting%2520carcinoma-associated%2520fibroblasts%2520within%2520the%2520tumor%2520stroma%2520with%2520a%2520fibroblast%2520activation%2520protein-activated%2520prodrug%26jtitle%3DJ.%2520Natl.%2520Cancer%2520I.%26date%3D2012%26volume%3D104%26spage%3D1320%26epage%3D1334%26doi%3D10.1093%2Fjnci%2Fdjs336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1378</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-1170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1158%2F1535-7163.MCT-08-1170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=19417147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jslGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1378-1386&author=A.+M.+LeBeauauthor=W.+N.+Brennenauthor=S.+Aggarwalauthor=S.+R.+Denmeade&title=Targeting+the+cancer+stroma+with+a+fibroblast+activation+protein-activated+promelittin+protoxin&doi=10.1158%2F1535-7163.MCT-08-1170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin</span></div><div class="casAuthors">LeBeau Aaron M; Brennen W Nathaniel; Aggarwal Saurabh; Denmeade Samuel R</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1378-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fibroblast-Activation Protein-α (FAP) is a membrane-bound serine protease that is expressed on the surface of reactive stromal fibroblasts present within the majority of human epithelial tumors but is not expressed by normal tissues.  FAP is a postprolyl peptidase that differs from other dipeptidyl prolyl peptidases such as diprolylpeptidase 4 in that it also has gelatinase and collagenase endopeptidase activity.  Therefore, FAP represents a potential pan-tumor target whose enzymatic activity can be exploited for the intratumoral activation of prodrugs and protoxins.  To evaluate FAP as a tumor-specific target, putative FAP-selective peptide protoxins were constructed through modification of the prodomain of melittin, a 26 amino acid amphipathic cytolytic peptide that is the main toxic component in the venom of the common European honeybee Apis milefera.  Melittin is synthesized as promelittin, containing a 22 amino acid NH(2)-terminal prodomain rich in the amino acids proline and alanine.  In this study, peptides containing truncated melittin prodomain sequences were tested on erythrocytes to determine the optimal prodomain length for inhibiting cytolytic activity.  Once optimized, modified promelittin peptides were generated in which previously identified FAP substrate sequences were introduced into the prodomain.  Peptide protoxins were identified that were efficiently activated by FAP and selectively toxic to FAP-expressing cell lines with an IC(50) value in the low micromolar range that is similar to melittin.  Intratumoral injection of an FAP-activated protoxin produced significant lysis and growth inhibition of human breast and prostate cancer xenografts with minimal toxicity to the host animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSU7D_2lNRo3L5XHngOXiV_fW6udTcc2eZ1CfxJrKcULrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jslGiuw%253D%253D&md5=3f5a2d4bc4a6632784309d09ea3c39b7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1170%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DTargeting%2520the%2520cancer%2520stroma%2520with%2520a%2520fibroblast%2520activation%2520protein-activated%2520promelittin%2520protoxin%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1378%26epage%3D1386%26doi%3D10.1158%2F1535-7163.MCT-08-1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span> </span><span class="NLM_article-title">Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.bcp.2012.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=22305746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Olu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1251-1260&author=M.+Liauthor=S.+Wuauthor=Z.+Liuauthor=W.+Zhangauthor=J.+Xuauthor=Y.+Wangauthor=J.+Liuauthor=D.+Zhangauthor=H.+Tianauthor=Y.+Liauthor=W.+Ye&title=Arenobufagin%2C+a+bufadienolide+compound+from+toad+venom%2C+inhibits+VEGF-mediated+angiogenesis+through+suppression+of+VEGFR-2+signaling+pathway&doi=10.1016%2Fj.bcp.2012.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway</span></div><div class="casAuthors">Li, Manmei; Wu, Shuai; Liu, Zhong; Zhang, Wei; Xu, Jing; Wang, Ying; Liu, Junshan; Zhang, Dongmei; Tian, Haiyan; Li, Yaolan; Ye, Wencai</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1251-1260</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Angiogenesis is crucial for carcinogenesis and other angiogenic processes.  Arenobufagin, one of the major components of toad venom, is a traditional Chinese medicine used for cancer therapy.  It inhibits cell growth in several cancer cell lines.  However, little is known about arenobufagin's anti-angiogenic activity.  In this study, we showed that arenobufagin inhibited vascular endothelial growth factor (VEGF)-induced viability, migration, invasion and tube formation in human umbilical vein endothelial cells (HUVECs) in vitro.  Arenobufagin also suppressed sprouting formation from VEGF-treated aortic rings in an ex vivo model.  Furthermore, we found that arenobufagin blocked angiogenesis in a matrigel plugs assay.  Computer simulations suggested that arenobufagin interacted with the ATP-binding sites of VEGFR-2 by docking.  In addn., arenobufagin inhibited VEGF-induced VEGFR-2 auto-phosphorylation and suppressed the activity of VEGFR-2-mediated signaling cascades.  Taken together, our findings demonstrate that arenobufagin is a specific inhibitor of VEGF-mediated angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzhWOnk2ZnP7Vg90H21EOLACvtfcHk0lhFSwhNKefGJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Olu7Y%253D&md5=27ce325f99dfad8e9432c9f39bed29ba</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DArenobufagin%252C%2520a%2520bufadienolide%2520compound%2520from%2520toad%2520venom%252C%2520inhibits%2520VEGF-mediated%2520angiogenesis%2520through%2520suppression%2520of%2520VEGFR-2%2520signaling%2520pathway%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1251%26epage%3D1260%26doi%3D10.1016%2Fj.bcp.2012.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span><span class="refDoi"> DOI: 10.1016/j.febslet.2006.01.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1016%2Fj.febslet.2006.01.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=1581-1586&author=C.+Y.+Edosadaauthor=C.+Quanauthor=T.+Tranauthor=V.+Phamauthor=C.+Wiesmannauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Peptide+substrate+profiling+defines+fibroblast+activation+protein+as+an+endopeptidase+of+strict+Gly%282%29-Pro%281%29-cleaving+specificity&doi=10.1016%2Fj.febslet.2006.01.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2006.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2006.01.087%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DPeptide%2520substrate%2520profiling%2520defines%2520fibroblast%2520activation%2520protein%2520as%2520an%2520endopeptidase%2520of%2520strict%2520Gly%25282%2529-Pro%25281%2529-cleaving%2520specificity%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D1581%26epage%3D1586%26doi%3D10.1016%2Fj.febslet.2006.01.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1093/jb/mvr017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fjb%2Fmvr017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=21288888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVaqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2011&pages=685-692&author=C.+H.+Huangauthor=C.+S.+Suenauthor=C.+T.+Linauthor=C.+H.+Chienauthor=H.+Y.+Leeauthor=K.+M.+Chungauthor=T.+Y.+Tsaiauthor=W.+T.+Jiaangauthor=M.+J.+Hwangauthor=X.+Chen&title=Cleavage-site+specificity+of+prolyl+endopeptidase+FAP+investigated+with+a+full-length+protein+substrate&doi=10.1093%2Fjb%2Fmvr017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate</span></div><div class="casAuthors">Huang, Chih-Hsiang; Suen, Ching-Shu; Lin, Ching-Ting; Chien, Chia-Hui; Lee, Hsin-Ying; Chung, Kuei-Min; Tsai, Ting-Yueh; Jiaang, Weir-Tong; Hwang, Ming-Jing; Chen, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAP) is a prolyl-cleaving endopeptidase proposed as an anti-cancer drug target.  It is necessary to define its cleavage-site specificity to facilitate the identification of its in vivo substrates and to understand its biol. functions.  We found that the previously identified substrate of FAP, α2-anti-plasmin (α2-AP), is not a robust substrate in vitro.  Instead, an intracellular protein, SPRY2, is cleavable by FAP and more suitable for investigation of its substrate specificity in the context of the full-length globular protein.  FAP prefers uncharged residues, including small or bulky hydrophobic amino acids, but not charged amino acids, esp. acidic residue at P1', P3 and P4 sites.  Mol. modeling anal. shows that the substrate-binding site of FAP is surrounded by multiple tyrosine residues and some neg. charged residues, which may exhibit a low preference for substrates with acidic residues.  This provides an explanation why FAP cannot cleave interleukins, which have a glutamate at either P4 or P2', despite their P3-P2-P1 sites being identical to SPRY2 or α-AP.  Our study provided new information on FAP cleavage-site specificity, which differs from the data obtained by profiling with a peptide library or with the denatured protein, gelatin, as the substrate.  Furthermore, our study suggests that neg. charged residues should be avoided when designing FAP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRyKb4ZKvcxLVg90H21EOLACvtfcHk0ljSyrngNrsWpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVaqsrk%253D&md5=e0abef970e8f795da1acd48d2dee6a43</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvr017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvr017%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DSuen%26aufirst%3DC.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BT.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DChung%26aufirst%3DK.%2BM.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26aulast%3DHwang%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DCleavage-site%2520specificity%2520of%2520prolyl%2520endopeptidase%2520FAP%2520investigated%2520with%2520a%2520full-length%2520protein%2520substrate%26jtitle%3DJ.%2520Biochem.%26date%3D2011%26volume%3D149%26spage%3D685%26epage%3D692%26doi%3D10.1093%2Fjb%2Fmvr017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5158</span><span class="refDoi"> DOI: 10.1021/bi900257m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900257m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtF2rsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5149-5158&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=S.+Terzyanauthor=V.+J.+Christiansenauthor=P.+A.+McKee&title=Using+substrate+specificity+of+antiplasmin-cleaving+enzyme+for+fibroblast+activation+protein+inhibitor+design&doi=10.1021%2Fbi900257m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Using Substrate Specificity of Antiplasmin-Cleaving Enzyme for Fibroblast Activation Protein Inhibitor Design</span></div><div class="casAuthors">Lee, Kyung N.; Jackson, Kenneth W.; Terzyan, Simon; Christiansen, Victoria J.; McKee, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5149-5158</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Circulating antiplasmin-cleaving enzyme (APCE), a prolyl-specific serine proteinase, is essentially identical to membrane-inserted fibroblast activation protein (FAP) that is transiently expressed during epithelial-derived cancer growth.  Human precursive α2-antiplasmin (Met-α2AP), the only known physiol. substrate for APCE, is cleaved N-terminally to Asn-α2AP that is rapidly crosslinked to fibrin and protects it from digestion by plasmin.  Identifying a specific inhibitor of APCE/FAP continues to be intensely pursued.  Recombinant FAP cleavage of peptide libraries of short amino acid sequences surrounding the scissile bond, -Pro12-Asn13-, indicated that P2 Gly and P1 Pro are required, just as we found for APCE.  We examd. cleavage of P4-P4' peptides, using 19 amino acid substitutions at each position and selected ones in P8-P5.  Km values detd. for peptide substrates showed that P7 Arg has the highest affinity for APCE.  Peptide cleavage rate increased with Arg in P6 rather than P5 or native P7.  Placing Arg in P4 or P8 reduced cleavage rates dramatically.  Cleavage of substrates with extended peptide sequences before or after the scissile bond showed endopeptidase to be superior to dipeptidase activity for APCE.  A substrate analog inhibitor, Phe-Arg-(8-amino-3,6-dioxaoctanoic acid)-Gly-[r]-fluoropyrrolidide, inhibited APCE with a Ki of 54 μM but not dipeptidyl peptidase IV even at 2 mM.  The inhibitor also blocked cleavage of Met-α2AP with an IC50 of 91 μM.  Replacing Arg with Gly at the same distance from fluoropyrrolidide as P7 Arg is from P1 Pro reduced its inhibition of APCE ∼10-fold.  Results indicate that Arg at P5, P6, or P7 distances from P1 enhances affinity and efficiency of substrates or inhibitors toward APCE or FAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFclagXGtiPLVg90H21EOLACvtfcHk0ljSyrngNrsWpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtF2rsbg%253D&md5=2e9f547f3a5fcf510b0d8f2863958426</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi900257m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900257m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DUsing%2520substrate%2520specificity%2520of%2520antiplasmin-cleaving%2520enzyme%2520for%2520fibroblast%2520activation%2520protein%2520inhibitor%2520design%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D5149%26epage%3D5158%26doi%3D10.1021%2Fbi900257m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hutzler, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, T. S.</span><span> </span><span class="NLM_article-title">Atypical kinetic profiles in drug metabolism reactions</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1124/dmd.30.4.355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1124%2Fdmd.30.4.355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=11901086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Ols7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=355-362&author=J.+M.+Hutzlerauthor=T.+S.+Tracy&title=Atypical+kinetic+profiles+in+drug+metabolism+reactions&doi=10.1124%2Fdmd.30.4.355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical kinetic profiles in drug metabolism reactions</span></div><div class="casAuthors">Hutzler, J. Matthew; Tracy, Timothy S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-362</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The cytochrome P 450 enzymes are involved in the biotransformation of both xenobiotic and endobiotic hydrophobic compds., implicated in the bioactivation of certain procarcinogens (e.g., benzo[a]pyrene), and responsible for many metab.-based drug-drug interactions.  Consequently, the goal of drug metab. and toxicol. labs is to not only to det. the P 450 isoform contribution to the metab. of a given compd. but also to understand the various factors that effect the activity and behavior of these isoforms.  Classically, metab. of a particular compd. is described kinetically using the Michaelis-Menten equation, which yields a hyperbolic rate profile and ests. of maximal reaction velocity (Vmax) and apparent Km.  It is evident, however, that for some drugs the kinetic profile is better described by a non-Michaelis-Menten or atypical kinetic model.  Atypical kinetic profiles are proposed to fall into five categories, i.e., activation, autoactivation, substrate inhibition, partial inhibition, and biphasic metab.  Each of these categories is described with some specific examples.  The implications of atypical kinetics with respect to in vitro-in vivo correlations are discussed, as well as artifactual sources of atypical kinetic profiles and in vivo observations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOBfZ77w9Wu7Vg90H21EOLACvtfcHk0lhvsacdYKplTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Ols7s%253D&md5=b98944bf901e233b623303c6d09fae15</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.4.355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.4.355%26sid%3Dliteratum%253Aachs%26aulast%3DHutzler%26aufirst%3DJ.%2BM.%26aulast%3DTracy%26aufirst%3DT.%2BS.%26atitle%3DAtypical%2520kinetic%2520profiles%2520in%2520drug%2520metabolism%2520reactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D355%26epage%3D362%26doi%3D10.1124%2Fdmd.30.4.355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kole, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topaloglu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span><span class="refDoi"> DOI: 10.1021/bi701921b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi701921b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1076-1086&author=S.+Aggarwalauthor=W.+N.+Brennenauthor=T.+P.+Koleauthor=E.+Schneiderauthor=O.+Topalogluauthor=M.+Yatesauthor=R.+J.+Cotterauthor=S.+R.+Denmeade&title=Fibroblast+activation+protein+peptide+substrates+identified+from+human+collagen+I+derived+gelatin+cleavage+sites&doi=10.1021%2Fbi701921b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi701921b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701921b%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DKole%26aufirst%3DT.%2BP.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DTopaloglu%26aufirst%3DO.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DFibroblast%2520activation%2520protein%2520peptide%2520substrates%2520identified%2520from%2520human%2520collagen%2520I%2520derived%2520gelatin%2520cleavage%2520sites%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D1076%26epage%3D1086%26doi%3D10.1021%2Fbi701921b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Fricker, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastreich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Automated drawing of structural molecular formulas under constraints</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1078</span><span class="refDoi"> DOI: 10.1021/ci049958u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci049958u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVyrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=1065-1078&author=P.+C.+Frickerauthor=M.+Gastreichauthor=M.+Rarey&title=Automated+drawing+of+structural+molecular+formulas+under+constraints&doi=10.1021%2Fci049958u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Automated Drawing of Structural Molecular Formulas under Constraints</span></div><div class="casAuthors">Fricker, Patrick C.; Gastreich, Marcus; Rarey, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1065-1078</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present a new algorithm for automated drawing of 2D structural formulas of mols.  The algorithm is based on the classical scheme of a drawing queue placing the mol. fragments in a sequential way.  We extend the concept of so-called prefabricated units developed for complex ring systems to automatically created drawing units for chains and rings which will then be assembled in a sequential fashion.  The approach is fast and can be naturally extended to the problem of drawing mols. with common core structures.  Further on, we present an algorithm that allows the drawing of 2D structural formulas under directional constraints assigned to a subset of bonds.  Since no numerical optimization is necessary, the algorithm creates drawings of small org. mols. on the order of 500 structures per s.  The new algorithm is relevant for all kinds of prediction and anal. software presenting a large no. of probably similar mol. structures to the user of the software.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgX0puSSdKbVg90H21EOLACvtfcHk0lia89xn9i6K0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVyrtLk%253D&md5=79d40a22b8fe66858694a695d69a5da5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fci049958u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci049958u%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DP.%2BC.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DAutomated%2520drawing%2520of%2520structural%2520molecular%2520formulas%2520under%2520constraints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2004%26volume%3D44%26spage%3D1065%26epage%3D1078%26doi%3D10.1021%2Fci049958u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Stierand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">From modeling to medicinal chemistry: automatic generation of two-dimensional complex diagrams</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1002/cmdc.200700010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1002%2Fcmdc.200700010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=853-860&author=K.+Stierandauthor=M.+Rarey&title=From+modeling+to+medicinal+chemistry%3A+automatic+generation+of+two-dimensional+complex+diagrams&doi=10.1002%2Fcmdc.200700010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700010%26sid%3Dliteratum%253Aachs%26aulast%3DStierand%26aufirst%3DK.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DFrom%2520modeling%2520to%2520medicinal%2520chemistry%253A%2520automatic%2520generation%2520of%2520two-dimensional%2520complex%2520diagrams%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D853%26epage%3D860%26doi%3D10.1002%2Fcmdc.200700010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Stierand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maass, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Molecular complexes at a glance: automated generation of two-dimensional complex diagrams</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1710</span><span class="NLM_x">–</span> <span class="NLM_lpage">1716</span><span class="refDoi"> DOI: 10.1093/bioinformatics/btl150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1093%2Fbioinformatics%2Fbtl150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=1710-1716&author=K.+Stierandauthor=P.+C.+Maassauthor=M.+Rarey&title=Molecular+complexes+at+a+glance%3A+automated+generation+of+two-dimensional+complex+diagrams&doi=10.1093%2Fbioinformatics%2Fbtl150"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtl150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtl150%26sid%3Dliteratum%253Aachs%26aulast%3DStierand%26aufirst%3DK.%26aulast%3DMaass%26aufirst%3DP.%2BC.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DMolecular%2520complexes%2520at%2520a%2520glance%253A%2520automated%2520generation%2520of%2520two-dimensional%2520complex%2520diagrams%26jtitle%3DBioinformatics%26date%3D2006%26volume%3D22%26spage%3D1710%26epage%3D1716%26doi%3D10.1093%2Fbioinformatics%2Fbtl150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Stierand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Drawing the PDB: protein-ligand complexes in two dimensions</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1021/ml100164p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100164p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=540-545&author=K.+Stierandauthor=M.+Rarey&title=Drawing+the+PDB%3A+protein-ligand+complexes+in+two+dimensions&doi=10.1021%2Fml100164p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Drawing the PCB: Protein-Ligand Complexes in Two Dimensions</span></div><div class="casAuthors">Stierand, Katrin; Rarey, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">540-545</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two-dimensional representation of mols. is a popular communication medium in chem. and the assocd. scientific fields.  Computational methods for drawing small mols. with and without manual investigation are well-established and widely spread in terms of numerous software tools.  Concerning the planar depiction of mol. complexes, there is considerably less choice.  We developed the software PoseView, which automatically generates two-dimensional diagrams of macromol. complexes, showing the ligand, the interactions, and the interacting residues.  All depicted mols. are drawn on an at. level as structure diagrams; thus, the output plots are clearly structured and easily readable for the scientist.  We tested the performance of PoseView in a large-scale application on nearly all drug-like complexes of the PDB (approx. 200000 complexes); for more than 92% of the complexes considered for drawing, a layout could be computed.  In the following, we will present the results of this application study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG4AYcqSlSGbVg90H21EOLACvtfcHk0ljbiHK2LUdP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtr3M&md5=bb61ee7c42e86e5a931b370255a894a7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fml100164p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100164p%26sid%3Dliteratum%253Aachs%26aulast%3DStierand%26aufirst%3DK.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DDrawing%2520the%2520PDB%253A%2520protein-ligand%2520complexes%2520in%2520two%2520dimensions%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D540%26epage%3D545%26doi%3D10.1021%2Fml100164p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Tran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnasamy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Restifo, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. A.</span><span> </span><span class="NLM_article-title">Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span><span class="refDoi"> DOI: 10.1084/jem.20130110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1084%2Fjem.20130110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=1125-1135&author=E.+Tranauthor=D.+Chinnasamyauthor=Z.+Yuauthor=R.+A.+Morganauthor=C.+C.+Leeauthor=N.+P.+Restifoauthor=S.+A.+Rosenberg&title=Immune+targeting+of+fibroblast+activation+protein+triggers+recognition+of+multipotent+bone+marrow+stromal+cells+and+cachexia&doi=10.1084%2Fjem.20130110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1084%2Fjem.20130110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20130110%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DE.%26aulast%3DChinnasamy%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DMorgan%26aufirst%3DR.%2BA.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26aulast%3DRosenberg%26aufirst%3DS.%2BA.%26atitle%3DImmune%2520targeting%2520of%2520fibroblast%2520activation%2520protein%2520triggers%2520recognition%2520of%2520multipotent%2520bone%2520marrow%2520stromal%2520cells%2520and%2520cachexia%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D1125%26epage%3D1135%26doi%3D10.1084%2Fjem.20130110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2008.07241.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1111%2Fj.1365-2141.2008.07241.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=18510677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2008&pages=827-830&author=S.+Baeauthor=C.+W.+Parkauthor=H.+K.+Sonauthor=H.+K.+Juauthor=D.+Paikauthor=C.+J.+Jeonauthor=G.+Y.+Kohauthor=J.+Kimauthor=H.+Kim&title=Fibroblast+activation+protein+alpha+identifies+mesenchymal+stromal+cells+from+human+bone+marrow&doi=10.1111%2Fj.1365-2141.2008.07241.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow</span></div><div class="casAuthors">Bae, Sohyun; Park, Chae Woon; Son, Hye Kyung; Ju, Hye Kyung; Paik, Donggi; Jeon, Choon-Ju; Koh, Gou Young; Kim, Jaeseob; Kim, Hoeon</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mesenchymal stromal cells (MSCs) have gained widespread popularity in cell therapy, but their development into clin. products has been impeded by the scarcity of cell-specific markers.  We previously explored transcriptome and membrane proteome of MSCs, from which fibroblast activation protein α (FAP) was recognized as a prime surface marker candidate.  The present study showed that FAP was constitutively expressed on MSCs, but not on other cells.  FAP immunoselection yielded homogeneous MSCs from cryopreserved bone marrow (BM).  These results suggest that FAP serves as a surface protein marker that can singly define MSCs from BM and possibly from other sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomL8KTuYNoSrVg90H21EOLACvtfcHk0ljfshFL457_BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK&md5=9df43578ca2dba65fe288a3e48c2e5ba</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2008.07241.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2008.07241.x%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%2BW.%26aulast%3DSon%26aufirst%3DH.%2BK.%26aulast%3DJu%26aufirst%3DH.%2BK.%26aulast%3DPaik%26aufirst%3DD.%26aulast%3DJeon%26aufirst%3DC.%2BJ.%26aulast%3DKoh%26aufirst%3DG.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520identifies%2520mesenchymal%2520stromal%2520cells%2520from%2520human%2520bone%2520marrow%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D142%26spage%3D827%26epage%3D830%26doi%3D10.1111%2Fj.1365-2141.2008.07241.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3783</span><span class="NLM_x">–</span> <span class="NLM_lpage">3788</span><span class="refDoi"> DOI: 10.1182/blood-2003-12-4240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1182%2Fblood-2003-12-4240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=3783-3788&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=K.+H.+Chungauthor=P.+A.+McKee&title=A+novel+plasma+proteinase+potentiates+alpha2-antiplasmin+inhibition+of+fibrin+digestion&doi=10.1182%2Fblood-2003-12-4240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-12-4240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-12-4240%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DChung%26aufirst%3DK.%2BH.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520plasma%2520proteinase%2520potentiates%2520alpha2-antiplasmin%2520inhibition%2520of%2520fibrin%2520digestion%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D3783%26epage%3D3788%26doi%3D10.1182%2Fblood-2003-12-4240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span><span class="refDoi"> DOI: 10.1182/blood-2005-08-3452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1182%2Fblood-2005-08-3452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=1397-1404&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=C.+S.+Leeauthor=J.+G.+Chunauthor=P.+A.+McKee&title=Antiplasmin-cleaving+enzyme+is+a+soluble+form+of+fibroblast+activation+protein&doi=10.1182%2Fblood-2005-08-3452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-08-3452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-08-3452%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChun%26aufirst%3DJ.%2BG.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DAntiplasmin-cleaving%2520enzyme%2520is%2520a%2520soluble%2520form%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D1397%26epage%3D1404%26doi%3D10.1182%2Fblood-2005-08-3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Jia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span> </span><span class="NLM_article-title">FAP-alpha (Fibroblast activation protein-alpha) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway</span> <span class="citation_source-journal">BMC Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/1471-2121-15-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.1186%2F1471-2121-15-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=24885257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=16&author=J.+Jiaauthor=T.+A.+Martinauthor=L.+Yeauthor=W.+G.+Jiang&title=FAP-alpha+%28Fibroblast+activation+protein-alpha%29+is+involved+in+the+control+of+human+breast+cancer+cell+line+growth+and+motility+via+the+FAK+pathway&doi=10.1186%2F1471-2121-15-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway</span></div><div class="casAuthors">Jia, Jun; Martin, Tracey Amanda; Ye, Lin; Jiang, Wen Guo</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">BCBMAY</span>;
        ISSN:<span class="NLM_cas:issn">1471-2121</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Fibroblast Activation Protein alpha (FAP-α) or seprase is an integral membrane serine peptidase.  Previous work has not satisfactorily explained both the suppression and promotion effects that have been obsd. in cancer.  The purpose of this work was to investigate the role of FAP-α in human breast cancer.  Expression of FAP-α was characterized in primary tumor samples and in cell lines, along with the effects of FAP-α expression on in vitro growth, invasion, attachment and migration.  Furthermore the potential interaction of FAP-α with other signalling pathways was investigated.  Results: FAP-α was significantly increased in patients with poor outcome and survival.  In vitro results showed that breast cancer cells over expressing FAP-α had increased growth ability and impaired migratory ability.  The growth of MDA-MB-231 cells and the adhesion and invasion ability of both MCF-7 cells and MDA-MB-231 cells were not dramatically influenced by FAP-α expression.  Over-expression of FAP-α resulted in a redn. of phosphorylated focal adhesion kinase (FAK) level in both cells cultured in normal media and serum-free media.  An inhibitor to FAK restored the reduced motility ability of both MCF-7exp cells and MDA-MB-231exp cells and prevented the change in phosphorylated FAK levels.  However, inhibitors to PI3K, ERK, PLCY, NWASP, ARP2/3, and ROCK had no influence this.  Conclusions: FAP-α in significantly assocd. with poor outcome in patients with breast cancer.  In vitro, FAP-α promotes proliferation and inhibits migration of breast cancer cells, potentially by regulating the FAK pathway.  These results suggest FAP-α could be a target for future therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0YeU4O0xHbVg90H21EOLACvtfcHk0lipIRlL948aYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFSisr8%253D&md5=efeaff2ac55fdf9b14eace3fb29920e3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1186%2F1471-2121-15-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2121-15-16%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DT.%2BA.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DFAP-alpha%2520%2528Fibroblast%2520activation%2520protein-alpha%2529%2520is%2520involved%2520in%2520the%2520control%2520of%2520human%2520breast%2520cancer%2520cell%2520line%2520growth%2520and%2520motility%2520via%2520the%2520FAK%2520pathway%26jtitle%3DBMC%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D16%26doi%3D10.1186%2F1471-2121-15-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span> </span><span class="NLM_article-title">Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5734</span><span class="NLM_x">–</span> <span class="NLM_lpage">5743</span><span class="refDoi"> DOI: 10.1021/jm400881m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400881m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5734-5743&author=J.+Liuauthor=D.+Zhangauthor=Y.+Liauthor=W.+Chenauthor=Z.+Ruanauthor=L.+Dengauthor=L.+Wangauthor=H.+Tianauthor=A.+Yiuauthor=C.+Fanauthor=H.+Luoauthor=S.+Liuauthor=Y.+Wangauthor=G.+Xiaoauthor=L.+Chenauthor=W.+Ye&title=Discovery+of+bufadienolides+as+a+novel+class+of+ClC-3+chloride+channel+activators+with+antitumor+activities&doi=10.1021%2Fjm400881m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm400881m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400881m%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DYiu%26aufirst%3DA.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520bufadienolides%2520as%2520a%2520novel%2520class%2520of%2520ClC-3%2520chloride%2520channel%2520activators%2520with%2520antitumor%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5734%26epage%3D5743%26doi%3D10.1021%2Fjm400881m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Zhou, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P. Q.</span><span> </span><span class="NLM_article-title">Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats</span> <span class="citation_source-journal">J. Poteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2908</span><span class="refDoi"> DOI: 10.1021/pr050456l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr050456l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyrsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2901-2908&author=S.+G.+Zhouauthor=S.+F.+Zhouauthor=H.+Q.+Huangauthor=J.+W.+Chenauthor=M.+Huangauthor=P.+Q.+Liu&title=Proteomic+analysis+of+hypertrophied+myocardial+protein+patterns+in+renovascularly+hypertensive+and+spontaneously+hypertensive+rats&doi=10.1021%2Fpr050456l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic Analysis of Hypertrophied Myocardial Protein Patterns in Renovascularly Hypertensive and Spontaneously Hypertensive Rats</span></div><div class="casAuthors">Zhou, Si-Gui; Zhou, Shu-Feng; Huang, He-Qing; Chen, Jian-Wen; Huang, Min; Liu, Pei-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2901-2908</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cardiac protein profiles of spontaneously hypertensive and renovascularly hypertensive hypertrophy showed a significant alteration compared with normal hearts.  Most proteins with significant modulations in their expressions belong to the category of metabolic and stress-related proteins.  Among these proteins, glutathione-S-transferase mu2 and short-chain acyl-CoA dehydrogenase may be two candidate proteins assocd. with left ventricular hypertrophy in spontaneously hypertensive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxVJ6ioM5x1rVg90H21EOLACvtfcHk0li2q4d8jQUKBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyrsbbL&md5=f5ceb1c46fb3190a26bfdff83c1bde7c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fpr050456l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr050456l%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%2BG.%26aulast%3DZhou%26aufirst%3DS.%2BF.%26aulast%3DHuang%26aufirst%3DH.%2BQ.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DP.%2BQ.%26atitle%3DProteomic%2520analysis%2520of%2520hypertrophied%2520myocardial%2520protein%2520patterns%2520in%2520renovascularly%2520hypertensive%2520and%2520spontaneously%2520hypertensive%2520rats%26jtitle%3DJ.%2520Poteome%2520Res.%26date%3D2006%26volume%3D5%26spage%3D2901%26epage%3D2908%26doi%3D10.1021%2Fpr050456l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yu, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span> </span><span class="NLM_article-title">Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of egf receptor in vitro and in vivo</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">32990</span><span class="NLM_x">–</span> <span class="NLM_lpage">33003</span><span class="refDoi"> DOI: 10.18632/oncotarget.8843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;key=10.18632%2Foncotarget.8843" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=32990-33003&author=X.+W.+Yuauthor=S.+Linauthor=H.+Z.+Duauthor=R.+P.+Zhaoauthor=S.+Y.+Fengauthor=B.+Y.+Yuauthor=L.+Y.+Zhangauthor=R.+M.+Liauthor=C.+M.+Qianauthor=X.+J.+Luoauthor=S.+T.+Yuanauthor=L.+Sun&title=Synergistic+combination+of+DT-13+and+topotecan+inhibits+human+gastric+cancer+via+myosin+IIA-induced+endocytosis+of+egf+receptor+in+vitro+and+in+vivo&doi=10.18632%2Foncotarget.8843"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8843%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%2BW.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DH.%2BZ.%26aulast%3DZhao%26aufirst%3DR.%2BP.%26aulast%3DFeng%26aufirst%3DS.%2BY.%26aulast%3DYu%26aufirst%3DB.%2BY.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DR.%2BM.%26aulast%3DQian%26aufirst%3DC.%2BM.%26aulast%3DLuo%26aufirst%3DX.%2BJ.%26aulast%3DYuan%26aufirst%3DS.%2BT.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DSynergistic%2520combination%2520of%2520DT-13%2520and%2520topotecan%2520inhibits%2520human%2520gastric%2520cancer%2520via%2520myosin%2520IIA-induced%2520endocytosis%2520of%2520egf%2520receptor%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D32990%26epage%3D33003%26doi%3D10.18632%2Foncotarget.8843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68','PDB','1Z68'); return false;">PDB: 1Z68</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01755">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_12017"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01755">10.1021/acs.jmedchem.6b01755</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">(1) General methods, (2) additional experimental results, (3) <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and ESI-MS spectra of all compounds, and (4) HPLC data of <b>2a</b>–<b>h</b> and <b>3a</b>–<b>h</b> used in biological assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_001.pdf">jm6b01755_si_001.pdf (11.63 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01755/suppl_file/jm6b01755_si_002.csv">jm6b01755_si_002.csv (3.81 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01755&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01755%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01755" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998cd33a333ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
